Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

The Word Brain 2015Free PDF | Print
A short guide to fast language learning

Free Abstracts

  Nuclear Medicine

  Free Subscription


Articles published in J Nucl Med

Retrieve available abstracts of 1037 articles:
HTML format
Text format



Single Articles


    March 2015
  1. JAMAR F, Lhommel R
    Interim 18F-FDG-PET in diffuse large B-cell lymphoma : emerging worldwide?
    J Nucl Med. 2015 Mar 19. pii: jnumed.114.151183.
    PubMed     Text format    


  2. MOREL O, Mandry D, Micard E, Kauffmann C, et al
    Evidence of cyclic changes in the metabolism of abdominal aortic aneurysms during growth phases: a FDG-PET sequential observational study.
    J Nucl Med. 2015 Mar 19. pii: jnumed.114.146415.
    PubMed     Text format     Abstract available


  3. EIBER M, Maurer T, Souvatzoglou M, Beer AJ, et al
    Evaluation of hybrid 68Ga-PSMA-ligand PET/CT in 248 patients with biochemical recurrence after radical prostatectomy.
    J Nucl Med. 2015 Mar 19. pii: jnumed.115.154153.
    PubMed     Text format     Abstract available


  4. FAHEY FH, Bom HH, Chiti A, Choi YY, et al
    Standardization of Administered Activities in Pediatric Nuclear Medicine: A Report of the First Nuclear Medicine Global Initiative Project, Part 1: Statement of the Issue and a Review of Available Resources.
    J Nucl Med. 2015 Mar 12. pii: jnumed.114.152249.
    PubMed     Text format     Abstract available


  5. LYOO CH, Ikawa M, Liow JS, Zoghbi SS, et al
    Cerebellum can serve as a pseudo-reference region in Alzheimer's disease to detect neuroinflammation measured with PET radioligand binding to translocator protein (TSPO).
    J Nucl Med. 2015 Mar 12. pii: jnumed.114.146027.
    PubMed     Text format     Abstract available


  6. KOLB A, Sauter AW, Eriksson LA, Vandenbrouke A, et al
    Shine-through in PET/MRI: effects of the magnetic field on positron range and subsequent image artifacts.
    J Nucl Med. 2015 Mar 12. pii: jnumed.114.147637.
    PubMed     Text format     Abstract available


  7. SCHWARZ SW, Oyama R
    The Role of Exploratory INDs for Translating Radiopharmaceuticals into First-In-Human Studies.
    J Nucl Med. 2015 Mar 12. pii: jnumed.114.146472.
    PubMed     Text format     Abstract available


  8. TSENG JR, Lin CW, Chen SH, Yen TH, et al
    Clinical Usefulness of FDG PET/CT for the Detection of Infections of Unknown Origin in Patients Undergoing Maintenance Hemodialysis.
    J Nucl Med. 2015 Mar 12. pii: jnumed.114.151696.
    PubMed     Text format     Abstract available


  9. LANDAU SM, Fero A, Baker SL, Koeppe RA, et al
    Measurement of longitudinal A#946; change with 18F florbetapir PET and standard uptake value ratios.
    J Nucl Med. 2015 Mar 5. pii: jnumed.114.148981.
    PubMed     Text format     Abstract available


  10. KANEKO Y, Murray WK, Link E, Hicks RJ, et al
    Improving patient selection for FDG-PET scanning in the staging of gastric cancer.
    J Nucl Med. 2015 Mar 5. pii: jnumed.114.150946.
    PubMed     Text format     Abstract available


  11. CHEN K, Roontiva A, Thiyyagura P, Lee W, et al
    Improved power to characterize longitudinal amyloid-beta PET changes and evaluate amyloid-modifying treatments using a cerebral white matter reference region.
    J Nucl Med. 2015 Mar 5. pii: jnumed.114.149732.
    PubMed     Text format     Abstract available


  12. MEHRANIAN A, Zaidi H
    Impact of time-of-flight PET on quantification errors in MRI-based attenuation correction.
    J Nucl Med. 2015 Mar 5. pii: jnumed.114.148817.
    PubMed     Text format     Abstract available


  13. EINSTEIN AJ, Johnson LL, DeLuca A, Kontak AC, et al
    Radiation Dose and Prognosis of Ultra-Low Dose Stress-First Myocardial Perfusion SPECT in Patients with Chest Pain Using a High-Efficiency Camera.
    J Nucl Med. 2015 Mar 5. pii: jnumed.114.150664.
    PubMed     Text format     Abstract available


  14. JADVAR H, Subramaniam R, Berman CG, Boada F, et al
    American College of Radiology and Society of Nuclear Medicine and Molecular Imaging Joint Credentialing Statement for PET/MRI: Brain.
    J Nucl Med. 2015 Mar 5. pii: jnumed.115.155218.
    PubMed     Text format    


  15. LIN KS, Amouroux G, Pan J, Zhang Z, et al
    Comparative Studies of Three Gallium-68-labeled [des-Arg10]Kallidin Derivatives for Imaging Bradykinin B1 Receptor Expression with Positron Emission Tomography.
    J Nucl Med. 2015 Mar 5. pii: jnumed.114.152132.
    PubMed     Text format     Abstract available


    February 2015
  16. HUET P, Burg S, Le Guludec D, Hyafil F, et al
    Variability and uncertainty of FDG PET imaging protocols for assessing inflammation in atherosclerosis: suggestions for improvement.
    J Nucl Med. 2015 Feb 26. pii: jnumed.114.142596.
    PubMed     Text format     Abstract available


  17. CHEN W, Dilsizian V
    PET Assessment of Vascular Inflammation and Atherosclerotic Plaques: SUV or TBR?
    J Nucl Med. 2015 Feb 26. pii: jnumed.115.154385.
    PubMed     Text format    


  18. SU Z, Roncaroli F, Durrenberger PF, Coope DJ, et al
    The 18-kDa Mitochondrial Translocator Protein in Human Gliomas: A 11C-(R)PK11195 PET Imaging and Neuropathology Study.
    J Nucl Med. 2015 Feb 26. pii: jnumed.114.151621.
    PubMed     Text format     Abstract available


  19. FANCHON LM, Dogan S, Moreira AL, Carlin SA, et al
    Feasibility for in situ, High Resolution Correlation of Tracer Uptake with Histopathology by Quantitative Autoradiography of Biopsy Specimens Obtained under FDG PET/CT Guidance.
    J Nucl Med. 2015 Feb 26. pii: jnumed.114.148668.
    PubMed     Text format     Abstract available


  20. FENDLER WP, Lehmann M, Todica AS, Herrmann K, et al
    PET response criteria (PERCIST) predicts progression-free survival and time to local or distant progression after chemotherapy with regional hyperthermia for soft-tissue sarcoma.
    J Nucl Med. 2015 Feb 26. pii: jnumed.114.152462.
    PubMed     Text format     Abstract available


  21. JACOBSON O, Yan X, Gang N, Weiss ID, et al
    PET Imaging of Tenascin-C with a Radiolabeled Single-Strand DNA Aptamer.
    J Nucl Med. 2015 Feb 19. pii: jnumed.114.149484.
    PubMed     Text format     Abstract available


  22. BARRET O, Hannestad J, Vala C, Alagille D, et al
    Characterization in humans of 18F-MNI-444, a novel PET radiotracer for brain adenosine A2A receptors.
    J Nucl Med. 2015 Feb 19. pii: jnumed.114.152546.
    PubMed     Text format     Abstract available


  23. BIEGON A, Alexoff D, Kim SW, Logan J, et al
    Aromatase Imaging with [N-methyl-C-11]vorozole PET in Healthy Men and Women.
    J Nucl Med. 2015 Feb 19. pii: jnumed.114.150383.
    PubMed     Text format     Abstract available


  24. GURALNIK L, Rozenberg R, Frenkel A, Israel O, et al
    Metabolic PET/CT guided lung lesion biopsies - impact on diagnostic accuracy and rate of sampling error.
    J Nucl Med. 2015 Feb 19. pii: jnumed.113.131466.
    PubMed     Text format     Abstract available


  25. HOFMAN MS, Binns D, Johnston V, Siva S, et al
    Ga-68 EDTA PET/CT imaging and plasma clearance for glomerular filtration rate (GFR) quantification: comparison to conventional Cr-51 EDTA.
    J Nucl Med. 2015 Feb 12. pii: jnumed.114.147843.
    PubMed     Text format     Abstract available


  26. IVASHCHENKO O, van der Have F, Goorden M, Ramakers R, et al
    Ultra-high-sensitivity sub-mm mouse SPECT.
    J Nucl Med. 2015 Feb 12. pii: jnumed.114.147140.
    PubMed     Text format     Abstract available


  27. RAUSCHER I, Beer A, Schaeffeler C, Souvatzoglou M, et al
    Evaluation of 18F-Fluoride PET/MR and PET/CT in patients with unclear foot pain.
    J Nucl Med. 2015 Feb 12. pii: jnumed.114.150532.
    PubMed     Text format     Abstract available


  28. WITHOFS N, Signolle N, Somja J, Lovinfosse P, et al
    18F-FPRGD2 PET/CT imaging of integrin alphavbeta3 in renal carcinomas: Correlation with histopathology.
    J Nucl Med. 2015 Feb 5. pii: jnumed.114.149021.
    PubMed     Text format     Abstract available


  29. BEIJST C, Elschot M, Viergever MA, de Jong HW, et al
    A parallel cone collimator for high-energy SPECT.
    J Nucl Med. 2015 Feb 5. pii: jnumed.114.149658.
    PubMed     Text format     Abstract available


  30. CHIRINDEL A, Chaudhry M, Blakeley J, Wahl RL, et al
    18F-FDG PET/CT qualitative and quantitative evaluation in NF1 patients for Detection of Malignant Transformation - comparison of early to delayed imaging with and without liver activity normalization.
    J Nucl Med. 2015 Feb 5. pii: jnumed.114.142372.
    PubMed     Text format     Abstract available


  31. KOBYLECKI C, Langheinrich T, Hinz R, Vardy E, et al
    18F-florbetapir positron emission tomography in patients with frontotemporal dementia and Alzheimer's disease.
    J Nucl Med. 2015 Feb 5. pii: jnumed.114.147454.
    PubMed     Text format     Abstract available


  32. ILHAN H, Goritschan A, Paprottka P, Jakobs TF, et al
    Systematic evaluation of tumoral [Tc-99m]MAA-uptake using SPECT and SPECT/CT in 502 patients prior to Y-90 radioembolization.
    J Nucl Med. 2015 Feb 5. pii: jnumed.114.150565.
    PubMed     Text format     Abstract available


    January 2015
  33. YU EY, Duan F, Muzi M, Deng X, et al
    Castration-resistant prostate cancer bone metastasis response measured by 18F-fluoride PET after treatment with dasatinib and correlation with progression-free survival: Results from ACRIN 6687.
    J Nucl Med. 2015 Jan 29. pii: jnumed.114.146936.
    PubMed     Text format     Abstract available


  34. LEE SI, Catalano OA, Dehdashti F
    Gynecologic Cancer Imaging with MRI, FDG PET-CT and PET-MR.
    J Nucl Med. 2015 Jan 29. pii: jnumed.114.145011.
    PubMed     Text format     Abstract available


  35. RACHINGER W, Stoecklein VM, Terpolilli NA, Haug AR, et al
    Increased 68Ga-DOTATATE uptake in PET imaging discriminates meningioma and tumorfree tissue.
    J Nucl Med. 2015 Jan 29. pii: jnumed.114.149120.
    PubMed     Text format     Abstract available


  36. WALRAND S, Hesse M, Lhommel R, Jamar F, et al
    About the impact of image reconstruction bias on PET/CT 90Y dosimetry after radioembolization.
    J Nucl Med. 2015 Jan 29. pii: jnumed.114.152017.
    PubMed     Text format    


  37. MAKRIS NE, Boellaard R, van Lingen A, Lammertsma AA, et al
    PET/CT derived whole body and bone marrow dosimetry of 89Zr-cetuximab.
    J Nucl Med. 2015 Jan 22. pii: jnumed.114.147819.
    PubMed     Text format     Abstract available


  38. JAMES ML, Belichenko NP, Nguyen TV, Andrews LE, et al
    PET imaging of translocator protein (18kDa) in a mouse model of Alzheimer's disease using 18F-PBR06.
    J Nucl Med. 2015 Jan 22. pii: jnumed.114.141648.
    PubMed     Text format     Abstract available


  39. MARCUS C, Paidpally V, Antoniou A, Zaheer A, et al
    FDG PET/CT & Lung Cancer: Value of Fourth and Subsequent Post Therapy follow up scans in Patient Management.
    J Nucl Med. 2015 Jan 22. pii: jnumed.114.147884.
    PubMed     Text format     Abstract available


  40. LIN YC, Chen SW, Hsieh TC, Yen KY, et al
    Risk Stratification of Metastatic Neck Nodes by Computed Tomogram and Positron Emission Tomogram in Patients with Head and Neck Cancer Receiving Definitive Radiotherapy.
    J Nucl Med. 2015 Jan 22. pii: jnumed.114.148023.
    PubMed     Text format     Abstract available


  41. NAGANAWA M, Zheng MQ, Henry S, Nabulsi N, et al
    Test-retest reproducibility of binding parameters in humans with 11C-LY2795050, an antagonist PET radiotracer for the kappa opioid receptor.
    J Nucl Med. 2015 Jan 15. pii: jnumed.114.147975.
    PubMed     Text format     Abstract available


  42. WEHRL H, Sauter A, Divine MR, Pichler BJ, et al
    Combined PET/MR: a Technology Becomes Mature.
    J Nucl Med. 2015 Jan 15. pii: jnumed.114.150318.
    PubMed     Text format     Abstract available


  43. HILLNER BE, Siegel BA, Hanna L, Duan F, et al
    18F-Fluoride PET Used for Treatment Monitoring of Systemic Cancer Therapy: Results from the National Oncologic PET Registry.
    J Nucl Med. 2015 Jan 15. pii: jnumed.114.150391.
    PubMed     Text format     Abstract available


  44. APPEL L, Jonasson M, Danfors T, Nyholm D, et al
    Use of 11C-PE2I Positron Emission Tomography in Differential Diagnosis of Parkinsonian Disorders.
    J Nucl Med. 2015 Jan 15. pii: jnumed.114.148619.
    PubMed     Text format     Abstract available


  45. AIRAS L, Dickens A, Elo P, Marjamaki PM, et al
    In vivo Positron Emission Tomography Imaging Demonstrates Diminished Microglial Activation after Fingolimod Treatment in an Animal Model of Multiple Sclerosis.
    J Nucl Med. 2015 Jan 8. pii: jnumed.114.149955.
    PubMed     Text format     Abstract available


  46. FURST S, Grimm R, Hong I, Souvatzoglou M, et al
    Motion Correction Strategies for Integrated PET/MR.
    J Nucl Med. 2015 Jan 8. pii: jnumed.114.146787.
    PubMed     Text format     Abstract available


  47. CALAIS J, Thureau S, Dubray B, Modzelewski R, et al
    High 18F-FDG uptake areas on pre-radiotherapy PET/CT identify preferential sites of local relapse after chemo-radiotherapy for non-small cell lung cancer.
    J Nucl Med. 2015 Jan 8. pii: jnumed.114.144253.
    PubMed     Text format     Abstract available


  48. USLU L, Donig J, Link M, Rosenberg J, et al
    Value of 18F-FDG PET and PET/CT for Evaluation of Pediatric Malignancies.
    J Nucl Med. 2015 Jan 8. pii: jnumed.114.146290.
    PubMed     Text format     Abstract available


  49. LI Y, Tsui W, Rusinek H, Butler T, et al
    Cortical Lamina Binding of PET Amyloid and Tau Tracers in Alzheimer's disease.
    J Nucl Med. 2015 Jan 8. pii: jnumed.114.149229.
    PubMed     Text format     Abstract available



  50. Nuclear medicine residency programs ranked.
    J Nucl Med. 2015;56:14N.
    PubMed     Text format    



  51. SNMMI leadership update: facilitation and collaboration to lead the future.
    J Nucl Med. 2015;56:16N.
    PubMed     Text format    



  52. Joint NCI/SNMMI workshop on targeted radionuclide therapy.
    J Nucl Med. 2015;56:13N.
    PubMed     Text format    



  53. SNMMI comments on NRC part 35 and part 20 rules.
    J Nucl Med. 2015;56:11N.
    PubMed     Text format    


  54. KUIK WJ, Kema IP, Brouwers AH, Zijlma R, et al
    In vivo biodistribution of no-carrier-added 6-18F-fluoro-3,4-dihydroxy-L-phenylalanine (18F-DOPA), produced by a new nucleophilic substitution approach, compared with carrier-added 18F-DOPA, prepared by conventional electrophilic substitution.
    J Nucl Med. 2015;56:106-12.
    PubMed     Text format     Abstract available


  55. WAYUA C, Low PS
    Evaluation of a nonpeptidic ligand for imaging of cholecystokinin 2 receptor-expressing cancers.
    J Nucl Med. 2015;56:113-9.
    PubMed     Text format     Abstract available


    December 2014
  56. CIMITAN M, Evangelista L, Hodolic M, Mariani G, et al
    Gleason score at diagnosis predicts the detection rate of 18F-choline PET/CT performed at biochemical recurrence of prostate cancer: experience with 1,000 patients.
    J Nucl Med. 2014 Dec 31. pii: jnumed.114.141887.
    PubMed     Text format     Abstract available


  57. NENSA F, Tezgah E, Poeppel TD, Jensen CJ, et al
    Integrated 18F-FDG-PET/MRI in the assessment of cardiac masses: A pilot study.
    J Nucl Med. 2014 Dec 31. pii: jnumed.114.147744.
    PubMed     Text format     Abstract available


  58. VAN DIJK LK, Boerman OC, Franssen GM, Kaanders JH, et al
    Cetuximab-F(ab')2-SPECT and FDG-PET for prediction and response monitoring of combined modality treatment of human head and neck carcinomas in a mouse model.
    J Nucl Med. 2014 Dec 31. pii: jnumed.114.148296.
    PubMed     Text format     Abstract available


  59. JANSEN N, Suchorska B, Wenter V, Schmid-Tannwald C, et al
    Prognostic Significance of Dynamic 18F-FET-PET in Newly Diagnosed Astrocytic High Grade Glioma.
    J Nucl Med. 2014 Dec 23. pii: jnumed.114.144675.
    PubMed     Text format     Abstract available


  60. BONDUE B, Sherer F, Van Simaeys G, Doumont G, et al
    PET-CT with 18F-FDG and 18F-FBEM-labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosis.
    J Nucl Med. 2014 Dec 23. pii: jnumed.114.147421.
    PubMed     Text format     Abstract available


  61. JHAVERI K, Linden H
    Measuring Tumor Metabolism by FDG PET predicts outcome in a multicenter study: A step-off in the right direction.
    J Nucl Med. 2014 Dec 23. pii: jnumed.114.151175.
    PubMed     Text format    


  62. PARK JW, Jung K, Lee JH, Quach CH, et al
    18F-FDG PET/CT Monitoring of beta3 Agonist-Stimulated Brown Adipocyte Recruitment in White Adipose Tissue.
    J Nucl Med. 2014 Dec 18. pii: jnumed.114.147603.
    PubMed     Text format     Abstract available


  63. KANG C, Lin C, Yang L, Ho T, et al
    Positive Clinical Impact of an Additional PET/CT Scan before Adjuvant Radiotherapy or Concurrent Chemoradiotherapy in Patients with Advanced Oral Cavity Squamous Cell Carcinoma.
    J Nucl Med. 2014 Dec 18. pii: jnumed.114.145300.
    PubMed     Text format     Abstract available


  64. PARK SY, Cho A, Yu WS, Lee CY, et al
    Prognostic value of total lesion glycolysis by18F-fluorodeoxyglucose positron emission tomography/computed tomography in surgically resected stage IA non-small cell lung cancer.
    J Nucl Med. 2014 Dec 18. pii: jnumed.114.147561.
    PubMed     Text format     Abstract available


  65. FLETCHER JW, Logan TF, Eitel JA, Mathias CJ, et al
    Whole-body PET/CT Evaluation of Tumor Perfusion using Generator-based 62Cu-ETS: Validation by Direct Comparison to 15O-Water in Metastatic Renal Cell Carcinoma.
    J Nucl Med. 2014 Dec 18. pii: jnumed.114.148106.
    PubMed     Text format     Abstract available


  66. DUNKL V, Cleff C, Stoffels G, Judov N, et al
    The usefulness of dynamic O-(2-[18F]fluoroethyl)-L-tyrosine-PET in the clinical evaluation of brain tumors in children and adolescents.
    J Nucl Med. 2014 Dec 18. pii: jnumed.114.148734.
    PubMed     Text format     Abstract available


  67. HUANG HJ, Isakow W, Byers DE, Engle JT, et al
    Imaging pulmonary iNOS expression with positron emission tomography.
    J Nucl Med. 2014 Dec 18. pii: jnumed.114.146381.
    PubMed     Text format     Abstract available


  68. SURTI S
    Update in time-of-flight PET imaging.
    J Nucl Med. 2014 Dec 18. pii: jnumed.114.145029.
    PubMed     Text format     Abstract available


  69. SUNDERLAND JJ, Christian PE
    Quantitative PET/CT scanner performance characterization based upon the Clinical Trials Network oncology clinical simulator phantom.
    J Nucl Med. 2014 Dec 18. pii: jnumed.114.148056.
    PubMed     Text format     Abstract available


  70. KREISL WC, Bhatia R, Morse CL, Woock AE, et al
    Increased P-gp inhibition at the human blood brain barrier can be safely achieved by performing PET during peak plasma concentrations of tariquidar.
    J Nucl Med. 2014 Dec 11. pii: jnumed.114.146894.
    PubMed     Text format     Abstract available


  71. BURGER IA, Wurnig MC, Becker A, Kenkel D, et al
    Hybrid PET/MRI: An Algorithm to reduce Metal Artifacts from Dental Implants in Dixon-based Attenuation Map Generation using a MAVRIC sequence.
    J Nucl Med. 2014 Dec 11. pii: jnumed.114.145862.
    PubMed     Text format     Abstract available


  72. HATT M, Majdoub M, Vallieres M, Tixier F, et al
    FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort.
    J Nucl Med. 2014 Dec 11. pii: jnumed.114.144055.
    PubMed     Text format     Abstract available


  73. HERRMANN K, Czernin J, Wolin EM, Gupta P, et al
    Impact of 68Ga-DOTATATE PET/CT on the Management of Neuroendocrine Tumors: The Referring Physician's Perspective.
    J Nucl Med. 2014 Dec 11. pii: jnumed.114.148247.
    PubMed     Text format     Abstract available


  74. CHEN CJ, Bando K, Ashino H, Taguchi K, et al
    In Vivo SPECT Imaging of Amyloid-beta Deposition with Radioiodinated Imidazo[1,2-alpha]pyridine Derivative DRM106 in Mouse Model of Alzheimer's Disease.
    J Nucl Med. 2014 Dec 4. pii: jnumed.114.146944.
    PubMed     Text format     Abstract available


  75. SHALGUNOV V, van Wieringen JP, Janssen H, Fransen PM, et al
    Synthesis And Evaluation In Rats Of The Dopamine D2/3 Receptor Agonist 18F-AMC20 As Potential Radioligand For PET.
    J Nucl Med. 2014 Dec 4. pii: jnumed.114.145466.
    PubMed     Text format     Abstract available


  76. CONNOLLY RM, Leal JP, Goetz MP, Zhang Z, et al
    TBCRC 008: Early change in 18-fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET) predicts response to preoperative systemic therapy (PST) in HER2-negative primary operable breast cancer.
    J Nucl Med. 2014 Dec 4. pii: jnumed.114.144741.
    PubMed     Text format     Abstract available


  77. OOSTING SF, Brouwers AH, van Es SC, Nagengast WB, et al
    89Zr-bevacizumab PET Visualizes Heterogeneous Tracer Accumulation in Tumor Lesions of Renal Cell Carcinoma Patients and Differential Effects of Anti-angiogenic Treatment.
    J Nucl Med. 2014 Dec 4. pii: jnumed.114.144840.
    PubMed     Text format     Abstract available


  78. KIM M, Achmad A, Higuchi T, Arisaka Y, et al
    Effects of intra-tumoral inflammatory process on 18F-FDG uptake: pathologic and comparative study with 18F-FAMT PET/CT in oral squamous cell carcinoma.
    J Nucl Med. 2014 Dec 4. pii: jnumed.114.144014.
    PubMed     Text format     Abstract available


  79. VAN KRUCHTEN M, de Vries EF, Arts HJ, Jager NM, et al
    Assessment of Estrogen Receptor Expression in Epithelial Ovarian Cancer Patients using 18F-FES-PET/CT.
    J Nucl Med. 2014 Dec 4. pii: jnumed.114.147579.
    PubMed     Text format     Abstract available


  80. CERCI JJ, Fanti S, Redondo F, Gyorke T, et al
    Reply: Critical Views on the Prognostic Potential and Interpretation of Bone Marrow 18F-FDG PET in Diffuse Large B-Cell Lymphoma.
    J Nucl Med. 2014 Dec 4. pii: jnumed.114.150086.
    PubMed     Text format    


  81. ADAMS H, Kwee TC
    Letter: Critical Views on the Prognostic Potential and Interpretation of Bone Marrow 18F-FDG PET in Diffuse Large B-Cell Lymphoma.
    J Nucl Med. 2014 Dec 4. pii: jnumed.114.148577.
    PubMed     Text format    


  82. KIM EE
    Nuclear Medicine: A Guide for Healthcare Professionals and Patients.
    J Nucl Med. 2014 Dec 4. pii: jnumed.114.148809.
    PubMed     Text format    


  83. KIM EE
    Radiology for PET/CT Reporting.
    J Nucl Med. 2014 Dec 4. pii: jnumed.114.148692.
    PubMed     Text format    



  84. 2014 Cassen Lecture: What Have We Learned from the National Oncologic PET Registry?
    J Nucl Med. 2014;55:9N-15N.
    PubMed     Text format    


  85. KIM EE
    Clinical Applications of SPECT-CT.
    J Nucl Med. 2014;55:2078.
    PubMed     Text format    


  86. KIM EE
    PET/MRI: Methodology and Clinical Applications.
    J Nucl Med. 2014;55:2078.
    PubMed     Text format    


  87. DORAN MG, Watson PA, Cheal SM, Spratt DE, et al
    Annotating STEAP1 Regulation in Prostate Cancer with 89Zr Immuno-PET.
    J Nucl Med. 2014;55:2045-9.
    PubMed     Text format     Abstract available


  88. ROUZET F, Chequer R, Benali K, Lepage L, et al
    Respective Performance of 18F-FDG PET and Radiolabeled Leukocyte Scintigraphy for the Diagnosis of Prosthetic Valve Endocarditis.
    J Nucl Med. 2014;55:1980-5.
    PubMed     Text format     Abstract available


  89. HILLMER AT, Wooten DW, Bajwa AK, Higgins AT, et al
    First-in-Human Evaluation of 18F-Mefway, a PET Radioligand Specific to Serotonin-1A Receptors.
    J Nucl Med. 2014;55:1973-9.
    PubMed     Text format     Abstract available


  90. FENG L, Svarer C, Thomsen G, de Nijs R, et al
    In Vivo Quantification of Cerebral Translocator Protein Binding in Humans Using 6-Chloro-2-(4'-123I-Iodophenyl)-3-(N,N-Diethyl)-Imidazo[1,2-a]Pyridine-3-Acetamid e SPECT.
    J Nucl Med. 2014;55:1966-72.
    PubMed     Text format     Abstract available


  91. O'BRIEN JT, Firbank MJ, Davison C, Barnett N, et al
    18F-FDG PET and Perfusion SPECT in the Diagnosis of Alzheimer and Lewy Body Dementias.
    J Nucl Med. 2014;55:1959-65.
    PubMed     Text format     Abstract available


  92. GRUENEISEN J, Schaarschmidt BM, Beiderwellen K, Schulze-Hagen A, et al
    Diagnostic Value of Diffusion-Weighted Imaging in Simultaneous 18F-FDG PET/MR Imaging for Whole-Body Staging of Women with Pelvic Malignancies.
    J Nucl Med. 2014;55:1930-5.
    PubMed     Text format     Abstract available


  93. KARANTANIS D, Kalkanis D, Czernin J, Herrmann K, et al
    Perceived Misinterpretation Rates in Oncologic 18F-FDG PET/CT Studies: A Survey of Referring Physicians.
    J Nucl Med. 2014;55:1925-9.
    PubMed     Text format     Abstract available


  94. SIEGEL JA, Stabin MG
    Medical imaging: the challenges of radiation risk assessment.
    J Nucl Med. 2014;55:16N-17N.
    PubMed     Text format    


  95. IWAMOTO M, Kawada K, Nakamoto Y, Itatani Y, et al
    Regulation of 18F-FDG Accumulation in Colorectal Cancer Cells with Mutated KRAS.
    J Nucl Med. 2014;55:2038-44.
    PubMed     Text format     Abstract available


  96. CORNELISSEN B, Able S, Kartsonaki C, Kersemans V, et al
    Imaging DNA Damage Allows Detection of Preneoplasia in the BALB-neuT Model of Breast Cancer.
    J Nucl Med. 2014;55:2026-31.
    PubMed     Text format     Abstract available


  97. CHENG DW, Ersahin D, Staib LH, Della Latta D, et al
    Using SUV as a guide to 18F-FDG dose reduction.
    J Nucl Med. 2014;55:1998-2002.
    PubMed     Text format     Abstract available


  98. SCHUSTER DM, Nanni C, Fanti S, Oka S, et al
    Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid: physiologic uptake patterns, incidental findings, and variants that may simulate disease.
    J Nucl Med. 2014;55:1986-92.
    PubMed     Text format     Abstract available


  99. HICKS RJ
    The customer is always right, even when you are justifiably wrong.
    J Nucl Med. 2014;55:1923-4.
    PubMed     Text format    


  100. JAGER NA, Westra J, Golestani R, van Dam GM, et al
    Folate receptor-beta imaging using 99mTc-folate to explore distribution of polarized macrophage populations in human atherosclerotic plaque.
    J Nucl Med. 2014;55:1945-51.
    PubMed     Text format     Abstract available


    November 2014
  101. MURTHY VL, Lee BC, Sitek A, Naya M, et al
    Comparison and Prognostic Validation of Multiple Methods of Quantification of Myocardial Blood Flow with 82Rb PET.
    J Nucl Med. 2014 Nov 26. pii: jnumed.114.145342.
    PubMed     Text format     Abstract available


  102. CARR R, Fanti S, Paez D, Cerci JJ, et al
    Prospective International Cohort Study Demonstrates Inability of Interim PET to Predict Treatment Failure in Diffuse Large B-Cell Lymphoma.
    J Nucl Med. 2014 Nov 26. pii: jnumed.114.145326.
    PubMed     Text format     Abstract available


  103. PRESTWICH R, Sen M, Scarsbrook A
    Letter: Qualitative 18F-FDG PET/CT Response Evaluation After Chemotherapy or Radiotherapy for Head and Neck Squamous Cell Carcinoma: Is There an Equivocal Group?
    J Nucl Med. 2014 Nov 26. pii: jnumed.114.148114.
    PubMed     Text format    


  104. SUBRAMANIAM RM
    Reply: Qualitative 18F-FDG PET/CT Response Evaluation After Chemotherapy or Radiotherapy for Head and Neck Squamous Cell Carcinoma: Is There an Equivocal Group?
    J Nucl Med. 2014 Nov 26. pii: jnumed.114.148379.
    PubMed     Text format    


  105. CHATALIC KL, Franssen GM, van Weerden WM, McBride WJ, et al
    Preclinical Comparison of Al18F- and 68Ga-Labeled Gastrin-Releasing Peptide Receptor Antagonists for PET Imaging of Prostate Cancer.
    J Nucl Med. 2014 Nov 20. pii: jnumed.114.141143.
    PubMed     Text format     Abstract available


  106. CAOBELLI F, Ren Kaiser S, Thackeray JT, Bengel FM, et al
    IQ SPECT Allows a Significant Reduction in Administered Dose and Acquisition Time for Myocardial Perfusion Imaging: Evidence from a Phantom Study.
    J Nucl Med. 2014 Nov 20. pii: jnumed.114.143560.
    PubMed     Text format     Abstract available


  107. BOILEAU I, Bloomfield PM, Rusjan PM, Mizrahi R, et al
    Whole-Body Radiation Dosimetry of 11C-Carbonyl-URB694: A PET Tracer for Fatty Acid Amide Hydrolase.
    J Nucl Med. 2014 Nov 20. pii: jnumed.114.146464.
    PubMed     Text format     Abstract available


  108. ROY S, Wang WT, Carass A, Prince JL, et al
    PET Attenuation Correction Using Synthetic CT from Ultrashort Echo-Time MR Imaging.
    J Nucl Med. 2014 Nov 20. pii: jnumed.114.143958.
    PubMed     Text format     Abstract available



  109. SNMMI Leadership Update: The Importance of Quality, Evidence, and Value in Nuclear Medicine.
    J Nucl Med. 2014;55:26N.
    PubMed     Text format    


  110. KIM EE
    Whole-Body FDG PET Imaging in Oncology: Clinical Reports.
    J Nucl Med. 2014;55:1915.
    PubMed     Text format    


  111. MAHMOOD U
    2014 SNMMI highlights lecture: Oncology.
    J Nucl Med. 2014;55:9N-24N.
    PubMed     Text format    


  112. SEGALL G
    Enhancing the value of MOC.
    J Nucl Med. 2014;55:25N.
    PubMed     Text format    


  113. TERRY SY, Abiraj K, Lok J, Gerrits D, et al
    Can 111In-RGD2 monitor response to therapy in head and neck tumor xenografts?
    J Nucl Med. 2014;55:1849-55.
    PubMed     Text format     Abstract available


  114. ZHOU X, Chen R, Xie W, Ni Y, et al
    Relationship between 18F-FDG accumulation and lactate dehydrogenase A expression in lung adenocarcinomas.
    J Nucl Med. 2014;55:1766-71.
    PubMed     Text format     Abstract available


  115. INOUE K, Gibbs SL, Liu F, Lee JH, et al
    Microscopic validation of macroscopic in vivo images enabled by same-slide optical and nuclear fusion.
    J Nucl Med. 2014;55:1899-904.
    PubMed     Text format     Abstract available


  116. GJERLOFF T, Jakobsen S, Nahimi A, Munk OL, et al
    In vivo imaging of human acetylcholinesterase density in peripheral organs using 11C-donepezil: dosimetry, biodistribution, and kinetic analyses.
    J Nucl Med. 2014;55:1818-24.
    PubMed     Text format     Abstract available


  117. KRULL KR, Minoshima S, Edelmann M, Morris B, et al
    Regional brain glucose metabolism and neurocognitive function in adult survivors of childhood cancer treated with cranial radiation.
    J Nucl Med. 2014;55:1805-10.
    PubMed     Text format     Abstract available


  118. HEISS WD
    Radionuclide imaging in ischemic stroke.
    J Nucl Med. 2014;55:1831-41.
    PubMed     Text format     Abstract available


  119. DE PROST N, Feng Y, Wellman T, Tucci MR, et al
    18F-FDG kinetics parameters depend on the mechanism of injury in early experimental acute respiratory distress syndrome.
    J Nucl Med. 2014;55:1871-7.
    PubMed     Text format     Abstract available


  120. SATTLER B, Kranz M, Starke A, Wilke S, et al
    Internal dose assessment of (-)-18F-flubatine, comparing animal model datasets of mice and piglets with first-in-human results.
    J Nucl Med. 2014;55:1885-92.
    PubMed     Text format     Abstract available


  121. BODEI L, Kidd M, Baum RP, Modlin IM, et al
    PRRT: Defining the paradigm shift to achieve standardization and individualization.
    J Nucl Med. 2014;55:1753-6.
    PubMed     Text format     Abstract available


  122. BASU S, Ostwal V, Ranade R, Panda D, et al
    Supportive measures and finer practice points in 177Lu-DOTATATE PRRT for NET: aiming for optimal disease management.
    J Nucl Med. 2014;55:1916-7.
    PubMed     Text format    


    October 2014
  123. SHAM JG, Kievit FM, Grierson JR, Chiarelli PA, et al
    Glypican-3-Targeting F(ab')2 for 89Zr PET of Hepatocellular Carcinoma.
    J Nucl Med. 2014 Oct 30. pii: jnumed.114.145102.
    PubMed     Text format     Abstract available


  124. LIN LT, Chang CH, Yu HL, Liu RS, et al
    Evaluation of the Therapeutic and Diagnostic Effects of PEGylated Liposome-Embedded 188Re on Human Non-Small Cell Lung Cancer Using an Orthotopic Small-Animal Model.
    J Nucl Med. 2014 Oct 27. pii: jnumed.114.140418.
    PubMed     Text format     Abstract available


  125. SCHILLACI O
    Can PET/CT Guide the Personalized Treatment of Patients with Gastroenteropancreatic Neuroendocrine Neoplasms?
    J Nucl Med. 2014 Oct 23. pii: jnumed.114.147538.
    PubMed     Text format    


  126. VALLABHAJOSULA S, Nikolopoulou A, Babich JW, Osborne JR, et al
    99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen: Pharmacokinetics and Biodistribution Studies in Healthy Subjects and Patients with Metastatic Prostate Cancer.
    J Nucl Med. 2014 Oct 23. pii: jnumed.114.140426.
    PubMed     Text format     Abstract available


  127. JENTZEN W, Hoppenbrouwers J, van Leeuwen P, van der Velden D, et al
    Assessment of Lesion Response in the Initial Radioiodine Treatment of Differentiated Thyroid Cancer Using 124I PET Imaging.
    J Nucl Med. 2014 Oct 20. pii: jnumed.114.144089.
    PubMed     Text format     Abstract available


  128. VERWER EE, Bahce I, van Velden FH, Yaqub M, et al
    Parametric Methods for Quantification of 18F-FAZA Kinetics in Non-Small Cell Lung Cancer Patients.
    J Nucl Med. 2014 Oct 16. pii: jnumed.114.141846.
    PubMed     Text format     Abstract available


  129. SIMSEK DH, Kuyumcu S, Turkmen C, Sanli Y, et al
    Can Complementary 68Ga-DOTATATE and 18F-FDG PET/CT Establish the Missing Link Between Histopathology and Therapeutic Approach in Gastroenteropancreatic Neuroendocrine Tumors?
    J Nucl Med. 2014 Oct 14. pii: jnumed.114.142224.
    PubMed     Text format     Abstract available


  130. PAUL S, Khanapur S, Elsinga PH, Ishiwata K, et al
    PET Imaging of Adenosine A1 Receptor Occupancy.
    J Nucl Med. 2014 Oct 9. pii: jnumed.114.147736.
    PubMed     Text format    


  131. BAHRI H, Laurence L, Edeline J, Leghzali H, et al
    High Prognostic Value of 18F-FDG PET for Metastatic Gastroenteropancreatic Neuroendocrine Tumors: A Long-Term Evaluation.
    J Nucl Med. 2014 Oct 6. pii: jnumed.114.144386.
    PubMed     Text format     Abstract available


  132. IZQUIERDO-GARCIA D, Hansen AE, Forster S, Benoit D, et al
    An SPM8-Based Approach for Attenuation Correction Combining Segmentation and Nonrigid Template Formation: Application to Simultaneous PET/MR Brain Imaging.
    J Nucl Med. 2014 Oct 2. pii: jnumed.113.136341.
    PubMed     Text format     Abstract available


  133. RYLOVA SN, Barnucz E, Barnucz E, Fani M, et al
    Does Imaging alphavbeta3 Integrin Expression with PET Detect Changes in Angiogenesis During Bevacizumab Therapy?
    J Nucl Med. 2014 Oct 2. pii: jnumed.114.137570.
    PubMed     Text format     Abstract available


  134. MANSI L, Cuccurullo V
    Diagnostic imaging in neuroendocrine tumors.
    J Nucl Med. 2014;55:1576-7.
    PubMed     Text format    


  135. MORGAT C, Mishra AK, Varshney R, Allard M, et al
    Targeting neuropeptide receptors for cancer imaging and therapy: perspectives with bombesin, neurotensin, and neuropeptide-Y receptors.
    J Nucl Med. 2014;55:1650-7.
    PubMed     Text format     Abstract available


  136. BROISAT A, Toczek J, Dumas LS, Ahmadi M, et al
    99mTc-cAbVCAM1-5 imaging is a sensitive and reproducible tool for the detection of inflamed atherosclerotic lesions in mice.
    J Nucl Med. 2014;55:1678-84.
    PubMed     Text format     Abstract available


  137. SUZUKI C, Tsuji AB, Kato K, Kikuchi T, et al
    Preclinical characterization of 5-amino-4-oxo-[6-11C]hexanoic acid as an imaging probe to estimate protoporphyrin IX accumulation induced by exogenous aminolevulinic acid.
    J Nucl Med. 2014;55:1671-7.
    PubMed     Text format     Abstract available


  138. BARRET O, Hannestad J, Alagille D, Vala C, et al
    Adenosine 2A receptor occupancy by tozadenant and preladenant in rhesus monkeys.
    J Nucl Med. 2014;55:1712-8.
    PubMed     Text format     Abstract available


  139. DEMEURE F, Hanin FX, Bol A, Vincent MF, et al
    A randomized trial on the optimization of 18F-FDG myocardial uptake suppression: implications for vulnerable coronary plaque imaging.
    J Nucl Med. 2014;55:1629-35.
    PubMed     Text format     Abstract available


  140. BRUST P, Deuther-Conrad W, Becker G, Patt M, et al
    Distinctive in vivo kinetics of the new sigma1 receptor ligands (R)-(+)- and (S)-(-)-18F-fluspidine in porcine brain.
    J Nucl Med. 2014;55:1730-6.
    PubMed     Text format     Abstract available


  141. MULLER C, Bunka M, Haller S, Koster U, et al
    Promising prospects for 44Sc-/47Sc-based theragnostics: application of 47Sc for radionuclide tumor therapy in mice.
    J Nucl Med. 2014;55:1658-64.
    PubMed     Text format     Abstract available


    September 2014
  142. BURGER IA, Zitzmann-Kolbe S, Pruim J, Friebe M, et al
    First Clinical Results of (d)-18F-Fluoromethyltyrosine (BAY 86-9596) PET/CT in Patients with Non-Small Cell Lung Cancer and Head and Neck Squamous Cell Carcinoma.
    J Nucl Med. 2014 Sep 25. pii: jnumed.114.140699.
    PubMed     Text format     Abstract available


  143. BEAINO W, Anderson CJ
    PET Imaging of Very Late Antigen-4 in Melanoma: Comparison of 68Ga- and 64Cu-Labeled NODAGA and CB-TE1A1P-LLP2A Conjugates.
    J Nucl Med. 2014 Sep 25. pii: jnumed.114.144881.
    PubMed     Text format     Abstract available


  144. LIU C, Sinusas AJ
    Is Assessment of Absolute Myocardial Perfusion with SPECT Ready for Prime Time?
    J Nucl Med. 2014 Sep 18. pii: jnumed.114.144550.
    PubMed     Text format    


  145. VAN DIJK LK, Boerman OC, Franssen GM, Lok J, et al
    Early Response Monitoring with 18F-FDG PET and Cetuximab-F(ab')2-SPECT After Radiotherapy of Human Head And Neck Squamous Cell Carcinomas in a Mouse Model.
    J Nucl Med. 2014 Sep 18. pii: jnumed.114.141762.
    PubMed     Text format     Abstract available


  146. CERCI JJ, Gyorke T, Fanti S, Paez D, et al
    Combined PET and Biopsy Evidence of Marrow Involvement Improves Prognostic Prediction in Diffuse Large B-Cell Lymphoma.
    J Nucl Med. 2014 Sep 11. pii: jnumed.113.134486.
    PubMed     Text format     Abstract available


  147. RIEDL CC, Slobod E, Jochelson M, Morrow M, et al
    Retrospective Analysis of 18F-FDG PET/CT for Staging Asymptomatic Breast Cancer Patients Younger Than 40 Years.
    J Nucl Med. 2014 Sep 11. pii: jnumed.114.143297.
    PubMed     Text format     Abstract available


  148. HUANG W, Fan M, Liu B, Fu Z, et al
    Value of Metabolic Tumor Volume on Repeated 18F-FDG PET/CT for Early Prediction of Survival in Locally Advanced Non-Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy.
    J Nucl Med. 2014 Sep 11. pii: jnumed.114.142919.
    PubMed     Text format     Abstract available


  149. WELLS RG, Timmins R, Klein R, Lockwood J, et al
    Dynamic SPECT Measurement of Absolute Myocardial Blood Flow in a Porcine Model.
    J Nucl Med. 2014 Sep 4. pii: jnumed.114.139782.
    PubMed     Text format     Abstract available


  150. KAMSON DO, Lee TJ, Varadarajan K, Robinette NL, et al
    Clinical Significance of Tryptophan Metabolism in the Nontumoral Hemisphere in Patients with Malignant Glioma.
    J Nucl Med. 2014 Sep 4. pii: jnumed.114.141002.
    PubMed     Text format     Abstract available



  151. A new focus on women in nuclear medicine.
    J Nucl Med. 2014;55:15N.
    PubMed     Text format    


  152. SHAH M, Seibyl J, Cartier A, Bhatt R, et al
    Molecular imaging insights into neurodegeneration: focus on alpha-synuclein radiotracers.
    J Nucl Med. 2014;55:1397-400.
    PubMed     Text format     Abstract available


  153. KIM YI, Phi JH, Paeng JC, Choi H, et al
    In vivo evaluation of angiogenic activity and its correlation with efficacy of indirect revascularization surgery in pediatric moyamoya disease.
    J Nucl Med. 2014;55:1467-72.
    PubMed     Text format     Abstract available


  154. GRAHAM MM
    Ventilation-perfusion lung scanning: stuck in a rut?
    J Nucl Med. 2014;55:1395-6.
    PubMed     Text format    


  155. XIE T, Zaidi H
    Fetal and maternal absorbed dose estimates for positron-emitting molecular imaging probes.
    J Nucl Med. 2014;55:1459-66.
    PubMed     Text format     Abstract available


  156. WITNEY TH, Pisaneschi F, Alam IS, Trousil S, et al
    Preclinical evaluation of 3-18F-fluoro-2,2-dimethylpropionic acid as an imaging agent for tumor detection.
    J Nucl Med. 2014;55:1506-12.
    PubMed     Text format     Abstract available


  157. WILKS MQ, Knowles SM, Wu AM, Huang SC, et al
    Improved modeling of in vivo kinetics of slowly diffusing radiotracers for tumor imaging.
    J Nucl Med. 2014;55:1539-44.
    PubMed     Text format     Abstract available


  158. LIU Z, Pourghiasian M, Benard F, Pan J, et al
    Preclinical evaluation of a high-affinity 18F-trifluoroborate octreotate derivative for somatostatin receptor imaging.
    J Nucl Med. 2014;55:1499-505.
    PubMed     Text format     Abstract available


    August 2014
  159. ETCHEBEHERE EC, de Oliveira Santos A, Gumz B, Vicente A, et al
    68Ga-DOTATATE PET/CT, 99mTc-HYNIC-Octreotide SPECT/CT, and Whole-Body MR Imaging in Detection of Neuroendocrine Tumors: A Prospective Trial.
    J Nucl Med. 2014 Aug 28. pii: jnumed.114.144543.
    PubMed     Text format     Abstract available


  160. PREVRHAL S, Heinzer S, Wulker C, Renisch S, et al
    Fat-Constrained 18F-FDG PET Reconstruction in Hybrid PET/MR Imaging.
    J Nucl Med. 2014 Aug 28. pii: jnumed.114.139758.
    PubMed     Text format     Abstract available


  161. MACHULLA HJ, Malik N
    Fatty Acids as a Concept for Probes in Cardiologic PET/MR Imaging.
    J Nucl Med. 2014 Aug 25. pii: jnumed.114.146142.
    PubMed     Text format    


  162. GOURNI E, Mansi R, Jamous M, Waser B, et al
    N-Terminal Modifications Improve the Receptor Affinity and Pharmacokinetics of Radiolabeled Peptidic Gastrin-Releasing Peptide Receptor Antagonists: Examples of 68Ga- and 64Cu-Labeled Peptides for PET Imaging.
    J Nucl Med. 2014 Aug 21. pii: jnumed.114.141242.
    PubMed     Text format     Abstract available


  163. THURFJELL L, Lilja J, Lundqvist R, Buckley C, et al
    Automated Quantification of 18F-Flutemetamol PET Activity for Categorizing Scans as Negative or Positive for Brain Amyloid: Concordance with Visual Image Reads.
    J Nucl Med. 2014 Aug 21. pii: jnumed.114.142109.
    PubMed     Text format     Abstract available


  164. CHOI H, Cheon GJ, Kim HJ, Choi SH, et al
    Segmentation-Based MR Attenuation Correction Including Bones Also Affects Quantitation in Brain Study: An Initial Result of 18F-FP-CIT PET/MR for Patients with Parkinsonism.
    J Nucl Med. 2014 Aug 11. pii: jnumed.114.138636.
    PubMed     Text format     Abstract available


  165. LEE SH, Oh BM, Lee G, Choi H, et al
    Feasibility of 18F-FDG PET as a Noninvasive Diagnostic Tool of Muscle Denervation: A Preliminary Study.
    J Nucl Med. 2014 Aug 7. pii: jnumed.114.140731.
    PubMed     Text format     Abstract available


  166. KIM KI, Jang SJ, Park JH, Lee YJ, et al
    Detection of Increased 64Cu Uptake by Human Copper Transporter 1 Gene Overexpression Using PET with 64CuCl2 in Human Breast Cancer Xenograft Model.
    J Nucl Med. 2014 Aug 4. pii: jnumed.114.141127.
    PubMed     Text format     Abstract available


    July 2014
  167. MURAWSKI AM, Gurbani S, Klunk M, Younes L, et al
    Imaging the Evolution of Reactivation Pulmonary Tuberculosis in Mice Using 18F-FDG PET.
    J Nucl Med. 2014 Jul 31. pii: jnumed.114.144634.
    PubMed     Text format     Abstract available


  168. ZUKOTYNSKI K, Fahey F, Kocak M, Kun L, et al
    18F-FDG PET and MR Imaging Associations Across a Spectrum of Pediatric Brain Tumors: A Report from the Pediatric Brain Tumor Consortium.
    J Nucl Med. 2014 Jul 28. pii: jnumed.114.139626.
    PubMed     Text format     Abstract available


  169. PACKARD RR, Huang SC, Dahlbom M, Czernin J, et al
    Absolute Quantitation of Myocardial Blood Flow in Human Subjects With or Without Myocardial Ischemia Using Dynamic Flurpiridaz F 18 PET.
    J Nucl Med. 2014 Jul 28. pii: jnumed.114.141093.
    PubMed     Text format     Abstract available


  170. PEREZ-MEDINA C, Abdel-Atti D, Zhang Y, Longo VA, et al
    A Modular Labeling Strategy for In Vivo PET and Near-Infrared Fluorescence Imaging of Nanoparticle Tumor Targeting.
    J Nucl Med. 2014 Jul 24. pii: jnumed.114.141861.
    PubMed     Text format     Abstract available


  171. MANSI L, Cuccurullo V, Evangelista L
    Is Radiocholine PET/CT Already Clinically Useful in Patients with Prostate Cancer?
    J Nucl Med. 2014 Jul 24. pii: jnumed.114.142679.
    PubMed     Text format    


  172. DEGRADO TR, Pandey MK, Byrne JF, Engelbrecht HP, et al
    Preparation and Preliminary Evaluation of 63Zn-Zinc Citrate as a Novel PET Imaging Biomarker for Zinc.
    J Nucl Med. 2014 Jul 21. pii: jnumed.114.141218.
    PubMed     Text format     Abstract available


  173. DAHABREH IJ, Gatsonis C
    A Flexible, Multifaceted Approach Is Needed in Health Technology Assessment of PET.
    J Nucl Med. 2014 Jul 21. pii: jnumed.114.142331.
    PubMed     Text format    


  174. MACH RH
    New Targets for the Development of PET Tracers for Imaging Neurodegeneration in Alzheimer Disease.
    J Nucl Med. 2014 Jul 17. pii: jnumed.114.127811.
    PubMed     Text format     Abstract available


  175. SCHONITZER V, Haasters F, Kasbauer S, Ulrich V, et al
    In Vivo Mesenchymal Stem Cell Tracking with PET Using the Dopamine Type 2 Receptor and 18F-Fallypride.
    J Nucl Med. 2014 Jul 14. pii: jnumed.113.134775.
    PubMed     Text format     Abstract available


  176. OEHMIGEN M, Ziegler S, Jakoby BW, Georgi JC, et al
    Radiotracer Dose Reduction in Integrated PET/MR: Implications from National Electrical Manufacturers Association Phantom Studies.
    J Nucl Med. 2014 Jul 8. pii: jnumed.114.139147.
    PubMed     Text format     Abstract available


  177. HEISS WD
    Clinical Impact of Amino Acid PET in Gliomas.
    J Nucl Med. 2014 Jul 8. pii: jnumed.114.142661.
    PubMed     Text format    


  178. BHATTACHARYA A, Kochhar R, Sharma S, Ray P, et al
    PET/CT with 18F-FDG-Labeled Autologous Leukocytes for the Diagnosis of Infected Fluid Collections in Acute Pancreatitis.
    J Nucl Med. 2014 Jul 3. pii: jnumed.114.137232.
    PubMed     Text format     Abstract available


  179. KEHLER J, Kilburn JP, Estrada S, Christensen SR, et al
    Discovery and Development of 11C-Lu AE92686 as a Radioligand for PET Imaging of Phosphodiesterase10A in the Brain.
    J Nucl Med. 2014 Jul 3. pii: jnumed.114.140178.
    PubMed     Text format     Abstract available


    June 2014
  180. EINSTEIN AJ, Blankstein R, Andrews H, Fish M, et al
    Comparison of Image Quality, Myocardial Perfusion, and Left Ventricular Function Between Standard Imaging and Single-Injection Ultra-Low-Dose Imaging Using a High-Efficiency SPECT Camera: The MILLISIEVERT Study.
    J Nucl Med. 2014 Jun 30. pii: jnumed.114.138222.
    PubMed     Text format     Abstract available


  181. TAPP KN, Lea WB, Johnson MS, Tann M, et al
    The Impact of Image Reconstruction Bias on PET/CT 90Y Dosimetry After Radioembolization.
    J Nucl Med. 2014 Jun 30. pii: jnumed.113.133629.
    PubMed     Text format     Abstract available


  182. RIJPKEMA M, Oyen WJ, Bos D, Franssen GM, et al
    SPECT- and Fluorescence Image-Guided Surgery Using a Dual-Labeled Carcinoembryonic Antigen-Targeting Antibody.
    J Nucl Med. 2014 Jun 30. pii: jnumed.114.142141.
    PubMed     Text format     Abstract available


  183. LI F, Jiang S, Zu Y, Lee DY, et al
    A Tyrosine Kinase Inhibitor-Based High-Affinity PET Radiopharmaceutical Targets Vascular Endothelial Growth Factor Receptor.
    J Nucl Med. 2014 Jun 26. pii: jnumed.114.138925.
    PubMed     Text format     Abstract available


  184. TAHARI AK, Chien D, Azadi JR, Wahl RL, et al
    Optimum Lean Body Formulation for Correction of Standardized Uptake Value in PET Imaging.
    J Nucl Med. 2014 Jun 24. pii: jnumed.113.136986.
    PubMed     Text format     Abstract available


  185. HASHIMOTO H, Kawamura K, Igarashi N, Takei M, et al
    Radiosynthesis, Photoisomerization, Biodistribution, and Metabolite Analysis of 11C-PBB3 as a Clinically Useful PET Probe for Imaging of Tau Pathology.
    J Nucl Med. 2014 Jun 24. pii: jnumed.114.139550.
    PubMed     Text format     Abstract available


  186. ARMEANU-EBINGER S, Griessinger CM, Herrmann D, Fuchs J, et al
    PET/MR Imaging and Optical Imaging of Metastatic Rhabdomyosarcoma in Mice.
    J Nucl Med. 2014 Jun 24. pii: jnumed.114.138578.
    PubMed     Text format     Abstract available


  187. SUZUKI A, Leland P, Kobayashi H, Choyke PL, et al
    Analysis of Biodistribution of Intracranially Infused Radiolabeled Interleukin-13 Receptor-Targeted Immunotoxin IL-13PE by SPECT/CT in an Orthotopic Mouse Model of Human Glioma.
    J Nucl Med. 2014 Jun 19. pii: jnumed.114.138404.
    PubMed     Text format     Abstract available


  188. MARCUS C, Ciarallo A, Tahari AK, Mena E, et al
    Head and Neck PET/CT: Therapy Response Interpretation Criteria (Hopkins Criteria)-Interreader Reliability, Accuracy, and Survival Outcomes.
    J Nucl Med. 2014 Jun 19. pii: jnumed.113.136796.
    PubMed     Text format     Abstract available


  189. WARNOCK GI, Aerts J, Bahri MA, Bretin F, et al
    Evaluation of 18F-UCB-H as a Novel PET Tracer for Synaptic Vesicle Protein 2A in the Brain.
    J Nucl Med. 2014 Jun 16. pii: jnumed.113.136143.
    PubMed     Text format     Abstract available


  190. CASTELLUCCI P, Ceci F, Graziani T, Schiavina R, et al
    Early Biochemical Relapse After Radical Prostatectomy: Which Prostate Cancer Patient May Benefit from a Restaging 11C-Choline PET/CT Scan Before Salvage Radiation Therapy?
    J Nucl Med. 2014 Jun 16. pii: jnumed.114.138313.
    PubMed     Text format     Abstract available


  191. VAN BERKEL A, Rao JU, Kusters B, Demir T, et al
    Correlation Between In Vivo 18F-FDG PET and Immunohistochemical Markers of Glucose Uptake and Metabolism in Pheochromocytoma and Paraganglioma.
    J Nucl Med. 2014 Jun 12. pii: jnumed.114.137034.
    PubMed     Text format     Abstract available


  192. SIEPE B, Hoilund-Carlsen PF, Gerke O, Weber WA, et al
    The Move from Accuracy Studies to Randomized Trials in PET: Current Status and Future Directions.
    J Nucl Med. 2014 Jun 9. pii: jnumed.113.127076.
    PubMed     Text format     Abstract available


  193. LANZ B, Poitry-Yamate C, Gruetter R
    Image-Derived Input Function from the Vena Cava for 18F-FDG PET Studies in Rats and Mice.
    J Nucl Med. 2014 Jun 9. pii: jnumed.113.127381.
    PubMed     Text format     Abstract available


  194. SCHWARZ SW, Dick D, VanBrocklin HF, Hoffman JM, et al
    Regulatory Requirements for PET Drug Production.
    J Nucl Med. 2014 Jun 9. pii: jnumed.113.132472.
    PubMed     Text format     Abstract available


  195. DE PAULA FARIA D, Vlaming ML, Copray SC, Tielen F, et al
    PET Imaging of Disease Progression and Treatment Effects in the Experimental Autoimmune Encephalomyelitis Rat Model.
    J Nucl Med. 2014 Jun 9. pii: jnumed.114.137216.
    PubMed     Text format     Abstract available


  196. TIXIER F, Hatt M, Valla C, Fleury V, et al
    Visual Versus Quantitative Assessment of Intratumor 18F-FDG PET Uptake Heterogeneity: Prognostic Value in Non-Small Cell Lung Cancer.
    J Nucl Med. 2014 Jun 5. pii: jnumed.113.133389.
    PubMed     Text format     Abstract available


  197. COLASANTI A, Guo Q, Muhlert N, Giannetti P, et al
    In Vivo Assessment of Brain White Matter Inflammation in Multiple Sclerosis with 18F-PBR111 PET.
    J Nucl Med. 2014 Jun 5. pii: jnumed.113.135129.
    PubMed     Text format     Abstract available


  198. WALKER MD, Goorden MC, Dinelle K, Ramakers RM, et al
    Performance Assessment of a Preclinical PET Scanner with Pinhole Collimation by Comparison to a Coincidence-Based Small-Animal PET Scanner.
    J Nucl Med. 2014 Jun 5. pii: jnumed.113.136663.
    PubMed     Text format     Abstract available


  199. ZWAN MD, Ossenkoppele R, Tolboom N, Beunders AJ, et al
    Comparison of Simplified Parametric Methods for Visual Interpretation of 11C-Pittsburgh Compound-B PET Images.
    J Nucl Med. 2014 Jun 4. pii: jnumed.114.139121.
    PubMed     Text format     Abstract available


  200. BARRET O, Thomae D, Tavares A, Alagille D, et al
    In Vivo Assessment and Dosimetry of 2 Novel PDE10A PET Radiotracers in Humans: 18F-MNI-659 and 18F-MNI-654.
    J Nucl Med. 2014 Jun 4. pii: jnumed.113.122895.
    PubMed     Text format     Abstract available


    May 2014
  201. SILBERSTEIN EB
    Prevalence of Adverse Events to Radiopharmaceuticals from 2007 to 2011.
    J Nucl Med. 2014 May 29. pii: jnumed.114.138057.
    PubMed     Text format     Abstract available


  202. EZZIDDIN S, Adler L, Sabet A, Poppel TD, et al
    Prognostic Stratification of Metastatic Gastroenteropancreatic Neuroendocrine Neoplasms by 18F-FDG PET: Feasibility of a Metabolic Grading System.
    J Nucl Med. 2014 May 29. pii: jnumed.114.137166.
    PubMed     Text format     Abstract available


  203. LEE G, I H, Kim SJ, Jeong YJ, et al
    Clinical Implication of PET/MR Imaging in Preoperative Esophageal Cancer Staging: Comparison with PET/CT, Endoscopic Ultrasonography, and CT.
    J Nucl Med. 2014 May 27. pii: jnumed.114.138974.
    PubMed     Text format     Abstract available


  204. LEIMGRUBER A, Moller A, Everitt SJ, Chabrot M, et al
    Effect of Platinum-Based Chemoradiotherapy on Cellular Proliferation in Bone Marrow and Spleen, Estimated by 18F-FLT PET/CT in Patients with Locally Advanced Non-Small Cell Lung Cancer.
    J Nucl Med. 2014 May 27. pii: jnumed.113.136127.
    PubMed     Text format     Abstract available


  205. SWIERCZ R, Chiguru S, Tahmasbi A, Ramezani SM, et al
    Use of Fc-Engineered Antibodies as Clearing Agents to Increase Contrast During PET.
    J Nucl Med. 2014 May 27. pii: jnumed.113.136481.
    PubMed     Text format     Abstract available


  206. WU Z, Li L, Liu S, Yakushijin F, et al
    Facile Preparation of a Thiol-Reactive 18F-Labeling Agent and Synthesis of 18F-DEG-VS-NT for PET Imaging of a Neurotensin Receptor-Positive Tumor.
    J Nucl Med. 2014 May 22. pii: jnumed.114.137489.
    PubMed     Text format     Abstract available


  207. CHITNENI SK, Bida GT, Zalutsky MR, Dewhirst MW, et al
    Comparison of the Hypoxia PET Tracer 18F-EF5 to Immunohistochemical Marker EF5 in 3 Different Human Tumor Xenograft Models.
    J Nucl Med. 2014 May 22. pii: jnumed.114.137448.
    PubMed     Text format     Abstract available


  208. HYUN O J, Lodge MA, Jagannath S, Buscaglia JM, et al
    An Exocrine Pancreatic Stress Test with 11C-Acetate PET and Secretin Stimulation.
    J Nucl Med. 2014 May 19. pii: jnumed.113.135681.
    PubMed     Text format     Abstract available


  209. NIU G, Lang L, Kiesewetter DO, Ma Y, et al
    In Vivo Labeling of Serum Albumin for PET.
    J Nucl Med. 2014 May 19. pii: jnumed.114.139642.
    PubMed     Text format     Abstract available


  210. HITZ S, Habekost C, Furst S, Delso G, et al
    Systematic Comparison of the Performance of Integrated Whole-Body PET/MR Imaging to Conventional PET/CT for 18F-FDG Brain Imaging in Patients Examined for Suspected Dementia.
    J Nucl Med. 2014 May 15. pii: jnumed.113.126813.
    PubMed     Text format     Abstract available


  211. EVERITT SJ, Ball DL, Hicks RJ, Callahan J, et al
    Differential 18F-FDG and 18F-FLT Uptake on Serial PET/CT Imaging Before and During Definitive Chemoradiation for Non-Small Cell Lung Cancer.
    J Nucl Med. 2014 May 15. pii: jnumed.113.131631.
    PubMed     Text format     Abstract available


  212. WEHRL HF, Wiehr S, Divine MR, Gatidis S, et al
    Preclinical and Translational PET/MR Imaging.
    J Nucl Med. 2014 May 15. pii: jnumed.113.129221.
    PubMed     Text format     Abstract available


  213. SHAH M, Catafau AM
    Molecular Imaging Insights into Neurodegeneration: Focus on Tau PET Radiotracers.
    J Nucl Med. 2014 May 15. pii: jnumed.113.136069.
    PubMed     Text format     Abstract available


  214. WILSON GH 3RD, Gore JC, Yankeelov TE, Barnes S, et al
    An Approach to Breast Cancer Diagnosis via PET Imaging of Microcalcifications Using 18F-NaF.
    J Nucl Med. 2014 May 15. pii: jnumed.114.139170.
    PubMed     Text format     Abstract available


  215. HILLNER BE, Siegel BA, Hanna L, Duan F, et al
    Impact of 18F-Fluoride PET on Intended Management of Patients with Cancers Other Than Prostate Cancer: Results from the National Oncologic PET Registry.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  216. RAUSCHER I, Eiber M, Souvatzoglou M, Schwaiger M, et al
    PET/MR in Oncology: Non-18F-FDG Tracers for Routine Applications.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  217. KHONG PL, Huang B, Phin Lee EY, Sum Chan WK, et al
    Midtreatment 18F-FDG PET/CT Scan for Early Response Assessment of SMILE Therapy in Natural Killer/T-Cell Lymphoma: A Prospective Study from a Single Center.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  218. DISSELHORST JA, Bezrukov I, Kolb A, Parl C, et al
    Principles of PET/MR Imaging.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  219. WEBER WA
    PET/MR Imaging: A Critical Appraisal.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  220. DRZEZGA A, Barthel H, Minoshima S, Sabri O, et al
    Potential Clinical Applications of PET/MR Imaging in Neurodegenerative Diseases.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  221. KESTLER M, Munoz P, Rodriguez-Creixems M, Rotger A, et al
    Role of 18F-FDG PET in Patients with Infectious Endocarditis.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  222. KOUIJZER IJ, Bleeker-Rovers CP, Oyen WJ
    18F-FDG PET/CT for the Detection of Septic Embolisms in Patients with Infectious Endocarditis.
    J Nucl Med. 2014.
    PubMed     Text format    


  223. CZERNIN J, Ta L, Herrmann K
    Does PET/MR Imaging Improve Cancer Assessments? Literature Evidence from More Than 900 Patients.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  224. MIYAKE KK, Matsumoto K, Inoue M, Nakamoto Y, et al
    Performance Evaluation of a New Dedicated Breast PET Scanner Using NEMA NU4-2008 Standards.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  225. PERISSINOTTI A, Setoain X, Aparicio J, Rubi S, et al
    Clinical Role of Subtraction Ictal SPECT Coregistered to MR Imaging and 18F-FDG PET in Pediatric Epilepsy.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  226. ARPONEN E, Helin S, Marjamaki P, Gronroos T, et al
    A PET Tracer for Brain alpha2C Adrenoceptors, 11C-ORM-13070: Radiosynthesis and Preclinical Evaluation in Rats and Knockout Mice.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  227. VON SCHULTHESS GK, Veit-Haibach P
    Workflow Considerations in PET/MR Imaging.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  228. FINNEMA SJ, Stepanov V, Nakao R, Sromek AW, et al
    18F-MCL-524, an 18F-Labeled Dopamine D2 and D3 Receptor Agonist Sensitive to Dopamine: A Preliminary PET Study.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  229. BLASI F, Oliveira BL, Rietz TA, Rotile NJ, et al
    Effect of Chelate Type and Radioisotope on the Imaging Efficacy of Four Fibrin-Specific PET Probes.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  230. MAURER AH, Elsinga P, Fanti S, Nguyen B, et al
    Imaging the folate receptor on cancer cells with 99mTc-etarfolatide: properties, clinical use, and future potential of folate receptor imaging.
    J Nucl Med. 2014;55:701-4.
    PubMed     Text format     Abstract available


  231. CASTANARES MA, Mukherjee A, Chowdhury WH, Liu M, et al
    Evaluation of prostate-specific membrane antigen as an imaging reporter.
    J Nucl Med. 2014;55:805-11.
    PubMed     Text format     Abstract available


  232. TAVARES AA, Caille F, Barret O, Papin C, et al
    In vivo evaluation of 18F-MNI698: an 18F-labeled radiotracer for imaging of serotonin 4 receptors in brain.
    J Nucl Med. 2014;55:858-64.
    PubMed     Text format     Abstract available


  233. ZHENG F, Put S, Bouwens L, Lahoutte T, et al
    Molecular imaging with macrophage CRIg-targeting nanobodies for early and preclinical diagnosis in a mouse model of rheumatoid arthritis.
    J Nucl Med. 2014;55:824-9.
    PubMed     Text format     Abstract available


  234. AL-EJEH F, Staudacher AH, Smyth DR, Darby JM, et al
    Postchemotherapy and tumor-selective targeting with the La-specific DAB4 monoclonal antibody relates to apoptotic cell clearance.
    J Nucl Med. 2014;55:772-9.
    PubMed     Text format     Abstract available


  235. BUXTON DB
    Noninvasive measurement of mouse myocardial glucose uptake with 18F-FDG.
    J Nucl Med. 2014;55:866.
    PubMed     Text format    


  236. ROBERTS RO, Knopman DS, Cha RH, Mielke MM, et al
    Diabetes and elevated hemoglobin A1c levels are associated with brain hypometabolism but not amyloid accumulation.
    J Nucl Med. 2014;55:759-64.
    PubMed     Text format     Abstract available


  237. THORN SL, deKemp R, Dumouchel T, Klein R, et al
    Reply: Noninvasive measurement of mouse myocardial glucose uptake with 18F-FDG.
    J Nucl Med. 2014;55:866-7.
    PubMed     Text format    


  238. CHIN BB, Kronauge JF, Femia FJ, Chen J, et al
    Phase-1 clinical trial results of high-specific-activity carrier-free 123I-iobenguane.
    J Nucl Med. 2014;55:765-71.
    PubMed     Text format     Abstract available


  239. QIN C, Liu H, Chen K, Hu X, et al
    Theranostics of malignant melanoma with 64CuCl2.
    J Nucl Med. 2014;55:812-7.
    PubMed     Text format     Abstract available


  240. TAYLOR AT
    Radionuclides in nephrourology, Part 2: pitfalls and diagnostic applications.
    J Nucl Med. 2014;55:786-98.
    PubMed     Text format     Abstract available


    April 2014
  241. LEWIS DY, Boren J, Shaw GL, Bielik R, et al
    Late Imaging with [1-11C]Acetate Improves Detection of Tumor Fatty Acid Synthesis with PET.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  242. ANTONIOU AJ, Marcus C, Tahari AK, Wahl RL, et al
    Follow-up or Surveillance 18F-FDG PET/CT and Survival Outcome in Lung Cancer Patients.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  243. SCHELHAAS S, Wachsmuth L, Viel T, Honess DJ, et al
    Variability of Proliferation and Diffusion in Different Lung Cancer Models as Measured by 3'-Deoxy-3'-18F-Fluorothymidine PET and Diffusion-Weighted MR Imaging.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  244. RATIB O, Nkoulou R
    Potential Applications of PET/MR Imaging in Cardiology.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  245. HALLIGAN WT, Morris PB, Schoepf UJ, Mischen BT, et al
    Transient Ischemic Dilation of the Left Ventricle on SPECT: Correlation with Findings at Coronary CT Angiography.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  246. PURZ S, Sabri O, Viehweger A, Barthel H, et al
    Potential Pediatric Applications of PET/MR.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  247. EPPARD E, Wuttke M, Nicodemus PL, Rosch F, et al
    Ethanol-Based Post-processing of Generator-Derived 68Ga Toward Kit-Type Preparation of 68Ga-Radiopharmaceuticals.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  248. BUNDSCHUH RA, Dinges J, Neumann L, Seyfried M, et al
    Textural Parameters of Tumor Heterogeneity in 18F-FDG PET/CT for Therapy Response Assessment and Prognosis in Patients with Locally Advanced Rectal Cancer.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  249. TREVES ST, Lassmann M
    International Guidelines for Pediatric Radiopharmaceutical Administered Activities.
    J Nucl Med. 2014.
    PubMed     Text format    


  250. MARQUEZ BV, Ikotun OF, Parry JJ, Rogers BE, et al
    Development of a Radiolabeled Irreversible Peptide Ligand for PET Imaging of Vascular Endothelial Growth Factor.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  251. ITO H, Shimada H, Shinotoh H, Takano H, et al
    Quantitative Analysis of Amyloid Deposition in Alzheimer Disease Using PET and the Radiotracer 11C-AZD2184.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  252. GALLEZOT JD, Zheng MQ, Lim K, Lin SF, et al
    Parametric Imaging and Test-Retest Variability of 11C-(+)-PHNO Binding to D2/D3 Dopamine Receptors in Humans on the High-Resolution Research Tomograph PET Scanner.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  253. LIU Z, Liu H, Ma T, Sun X, et al
    Integrin alphavbeta6-Targeted SPECT Imaging for Pancreatic Cancer Detection.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  254. RISSANEN E, Tuisku J, Rokka J, Paavilainen T, et al
    In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand 11C-PK11195.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  255. LEE JW, Kang CM, Choi HJ, Lee WJ, et al
    Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative 18F-FDG PET/CT in Patients with Pancreatic Cancer.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  256. PARKER CA, Nabulsi N, Holden D, Lin SF, et al
    Evaluation of 11C-BU99008, a PET Ligand for the Imidazoline2 Binding Sites in Rhesus Brain.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  257. MOON SH, Kim HS, Hyun SH, Choi YS, et al
    Prediction of Occult Lymph Node Metastasis by Metabolic Parameters in Patients with Clinically N0 Esophageal Squamous Cell Carcinoma.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available



  258. CMS Issues New Instructions on PET Coverage.
    J Nucl Med. 2014;55:9N-10N.
    PubMed     Text format    



  259. Brookhaven names Fowler as Scientist Emeritus.
    J Nucl Med. 2014;55:13N.
    PubMed     Text format    


  260. HSIEH YJ, Hwu L, Chen YC, Ke CC, et al
    P21-driven multifusion gene system for evaluating the efficacy of histone deacetylase inhibitors by in vivo molecular imaging and for transcription targeting therapy of cancer mediated by histone deacetylase inhibitor.
    J Nucl Med. 2014;55:678-85.
    PubMed     Text format     Abstract available


  261. BOOIJ J, van Loon G, de Bruin K, Voorn P, et al
    Acute administration of haloperidol does not influence 123I-FP-CIT binding to the dopamine transporter.
    J Nucl Med. 2014;55:647-9.
    PubMed     Text format     Abstract available


  262. FRUHWIRTH GO, Diocou S, Blower PJ, Ng T, et al
    A whole-body dual-modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment response in different microenvironments.
    J Nucl Med. 2014;55:686-94.
    PubMed     Text format     Abstract available


  263. MIKKELSEN KS, Sorensen M, Frisch K, Villadsen GE, et al
    The lumped constant for the galactose analog 2-18F-fluoro-2-deoxy-D-galactose is increased in patients with parenchymal liver disease.
    J Nucl Med. 2014;55:590-4.
    PubMed     Text format     Abstract available


  264. PRUSZYNSKI M, Koumarianou E, Vaidyanathan G, Revets H, et al
    Improved tumor targeting of anti-HER2 nanobody through N-succinimidyl 4-guanidinomethyl-3-iodobenzoate radiolabeling.
    J Nucl Med. 2014;55:650-6.
    PubMed     Text format     Abstract available


  265. YANG FY, Chang WY, Li JJ, Wang HE, et al
    Pharmacokinetic analysis and uptake of 18F-FBPA-Fr after ultrasound-induced blood-brain barrier disruption for potential enhancement of boron delivery for neutron capture therapy.
    J Nucl Med. 2014;55:616-21.
    PubMed     Text format     Abstract available


    March 2014
  266. BRANDERHORST W, Blezer EL, Houtkamp M, Ramakers RM, et al
    Three-Dimensional Histologic Validation of High-Resolution SPECT of Antibody Distributions Within Xenografts.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  267. ROUSSEAU C, Rousseau T, Campion L, Lacoste J, et al
    Laparoscopic Sentinel Lymph Node Versus Hyperextensive Pelvic Dissection for Staging Clinically Localized Prostate Carcinoma: A Prospective Study of 200 Patients.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  268. TAKAHASHI K, Hosoya T, Onoe K, Doi H, et al
    11C-Cetrozole: An Improved C-11C-Methylated PET Probe for Aromatase Imaging in the Brain.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  269. HO CL, Chen S, Leung YL, Cheng T, et al
    11C-Acetate PET/CT for Metabolic Characterization of Multiple Myeloma: A Comparative Study with 18F-FDG PET/CT.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  270. KWEE SA, Lim J, Watanabe A, Kromer-Baker K, et al
    Prognosis Related to Metastatic Burden Measured by 18F-Fluorocholine PET/CT in Castration-Resistant Prostate Cancer.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  271. BABA S, Isoda T, Maruoka Y, Kitamura Y, et al
    Diagnostic and Prognostic Value of Pretreatment SUV in 18F-FDG/PET in Breast Cancer: Comparison with Apparent Diffusion Coefficient from Diffusion-Weighted MR Imaging.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  272. NAKATOMI Y, Mizuno K, Ishii A, Wada Y, et al
    Neuroinflammation in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An 11C-(R)-PK11195 PET Study.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  273. MARQUEZ BV, Zheleznyak A, Lapi SE
    Glypican-3-Targeted 89Zr PET Imaging of Hepatocellular Carcinoma: Where Antibody Imaging Dares to Tread.
    J Nucl Med. 2014.
    PubMed     Text format    


  274. ROHREN EM, Dillehay GL, Jadvar H
    SNMMI Comment on ASCO 2013 "Choosing Wisely" Recommendation on Use of PET/CT in Recurrent Cancer Surveillance.
    J Nucl Med. 2014.
    PubMed     Text format    


  275. SORENSEN J, Sandberg D, Sandstrom M, Wennborg A, et al
    First-in-Human Molecular Imaging of HER2 Expression in Breast Cancer Metastases Using the 111In-ABY-025 Affibody Molecule.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  276. MORANA G, Piccardo A, Milanaccio C, Puntoni M, et al
    Value of 18F-3,4-Dihydroxyphenylalanine PET/MR Image Fusion in Pediatric Supratentorial Infiltrative Astrocytomas: A Prospective Pilot Study.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  277. RAUSCHER I, Eiber M, Furst S, Souvatzoglou M, et al
    PET/MR Imaging for the Detection and Characterization of Pulmonary Lesions in Oncologic Patients: Technical and Diagnostic Evaluation, Compared with PET/CT.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  278. DELSO G, Carl M, Wiesinger F, Sacolick L, et al
    Anatomic Evaluation of 3-Dimensional Ultrashort-Echo-Time Bone Maps for PET/MR Attenuation Correction.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  279. CAI H, Wu JS, Muzik O, Hsieh JT, et al
    Reduced 64Cu Uptake and Tumor Growth Inhibition by Knockdown of Human Copper Transporter 1 in Xenograft Mouse Model of Prostate Cancer.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  280. SHAM JG, Kievit FM, Grierson JR, Miyaoka RS, et al
    Glypican-3-Targeted 89Zr PET Imaging of Hepatocellular Carcinoma.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  281. NOMURA S, Nozaki S, Hamazaki T, Takeda T, et al
    PET Imaging Analysis with 64Cu in Disulfiram Treatment for Aberrant Copper Biodistribution in Menkes Disease Mouse Model.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  282. WINTERDAHL M, Audrain H, Landau AM, Smith DF, et al
    PET Brain Imaging of Neuropeptide Y2 Receptors Using N-11C-Methyl-JNJ-31020028 in Pigs.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  283. TERWISSCHA VAN SCHELTINGA AG, Lub-de Hooge MN, Hinner MJ, Verheijen RB, et al
    In Vivo Visualization of MET Tumor Expression and Anticalin Biodistribution with the MET-Specific Anticalin 89Zr-PRS-110 PET Tracer.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  284. PLISSON C, Weinzimmer D, Jakobsen S, Natesan S, et al
    Phosphodiesterase 10A PET Radioligand Development Program: From Pig to Human.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  285. PRICE PM, Badawi RD, Cherry SR, Jones T, et al
    Ultra Staging to Unmask the Prescribing of Adjuvant Therapy in Cancer Patients: The Future Opportunity to Image Micrometastases Using Total-Body 18F-FDG PET Scanning.
    J Nucl Med. 2014.
    PubMed     Text format    


  286. DAUBE-WITHERSPOON ME, Surti S, Perkins AE, Karp JS, et al
    Determination of Accuracy and Precision of Lesion Uptake Measurements in Human Subjects with Time-of-Flight PET.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  287. LUEHMANN HP, Pressly ED, Detering L, Wang C, et al
    PET/CT Imaging of Chemokine Receptor CCR5 in Vascular Injury Model Using Targeted Nanoparticle.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  288. SEGALL GM
    PET/CT with Sodium 18F-Fluoride for Management of Patients with Prostate Cancer.
    J Nucl Med. 2014.
    PubMed     Text format    


  289. TRAJKOVIC-ARSIC M, Mohajerani P, Sarantopoulos A, Kalideris E, et al
    Multimodal molecular imaging of integrin alphavbeta3 for in vivo detection of pancreatic cancer.
    J Nucl Med. 2014;55:446-51.
    PubMed     Text format     Abstract available


  290. HAECKEL A, Appler F, Figge L, Kratz H, et al
    XTEN-annexin A5: XTEN allows complete expression of long-circulating protein-based imaging probes as recombinant alternative to PEGylation.
    J Nucl Med. 2014;55:508-14.
    PubMed     Text format     Abstract available


  291. ERIKSSON O, Selvaraju RK, Johansson L, Eriksson JW, et al
    Quantitative imaging of serotonergic biosynthesis and degradation in the endocrine pancreas.
    J Nucl Med. 2014;55:460-5.
    PubMed     Text format     Abstract available


  292. KEIDAR Z, Pirmisashvili N, Leiderman M, Nitecki S, et al
    18F-FDG uptake in noninfected prosthetic vascular grafts: incidence, patterns, and changes over time.
    J Nucl Med. 2014;55:392-5.
    PubMed     Text format     Abstract available


  293. PETROU M, Frey KA, Kilbourn MR, Scott PJ, et al
    In vivo imaging of human cholinergic nerve terminals with (-)-5-(18)F-fluoroethoxybenzovesamicol: biodistribution, dosimetry, and tracer kinetic analyses.
    J Nucl Med. 2014;55:396-404.
    PubMed     Text format     Abstract available


  294. SPINELLI AE, Boschi F
    Human Cerenkov imaging using 18F-FDG.
    J Nucl Med. 2014;55:523.
    PubMed     Text format    


  295. THOREK DL, Riedl CC, Grimm J
    Reply: Human Cerenkov imaging using 18F-FDG.
    J Nucl Med. 2014;55:523-4.
    PubMed     Text format    


  296. HANDLEY MG, Medina RA, Mariotti E, Kenny GD, et al
    Cardiac hypoxia imaging: second-generation analogues of 64Cu-ATSM.
    J Nucl Med. 2014;55:488-94.
    PubMed     Text format     Abstract available


    February 2014
  297. FILSS CP, Galldiks N, Stoffels G, Sabel M, et al
    Comparison of 18F-FET PET and Perfusion-Weighted MR Imaging: A PET/MR Imaging Hybrid Study in Patients with Brain Tumors.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  298. WEBSTER JM, Morton CA, Johnson BF, Yang H, et al
    Functional Imaging of Oxidative Stress with a Novel PET Imaging Agent, 18F-5-Fluoro-L-Aminosuberic Acid.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  299. HILLNER BE, Siegel BA, Hanna L, Duan F, et al
    Impact of 18F-Fluoride PET in Patients with Known Prostate Cancer: Initial Results from the National Oncologic PET Registry.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  300. ROSSI C, Kanoun S, Berriolo-Riedinger A, Dygai-Cochet I, et al
    Interim 18F-FDG PET SUVmax Reduction Is Superior to Visual Analysis in Predicting Outcome Early in Hodgkin Lymphoma Patients.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  301. HANSEN HD, Herth MM, Ettrup A, Andersen VL, et al
    Radiosynthesis and In Vivo Evaluation of Novel Radioligands for PET Imaging of Cerebral 5-HT7 Receptors.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  302. RAHM V, Boxheimer L, Bruehlmeier M, Berberat J, et al
    Focal Changes in Diffusivity on Apparent Diffusion Coefficient MR Imaging and Amino Acid Uptake on PET Do Not Colocalize in Nonenhancing Low-Grade Gliomas.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  303. BAQIR M, Lowe V, Yi ES, Ryu JH, et al
    18F-FDG PET Scanning in Pulmonary Amyloidosis.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  304. MANSI L, Ciarmiello A
    Perspectives on PET/MR Imaging: Are We Ready for Clinical Use?
    J Nucl Med. 2014.
    PubMed     Text format    


  305. HORTI AG, Gao Y, Kuwabara H, Wang Y, et al
    18F-ASEM, a Radiolabeled Antagonist for Imaging the alpha7-Nicotinic Acetylcholine Receptor with PET.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  306. ORLHAC F, Soussan M, Maisonobe JA, Garcia CA, et al
    Tumor Texture Analysis in 18F-FDG PET: Relationships Between Texture Parameters, Histogram Indices, Standardized Uptake Values, Metabolic Volumes, and Total Lesion Glycolysis.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  307. TAYLOR AT
    Radionuclides in Nephrourology, Part 1: Radiopharmaceuticals, Quality Control, and Quantitative Indices.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  308. CHACKO AM, Li C, Nayak M, Mikitsh JL, et al
    Development of 124I Immuno-PET Targeting Tumor Vascular TEM1/Endosialin.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  309. MCGINNITY CJ, Hammers A, Riano Barros DA, Luthra SK, et al
    Initial Evaluation of 18F-GE-179, A Putative PET Tracer for Activated N-Methyl D-Aspartate Receptors.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  310. FLECHSIG P, Kratochwil C, Schwartz LH, Rath D, et al
    Quantitative Volumetric CT-Histogram Analysis in N-Staging of 18F-FDG-Equivocal Patients with Lung Cancer.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  311. DICKENS AM, Vainio S, Marjamaki P, Johansson J, et al
    Detection of Microglial Activation in an Acute Model of Neuroinflammation Using PET and Radiotracers 11C-(R)-PK11195 and 18F-GE-180.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  312. MILES KA, Ganeshan B, Rodriguez-Justo M, Goh VJ, et al
    Multifunctional Imaging Signature for V-KI-RAS2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutations in Colorectal Cancer.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  313. HEUSCH P, Buchbender C, Kohler J, Nensa F, et al
    Thoracic Staging in Lung Cancer: Prospective Comparison of 18F-FDG PET/MRI and 18F-FDG PET/CT.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  314. KANG F, Ma W, Ma X, Shao Y, et al
    Propranolol Inhibits Glucose Metabolism and 18F-FDG Uptake of Breast Cancer Through Posttranscriptional Downregulation of Hexokinase-2.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  315. KNOWLES SM, Zettlitz KA, Tavare R, Rochefort MM, et al
    Quantitative ImmunoPET of Prostate Cancer Xenografts with 89Zr- and 124I-Labeled Anti-PSCA A11 Minibody.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  316. KUHN FP, Hullner M, Mader CE, Kastrinidis N, et al
    Contrast-Enhanced PET/MR Imaging Versus Contrast-Enhanced PET/CT in Head and Neck Cancer: How Much MR Information Is Needed?
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  317. CARLIN S, Zhang H, Reese M, Ramos NN, et al
    A Comparison of the Imaging Characteristics and Microregional Distribution of 4 Hypoxia PET Tracers.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available



  318. Combined nuclear medicine/diagnostic radiology residencies: an update.
    J Nucl Med. 2014;55:11N.
    PubMed     Text format    


  319. CHALLAPALLI A, Sharma R, Hallett WA, Kozlowski K, et al
    Biodistribution and radiation dosimetry of deuterium-substituted 18F-fluoromethyl-[1, 2-2H4]choline in healthy volunteers.
    J Nucl Med. 2014;55:256-63.
    PubMed     Text format     Abstract available


  320. EZZIDDIN S, Attassi M, Yong-Hing CJ, Ahmadzadehfar H, et al
    Predictors of long-term outcome in patients with well-differentiated gastroenteropancreatic neuroendocrine tumors after peptide receptor radionuclide therapy with 177Lu-octreotate.
    J Nucl Med. 2014;55:183-90.
    PubMed     Text format     Abstract available


  321. FOWLER AM
    A molecular approach to breast imaging.
    J Nucl Med. 2014;55:177-80.
    PubMed     Text format     Abstract available


  322. TERRY SY, Abiraj K, Frielink C, van Dijk LK, et al
    Imaging integrin alphavbeta3 on blood vessels with 111In-RGD2 in head and neck tumor xenografts.
    J Nucl Med. 2014;55:281-6.
    PubMed     Text format     Abstract available


  323. MUSELAERS CH, Stillebroer AB, Desar IM, Boers-Sonderen MJ, et al
    Tyrosine kinase inhibitor sorafenib decreases 111In-girentuximab uptake in patients with clear cell renal cell carcinoma.
    J Nucl Med. 2014;55:242-7.
    PubMed     Text format     Abstract available


  324. VELIKYAN I, Sundin A, Sorensen J, Lubberink M, et al
    Quantitative and qualitative intrapatient comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: net uptake rate for accurate quantification.
    J Nucl Med. 2014;55:204-10.
    PubMed     Text format     Abstract available


  325. REICHERT DE
    A digital revolution in radiosynthesis.
    J Nucl Med. 2014;55:181-2.
    PubMed     Text format    


  326. JAVED MR, Chen S, Kim HK, Wei L, et al
    Efficient radiosynthesis of 3'-deoxy-3'-18F-fluorothymidine using electrowetting-on-dielectric digital microfluidic chip.
    J Nucl Med. 2014;55:321-8.
    PubMed     Text format     Abstract available


    January 2014
  327. KHAYUM MA, de Vries EF, Glaudemans AW, Dierckx RA, et al
    In Vivo Imaging of Brain Estrogen Receptors in Rats: A 16alpha-18F-Fluoro-17beta-Estradiol PET Study.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  328. YAMANE T, Park MJ, Richter D, Nekolla SG, et al
    Small-Animal PET Imaging of Isolated Perfused Rat Heart.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  329. TSUKADA H, Nishiyama S, Fukumoto D, Kanazawa M, et al
    Novel PET Probes 18F-BCPP-EF and 18F-BCPP-BF for Mitochondrial Complex I: A PET Study in Comparison with 18F-BMS-747158-02 in Rat Brain.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  330. ZELIADT SB, Loggers ET, Slatore CG, Au DH, et al
    Preoperative PET and the Reduction of Unnecessary Surgery Among Newly Diagnosed Lung Cancer Patients in a Community Setting.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  331. JIN X, Mulnix T, Sandiego CM, Carson RE, et al
    Evaluation of Frame-Based and Event-by-Event Motion-Correction Methods for Awake Monkey Brain PET Imaging.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  332. KITAJIMA K, Murphy RC, Nathan MA, Froemming AT, et al
    Detection of Recurrent Prostate Cancer After Radical Prostatectomy: Comparison of 11C-Choline PET/CT with Pelvic Multiparametric MR Imaging with Endorectal Coil.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  333. EBENHAN T, Zeevaart JR, Venter JD, Govender T, et al
    Preclinical Evaluation of 68Ga-Labeled 1,4,7-Triazacyclononane-1,4,7-Triacetic Acid-Ubiquicidin as a Radioligand for PET Infection Imaging.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  334. PAUL S, Khanapur S, Sijbesma JW, Ishiwata K, et al
    Use of 11C-MPDX and PET to Study Adenosine A1 Receptor Occupancy by Nonradioactive Agonists and Antagonists.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  335. MOLLET P, Keereman V, Bini J, Izquierdo-Garcia D, et al
    Improvement of Attenuation Correction in Time-of-Flight PET/MR Imaging with a Positron-Emitting Source.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  336. GRIESSINGER CM, Kehlbach R, Bukala D, Wiehr S, et al
    In Vivo Tracking of Th1 Cells by PET Reveals Quantitative and Temporal Distribution and Specific Homing in Lymphatic Tissue.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  337. O'BRIEN ER, Kersemans V, Tredwell M, Checa B, et al
    Glial Activation in the Early Stages of Brain Metastasis: TSPO as a Diagnostic Biomarker.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  338. GIOVACCHINI G, Picchio M, Garcia-Parra R, Briganti A, et al
    11C-Choline PET/CT Predicts Prostate Cancer-Specific Survival in Patients with Biochemical Failure During Androgen-Deprivation Therapy.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  339. SUBRAMANIAM RM, Alluri KC, Tahari AK, Aygun N, et al
    PET/CT Imaging and Human Papilloma Virus-Positive Oropharyngeal Squamous Cell Cancer: Evolving Clinical Imaging Paradigm.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  340. NAYA M, Murthy VL, Taqueti VR, Foster CR, et al
    Preserved Coronary Flow Reserve Effectively Excludes High-Risk Coronary Artery Disease on Angiography.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  341. TOLMACHEV V, Varasteh Z, Honarvar H, Hosseinimehr SJ, et al
    Imaging of Platelet-Derived Growth Factor Receptor beta Expression in Glioblastoma Xenografts Using Affibody Molecule 111In-DOTA-Z09591.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  342. FAHEY F, Zukotynski K, Capala J, Knight N, et al
    Targeted Radionuclide Therapy: Proceedings of a Joint Workshop Hosted by the National Cancer Institute and the Society of Nuclear Medicine and Molecular Imaging.
    J Nucl Med. 2014.
    PubMed     Text format    


  343. SCHILLACI O
    18F-DOPA and Other Radiopharmaceuticals for Imaging Unknown Primary Neuroendocrine Tumours.
    J Nucl Med. 2014.
    PubMed     Text format    


  344. FRIEDMAN NC, Hassan A, Grady E, Matsuoka DT, et al
    Efficacy of Thyroid Blockade on Thyroid Radioiodine Uptake in 123I-mIBG Imaging.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


  345. SHRESTHA SS, Liow JS, Lu S, Jenko K, et al
    11C-CUMI-101, a PET Radioligand, Behaves as a Serotonin 1A Receptor Antagonist and Also Binds to alpha1 Adrenoceptors in Brain.
    J Nucl Med. 2014;55:141-6.
    PubMed     Text format     Abstract available


  346. NEVES AA, Brindle KM
    Imaging cell death.
    J Nucl Med. 2014;55:1-4.
    PubMed     Text format     Abstract available


  347. SAH BR, Schibli R, Waibel R, von Boehmer L, et al
    Tumor imaging in patients with advanced tumors using a new (99m) Tc-radiolabeled vitamin B12 derivative.
    J Nucl Med. 2014;55:43-9.
    PubMed     Text format     Abstract available


  348. OGAWA M, Umeda IO, Kosugi M, Kawai A, et al
    Development of 111In-labeled liposomes for vulnerable atherosclerotic plaque imaging.
    J Nucl Med. 2014;55:115-20.
    PubMed     Text format     Abstract available


  349. HUETING R, Kersemans V, Cornelissen B, Tredwell M, et al
    A comparison of the behavior of (64)Cu-acetate and (64)Cu-ATSM in vitro and in vivo.
    J Nucl Med. 2014;55:128-34.
    PubMed     Text format     Abstract available


  350. NOCK BA, Maina T, Krenning EP, de Jong M, et al
    "To serve and protect": enzyme inhibitors as radiopeptide escorts promote tumor targeting.
    J Nucl Med. 2014;55:121-7.
    PubMed     Text format     Abstract available


  351. CACHIN F, Miot-Noirault E, Gillet B, Isnardi V, et al
    (123)I-BZA2 as a melanin-targeted radiotracer for the identification of melanoma metastases: results and perspectives of a multicenter phase III clinical trial.
    J Nucl Med. 2014;55:15-22.
    PubMed     Text format     Abstract available


  352. BROOKS FJ, Grigsby PW
    The effect of small tumor volumes on studies of intratumoral heterogeneity of tracer uptake.
    J Nucl Med. 2014;55:37-42.
    PubMed     Text format     Abstract available


  353. SCHATKA I, Bengel FM
    Advanced imaging of cardiac sarcoidosis.
    J Nucl Med. 2014;55:99-106.
    PubMed     Text format     Abstract available


  354. THOREK DL, Riedl CC, Grimm J
    Clinical Cerenkov luminescence imaging of (18)F-FDG.
    J Nucl Med. 2014;55:95-8.
    PubMed     Text format     Abstract available


    December 2013
  355. JANSEN NL, Suchorska B, Wenter V, Eigenbrod S, et al
    Dynamic 18F-FET PET in Newly Diagnosed Astrocytic Low-Grade Glioma Identifies High-Risk Patients.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  356. LEE H, Kim SK, Kim YI, Kim TS, et al
    Early Determination of Prognosis by Interim 3'-Deoxy-3'-18F-Fluorothymidine PET in Patients with Non-Hodgkin Lymphoma.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  357. MAKRIS NE, Boellaard R, Visser EP, de Jong JR, et al
    Multicenter Harmonization of 89Zr PET/CT Performance.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  358. PANDIT-TASKAR N, Larson SM, Carrasquillo JA
    Bone-Seeking Radiopharmaceuticals for Treatment of Osseous Metastases, Part 1: alpha Therapy with 223Ra-Dichloride.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  359. IMPERIALE A, Rust E, Gabriel S, Detour J, et al
    18F-Fluorodihydroxyphenylalanine PET/CT in Patients with Neuroendocrine Tumors of Unknown Origin: Relation to Tumor Origin and Differentiation.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  360. AL-NABHANI KZ, Syed R, Michopoulou S, Alkalbani J, et al
    Qualitative and Quantitative Comparison of PET/CT and PET/MR imaging in Clinical Practice.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  361. MORTIMER JE, Bading JR, Colcher DM, Conti PS, et al
    Functional Imaging of Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Using 64Cu-DOTA-Trastuzumab PET.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  362. DELGADO RI, Swint JM, Lairson DR, Johnson NP, et al
    Cost Analysis of PET and Comprehensive Lifestyle Modification for the Reversal of Atherosclerosis.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  363. KIRISLI HA, Gupta V, Shahzad R, Al Younis I, et al
    Additional Diagnostic Value of Integrated Analysis of Cardiac CTA and SPECT MPI Using the SMARTVis System in Patients with Suspected Coronary Artery Disease.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  364. JAMES ML, Shen B, Nielsen CH, Behera D, et al
    Evaluation of sigma-1 Receptor Radioligand 18F-FTC-146 in Rats and Squirrel Monkeys Using PET.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  365. THIE JA
    Understanding SUV Variability in Reference Tissue for 18F-FDG PET with a Simple Measurement Model.
    J Nucl Med. 2013.
    PubMed     Text format    


  366. DIMITRAKOPOULOU-STRAUSS A, Frenkel A, Epelbaum R
    Reply: Understanding SUV Variability in Reference Tissue for 18F-FDG PET with a Simple Measurement Model.
    J Nucl Med. 2013.
    PubMed     Text format    


  367. SALAVATI A, Saboury B, Alavi A
    Comment on: "Tumor Aggressiveness and Patient Outcome in Cancer of the Pancreas Assessed by Dynamic 18F-FDG PET/CT"
    J Nucl Med. 2013.
    PubMed     Text format    


  368. EIBER M, Takei T, Souvatzoglou M, Mayerhoefer ME, et al
    Performance of Whole-Body Integrated 18F-FDG PET/MR in Comparison to PET/CT for Evaluation of Malignant Bone Lesions.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  369. DIVGI C
    Whither Goest Thou, Radiopharmaceutical Therapy?
    J Nucl Med. 2013.
    PubMed     Text format    


  370. WALRAND S, Hesse M, Chiesa C, Lhommel R, et al
    The Low Hepatic Toxicity per Gray of 90Y Glass Microspheres Is Linked to Their Transport in the Arterial Tree Favoring a Nonuniform Trapping as Observed in Posttherapy PET Imaging.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available



  371. GE beta-amyloid agent approved.
    J Nucl Med. 2013;54:10N.
    PubMed     Text format    


  372. MULLER C, Bunka M, Reber J, Fischer C, et al
    Promises of cyclotron-produced 44Sc as a diagnostic match for trivalent beta--emitters: in vitro and in vivo study of a 44Sc-DOTA-folate conjugate.
    J Nucl Med. 2013;54:2168-74.
    PubMed     Text format     Abstract available


  373. WONG KK, Piert M
    Reply: Regarding Dynamic bone imaging with 99mTc-labeled diphosphonates and 18F-NaF: mechanisms and applications.
    J Nucl Med. 2013;54:2190-1.
    PubMed     Text format    


  374. FREESMEYER M
    Regarding Dynamic bone imaging with 99mTc-labeled diphosphonates and 18F-NaF: mechanisms and applications.
    J Nucl Med. 2013;54:2190.
    PubMed     Text format    


  375. TAMARAPPOO B, Hachamovitch R
    18F-FDG Imaging of carotid arteries for identifying the vulnerable patient: are we at the beginning of the end?
    J Nucl Med. 2013;54:2021-3.
    PubMed     Text format    


  376. NOH TS, Moon SH, Cho YS, Hong SP, et al
    Relation of carotid artery 18F-FDG uptake to C-reactive protein and Framingham risk score in a large cohort of asymptomatic adults.
    J Nucl Med. 2013;54:2070-6.
    PubMed     Text format     Abstract available


  377. GAERTNER FC, Wiedemann T, Yousefi BH, Lee M, et al
    Preclinical evaluation of 18F-LMI1195 for in vivo imaging of pheochromocytoma in the MENX tumor model.
    J Nucl Med. 2013;54:2111-7.
    PubMed     Text format     Abstract available


    November 2013
  378. LIN SC, Lin KJ, Hsiao IT, Hsieh CJ, et al
    In Vivo Detection of Monoaminergic Degeneration in Early Parkinson Disease by 18F-9-Fluoropropyl-(+)-Dihydrotetrabenzazine PET.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  379. MIER W, Kratochwil C, Hassel JC, Giesel FL, et al
    Radiopharmaceutical Therapy of Patients with Metastasized Melanoma with the Melanin-Binding Benzamide 131I-BA52.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  380. VAN LAERE KJ, Sanabria-Bohorquez SM, Mozley DP, Burns DH, et al
    11C-MK-8278 PET as a Tool for Pharmacodynamic Brain Occupancy of Histamine 3 Receptor Inverse Agonists.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  381. RENAUD JM , Mylonas I, McArdle B, Dowsley T, et al
    Clinical Interpretation Standards and Quality Assurance for the Multicenter PET/CT Trial: 82Rb as an Alternative Radiopharmaceutical for Myocardial Imaging.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  382. GUO J , Guo N, Lang L, Kiesewetter DO, et al
    18F-Alfatide II and 18F-FDG Dual-Tracer Dynamic PET for Parametric, Early Prediction of Tumor Response to Therapy.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  383. BRAUN H , Ziegler S, Lentschig MG, Quick HH, et al
    Implementation and Performance Evaluation of Simultaneous PET/MR Whole-Body Imaging with Continuous Table Motion.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  384. HILLNER BE , Tosteson AN, Tosteson TD, Wang Q, et al
    Intended Versus Inferred Care After PET Performed for Initial Staging in the National Oncologic PET Registry.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  385. LI S , Sinusas AJ, Dobrucki LW, Liu YH, et al
    New Approach to Quantification of Molecularly Targeted Radiotracer Uptake from Hybrid Cardiac SPECT/CT: Methodology and Validation.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  386. NELSON JS , Christianson OI, Harkness BA, Madsen MT, et al
    Improved Nuclear Medicine Uniformity Assessment with Noise Texture Analysis.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  387. AWDE AR , Boisgard R, Theze B, Dubois A, et al
    The Translocator Protein Radioligand 18F-DPA-714 Monitors Antitumor Effect of Erufosine in a Rat 9L Intracranial Glioma Model.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  388. LIU Y , Hu X, Liu H, Bu L, et al
    A Comparative Study of Radiolabeled Bombesin Analogs for the PET Imaging of Prostate Cancer.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  389. LANGEN KJ , Rapp M, Galldiks N, Reifenberger G, et al
    Reply: Discriminating Ability of 18F-FET PET for Several Cerebral Neoplastic Lesions.
    J Nucl Med. 2013.
    PubMed     Text format    


  390. KAWADA T
    Discriminating Ability of 18F-FET PET for Several Cerebral Neoplastic Lesions.
    J Nucl Med. 2013.
    PubMed     Text format    


  391. PAPPAS V
    SNMMI leadership update: Expanded programs, sound finances for SNMMI.
    J Nucl Med. 2013;54:26N.
    PubMed     Text format    


  392. WAHL RL
    2013 SNMMI Highlights Lecture: oncology.
    J Nucl Med. 2013;54:11N-22N.
    PubMed     Text format    


  393. GLASER M, Iveson P, Hoppmann S, Indrevoll B, et al
    Three methods for 18F labeling of the HER2-binding affibody molecule Z(HER2:2891) including preclinical assessment.
    J Nucl Med. 2013;54:1981-8.
    PubMed     Text format     Abstract available


  394. FRINGS L, Spehl TS, Weber WA, Hull M, et al
    Amyloid-beta load predicts medial temporal lobe dysfunction in Alzheimer dementia.
    J Nucl Med. 2013;54:1909-14.
    PubMed     Text format     Abstract available


  395. HERNANDEZ AM, Huber JS, Murphy ST, Janabi M, et al
    Longitudinal evaluation of left ventricular substrate metabolism, perfusion, and dysfunction in the spontaneously hypertensive rat model of hypertrophy using small-animal PET/CT imaging.
    J Nucl Med. 2013;54:1938-45.
    PubMed     Text format     Abstract available


  396. MAURER AH, Camilleri M, Donohoe K, Knight LC, et al
    The SNMMI and EANM practice guideline for small-bowel and colon transit 1.0.
    J Nucl Med. 2013;54:2004-13.
    PubMed     Text format    


  397. ROSSIN R, Lappchen T, van den Bosch SM, Laforest R, et al
    Diels-Alder reaction for tumor pretargeting: in vivo chemistry can boost tumor radiation dose compared with directly labeled antibody.
    J Nucl Med. 2013;54:1989-95.
    PubMed     Text format     Abstract available


  398. GUO Q, Colasanti A, Owen DR, Onega M, et al
    Quantification of the specific translocator protein signal of 18F-PBR111 in healthy humans: a genetic polymorphism effect on in vivo binding.
    J Nucl Med. 2013;54:1915-23.
    PubMed     Text format     Abstract available


  399. WYCKHUYS T, Verhaeghe J, Wyffels L, Langlois X, et al
    N-acetylcysteine- and MK-801-induced changes in glutamate levels do not affect in vivo binding of metabotropic glutamate 5 receptor radioligand 11C-ABP688 in rat brain.
    J Nucl Med. 2013;54:1954-61.
    PubMed     Text format     Abstract available


  400. HARRIS SM, Davis JC, Snyder SE, Butch ER, et al
    Evaluation of the biodistribution of 11C-methionine in children and young adults.
    J Nucl Med. 2013;54:1902-8.
    PubMed     Text format     Abstract available


  401. SCALICI JM, Thomas S, Harrer C, Raines TA, et al
    Imaging VCAM-1 as an indicator of treatment efficacy in metastatic ovarian cancer.
    J Nucl Med. 2013;54:1883-9.
    PubMed     Text format     Abstract available


    October 2013
  402. LIU Z , Barber C, Wan L, Liu S, et al
    SPECT Imaging of Inflammatory Response in Ischemic-Reperfused Rat Hearts Using a 99mTc-Labeled Dual-Domain Cytokine Ligand.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  403. LIZARRAGA KJ , Allen-Auerbach M, Czernin J, Desalles AA, et al
    18F-FDOPA PET for Differentiating Recurrent or Progressive Brain Metastatic Tumors from Late or Delayed Radiation Injury After Radiation Treatment.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  404. JOHN AE , Luckett JC, Tatler AL, Awais RO, et al
    Preclinical SPECT/CT Imaging of alphavbeta6 Integrins for Molecular Stratification of Idiopathic Pulmonary Fibrosis.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  405. ALF MF , Duarte JM, Schibli R, Gruetter R, et al
    Brain Glucose Transport and Phosphorylation Under Acute Insulin-Induced Hypoglycemia in Mice: An 18F-FDG PET Study.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  406. GALLDIKS N , Stoffels G, Ruge MI, Rapp M, et al
    Role of O-(2-18F-Fluoroethyl)-L-Tyrosine PET as a Diagnostic Tool for Detection of Malignant Progression in Patients with Low-Grade Glioma.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  407. FUCHS TA , Sah BR, Stehli J, Bull S, et al
    Attenuation Correction Maps for SPECT Myocardial Perfusion Imaging from Contrast-Enhanced Coronary CT Angiography: Gemstone Spectral Imaging with Single-Source Dual Energy and Material Decomposition.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  408. LAM MG , Goris ML, Iagaru AH, Mittra ES, et al
    Prognostic Utility of 90Y Radioembolization Dosimetry Based on Fusion 99mTc-Macroaggregated Albumin-99mTc-Sulfur Colloid SPECT.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  409. LASTORIA S , Piccirillo MC, Caraco C, Nasti G, et al
    Early PET/CT Scan Is More Effective Than Response Evaluation Criteria In Solid Tumors in Predicting Outcome of Patients with Liver Metastases from Colorectal Cancer Treated with Preoperative Chemotherapy Plus Bevacizumab.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  410. DOSS M , Kolb HC, Walsh JC, Mocharla V, et al
    Biodistribution and Radiation Dosimetry of 18F-CP-18, a Potential Apoptosis Imaging Agent, as Determined from PET/CT Scans in Healthy Volunteers.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  411. SMITS ML , Elschot M, van den Bosch MA, van de Maat GH, et al
    In Vivo Dosimetry Based on SPECT and MR Imaging of 166Ho-Microspheres for Treatment of Liver Malignancies.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  412. VAN DIJK LK , Hoeben BA, Kaanders JH, Franssen GM, et al
    Imaging of Epidermal Growth Factor Receptor Expression in Head and Neck Cancer with USPECT and 111In-Labeled Cetuximab-F(ab')2.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  413. DEWARAJA YK , Ljungberg M, Green AJ, Zanzonico PB, et al
    MIRD Pamphlet No. 24: Guidelines for Quantitative 131I SPECT in Dosimetry Applications.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  414. HELLWIG S , Kreft A, Amtage F, Tuscher O, et al
    123I-Iodobenzamide SPECT Is Not an Independent Predictor of Dopaminergic Responsiveness in Patients with Suspected Atypical Parkinsonian Syndromes.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  415. SANDIEGO CM , Jin X, Mulnix T, Fowles K, et al
    Awake Nonhuman Primate Brain PET Imaging with Minimal Head Restraint: Evaluation of GABAA-Benzodiazepine Binding with 11C-Flumazenil in Awake and Anesthetized Animals.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  416. XI W , Su D, Nie B, Yu Y, et al
    18F-FDG PET Study Reveals Brain Functional Changes During Attention in Rats.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  417. PAIDPALLY V , Tahari AK, Lam S, Alluri K, et al
    Addition of 18F-FDG PET/CT to Clinical Assessment Predicts Overall Survival in HNSCC: A Retrospective Analysis with Follow-up for 12 Years.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  418. GEBHART G , Gamez C, Holmes E, Robles J, et al
    18F-FDG PET/CT for Early Prediction of Response to Neoadjuvant Lapatinib, Trastuzumab, and Their Combination in HER2-Positive Breast Cancer: Results from Neo-ALTTO.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available



  419. 2013 SNMMI Highlights Lecture: General Clinical Nuclear Medicine: Clinical SPECT/CT--Time for a New Standard of Care.
    J Nucl Med. 2013;54:19N-27N.
    PubMed     Text format    


  420. JADVAR H
    Molecular Imaging of Prostate Cancer with PET.
    J Nucl Med. 2013;54:1685-1688.
    PubMed     Text format     Abstract available



  421. 2013 SNMMI Highlights Lecture: Cardiovascular Sciences.
    J Nucl Med. 2013;54:9N-18N.
    PubMed     Text format    


  422. SAMEN E , Arnberg F, Lu L, Olofsson MH, et al
    Metabolism of epidermal growth factor receptor targeting probe [11C]PD153035: impact on biodistribution and tumor uptake in rats.
    J Nucl Med. 2013;54:1804-11.
    PubMed     Text format     Abstract available


  423. TAVARES AA , Batis JC, Papin C, Jennings D, et al
    Kinetic modeling, test-retest, and dosimetry of 123I-MNI-420 in humans.
    J Nucl Med. 2013;54:1760-7.
    PubMed     Text format     Abstract available


  424. SANDSTROM M , Velikyan I, Garske-Roman U, Sorensen J, et al
    Comparative biodistribution and radiation dosimetry of 68Ga-DOTATOC and 68Ga-DOTATATE in patients with neuroendocrine tumors.
    J Nucl Med. 2013;54:1755-9.
    PubMed     Text format     Abstract available


  425. CECCARINI J , Koole M, Van Laere K
    Reply: Task- versus amphetamine-induced displacement of high-affinity D2/3 receptor ligands.
    J Nucl Med. 2013;54:1849-50.
    PubMed     Text format    


  426. YAKUSHEV I , Forster S, Cumming P
    Task- versus amphetamine-induced displacement of high-affinity D2/3 receptor ligands.
    J Nucl Med. 2013;54:1849.
    PubMed     Text format    


    September 2013
  427. KIM EE
    The Requisites: Nuclear Medicine.
    J Nucl Med. 2013.
    PubMed     Text format    


  428. KENNY LM
    18F-FDG PET/CT for Early Prediction of Response to Neoadjuvant Lapatinib, Trastuzumab, and Their Combination in HER2-Positive Breast Cancer: Results from Neo-ALTTO.
    J Nucl Med. 2013.
    PubMed     Text format    


  429. KIM EE
    Practical SPECT/CT in Nuclear Medicine.
    J Nucl Med. 2013.
    PubMed     Text format    


  430. CYPESS AM , Doyle AN, Sass CA, Huang TL, et al
    Quantification of Human and Rodent Brown Adipose Tissue Function Using 99mTc-Methoxyisobutylisonitrile SPECT/CT and 18F-FDG PET/CT.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  431. BRADSHAW TJ , Bowen SR, Jallow N, Forrest LJ, et al
    Heterogeneity in Intratumor Correlations of 18F-FDG, 18F-FLT, and 61Cu-ATSM PET in Canine Sinonasal Tumors.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  432. CHENG NM , Dean Fang YH, Tung-Chieh Chang J, Huang CG, et al
    Textural Features of Pretreatment 18F-FDG PET/CT Images: Prognostic Significance in Patients with Advanced T-Stage Oropharyngeal Squamous Cell Carcinoma.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  433. TAMURA K , Kurihara H, Yonemori K, Tsuda H, et al
    64Cu-DOTA-Trastuzumab PET Imaging in Patients with HER2-Positive Breast Cancer.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  434. VIOLA-VILLEGAS NT , Rice SL, Carlin S, Wu X, et al
    Applying PET to Broaden the Diagnostic Utility of the Clinically Validated CA19.9 Serum Biomarker for Oncology.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  435. BERTHET L , Humbert O, Cochet A
    Reply: Prognostic Implications of Imaging-Based Bone Marrow Assessment in Lymphoma: 18F-FDG PET, MR Imaging, or 18F-FDG PET/MR Imaging?
    J Nucl Med. 2013.
    PubMed     Text format    


  436. JONES T , Budinger TF
    The Potential for Low-Dose Functional Studies in Maternal-Fetal Medicine Using PET/MR Imaging.
    J Nucl Med. 2013.
    PubMed     Text format    


  437. KUMAR A , Chugani HT
    The Role of Radionuclide Imaging in Epilepsy, Part 2: Epilepsy Syndromes.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  438. BOISSON F , Zahra D, Parmar A, Gregoire MC, et al
    Imaging Capabilities of the Inveon SPECT System Using Single-and Multipinhole Collimators.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  439. COURTOIS A , Nusgens BV, Hustinx R, Namur G, et al
    18F-FDG Uptake Assessed by PET/CT in Abdominal Aortic Aneurysms Is Associated with Cellular and Molecular Alterations Prefacing Wall Deterioration and Rupture.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  440. WELCH A , Mingarelli M, Riedel G, Platt B, et al
    Mapping Changes in Mouse Brain Metabolism with PET/CT.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  441. SEO HJ
    FDG PET/CT in Clinical Oncology: Case Based Approach with Teaching Points.
    J Nucl Med. 2013.
    PubMed     Text format    


  442. ADAMS HJ , Kwee TC, Nievelstein RA
    Prognostic Implications of Imaging-Based Bone Marrow Assessment in Lymphoma: 18F-FDG PET, MR Imaging, or 18F-FDG PET/MR Imaging?
    J Nucl Med. 2013.
    PubMed     Text format    


  443. BEZRUKOV I , Schmidt H, Mantlik F, Schwenzer N, et al
    MR-Based Attenuation Correction Methods for Improved PET Quantification in Lesions Within Bone and Susceptibility Artifact Regions.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  444. DILLEHAY G
    Advocating for appropriate and adequate reimbursement.
    J Nucl Med. 2013;54:20N.
    PubMed     Text format    


  445. ZUBAL G
    From the Exhibitors' Hall: SNMMI Annual Meeting 2013.
    J Nucl Med. 2013;54:17N-19N.
    PubMed     Text format    


  446. MINOSHIMA S
    2013 SNM Highlights Lecture: neuroscience.
    J Nucl Med. 2013;54:10N-16N.
    PubMed     Text format    


  447. VAN BERCKEL BN , Ossenkoppele R, Tolboom N, Yaqub M, et al
    Longitudinal amyloid imaging using 11C-PiB: methodologic considerations.
    J Nucl Med. 2013;54:1570-6.
    PubMed     Text format     Abstract available


  448. THORN SL , deKemp RA, Dumouchel T, Klein R, et al
    Repeatable noninvasive measurement of mouse myocardial glucose uptake with 18F-FDG: evaluation of tracer kinetics in a type 1 diabetes model.
    J Nucl Med. 2013;54:1637-44.
    PubMed     Text format     Abstract available


  449. WEBER WA , Wahl RL
    Surveillance of cancer patients with imaging: self-evident or evidence-based?
    J Nucl Med. 2013;54:1513-5.
    PubMed     Text format    


  450. RAFFEL DM , Koeppe RA, Jung YW, Gu G, et al
    Quantification of cardiac sympathetic nerve density with N-11C-guanyl-meta-octopamine and tracer kinetic analysis.
    J Nucl Med. 2013;54:1645-52.
    PubMed     Text format     Abstract available


    August 2013
  451. NAGY K , Toth M, Major P, Patay G, et al
    Performance Evaluation of the Small-Animal nanoScan PET/MRI System.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  452. WHITEHEAD TD , Nemanich ST, Dence C, Shoghi KI, et al
    A PET-Compatible Tissue Bioreactor for Research, Discovery, and Validation of Imaging Biomarkers and Radiopharmaceuticals: System Design and Proof-of-Concept Studies.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  453. WARNOCK G , Turtoi A, Blomme A, Bretin F, et al
    In Vivo PET/CT in a Human Glioblastoma Chicken Chorioallantoic Membrane Model: A New Tool for Oncology and Radiotracer Development.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  454. HUANG WY , Kao CH, Huang WS, Chen CM, et al
    18F-FDG PET and Combined 18F-FDG-Contrast CT Parameters as Predictors of Tumor Control for Hepatocellular Carcinoma After Stereotactic Ablative Radiotherapy.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  455. GEMIGNANI ML , Patil S, Seshan VE, Sampson M, et al
    Feasibility and Predictability of Perioperative PET and Estrogen Receptor Ligand in Patients with Invasive Breast Cancer.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  456. KUMAR A , Chugani HT
    The Role of Radionuclide Imaging in Epilepsy, Part 1: Sporadic Temporal and Extratemporal Lobe Epilepsy.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  457. CHALLAPALLI A , Kenny LM, Hallett WA, Kozlowski K, et al
    18F-ICMT-11, a Caspase-3-Specific PET Tracer for Apoptosis: Biodistribution and Radiation Dosimetry.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  458. BYUN BH , Kong CB, Park J, Seo Y, et al
    Initial Metabolic Tumor Volume Measured by 18F-FDG PET/CT Can Predict the Outcome of Osteosarcoma of the Extremities.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  459. HSIAO E , Ali B, Blankstein R, Skali H, et al
    Detection of Obstructive Coronary Artery Disease Using Regadenoson Stress and 82Rb PET/CT Myocardial Perfusion Imaging.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  460. RYBCZYNSKA AA , de Bruyn M, Ramakrishnan NK, de Jong JR, et al
    In Vivo Responses of Human A375M Melanoma to a sigma Ligand: 18F-FDG PET Imaging.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  461. EARY JF , Krohn KA
    Standards for Reporting PET Clinical Trials.
    J Nucl Med. 2013.
    PubMed     Text format    


  462. FLOETH FW , Galldiks N, Eicker S, Stoffels G, et al
    Hypermetabolism in 18F-FDG PET Predicts Favorable Outcome Following Decompressive Surgery in Patients with Degenerative Cervical Myelopathy.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  463. KIM SJ , Zheng MQ, Nabulsi N, Labaree D, et al
    Determination of the In Vivo Selectivity of a New kappa-Opioid Receptor Antagonist PET Tracer 11C-LY2795050 in the Rhesus Monkey.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  464. HOBBS RF , Wahl RL, Frey EC, Kasamon Y, et al
    Radiobiologic Optimization of Combination Radiopharmaceutical Therapy Applied to Myeloablative Treatment of Non-Hodgkin Lymphoma.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  465. THUREAU S , Chaumet-Riffaud P, Modzelewski R, Fernandez P, et al
    Interobserver Agreement of Qualitative Analysis and Tumor Delineation of 18F-Fluoromisonidazole and 3'-Deoxy-3'-18F-Fluorothymidine PET Images in Lung Cancer.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  466. ULRICH G , Dudeck O, Grosser OS, Amthauer H, et al
    Reply: Value of 99mTc-Macroaggregated Albumin SPECT for Radioembolization Treatment Planning.
    J Nucl Med. 2013.
    PubMed     Text format    



  467. CMS Final Decision on PET in Solid Tumors.
    J Nucl Med. 2013;54:11N.
    PubMed     Text format    


  468. OH SW , Lee DS
    Nuclear medicine therapy: principles and clinical applications.
    J Nucl Med. 2013;54:1508.
    PubMed     Text format    


  469. WRIGHT BD , Lapi SE
    Designing the Magic Bullet? The Advancement of Immuno-PET into Clinical Use.
    J Nucl Med. 2013;54:1171-4.
    PubMed     Text format     Abstract available


  470. ROACH PJ , Schembri GP, Bailey DL
    V/Q Scanning Using SPECT and SPECT/CT.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  471. ELSCHOT M , Lam MG, van den Bosch MA, Viergever MA, et al
    Quantitative Monte Carlo-Based 90Y SPECT Reconstruction.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  472. GOGGI JL , Bejot R, Moonshi SS, Bhakoo KK, et al
    Stratification of 18F-Labeled PET Imaging Agents for the Assessment of Antiangiogenic Therapy Responses in Tumors.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  473. HILLMAN BJ , Frank RA, Abraham BC
    The Medical Imaging & Technology Alliance Conference on Research Endpoints Appropriate for Medicare Coverage of New PET Radiopharmaceuticals.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  474. POUZOT C , Richard JC, Gros A, Costes N, et al
    Noninvasive Quantitative Assessment of Pulmonary Blood Flow with 18F-FDG PET.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available



  475. Treves receives 2013 De Hevesy Award.
    J Nucl Med. 2013;54:19N.
    PubMed     Text format    



  476. 2013 Aebersold Award honors Wong.
    J Nucl Med. 2013;54:18N.
    PubMed     Text format    


  477. OKAMURA N , Furumoto S, Harada R, Tago T, et al
    Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease.
    J Nucl Med. 2013;54:1420-7.
    PubMed     Text format     Abstract available


  478. AUTIO A , Vainio PJ, Suilamo S, Mali A, et al
    Preclinical evaluation of a radioiodinated fully human antibody for in vivo imaging of vascular adhesion protein-1-positive vasculature in inflammation.
    J Nucl Med. 2013;54:1315-9.
    PubMed     Text format     Abstract available


  479. SNELLMAN A , Lopez-Picon FR, Rokka J, Salmona M, et al
    Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease.
    J Nucl Med. 2013;54:1434-41.
    PubMed     Text format     Abstract available


  480. JOHNSON SE , Li Z, Liu Y, Moulder JE, et al
    Whole-body imaging of high-dose ionizing irradiation-induced tissue injuries using 99mTc-duramycin.
    J Nucl Med. 2013;54:1397-403.
    PubMed     Text format     Abstract available


  481. CROSS DJ , Anzai Y, Petrie EC, Martin N, et al
    Loss of olfactory tract integrity affects cortical metabolism in the brain and olfactory regions in aging and mild cognitive impairment.
    J Nucl Med. 2013;54:1278-84.
    PubMed     Text format     Abstract available


  482. YODER KK , Nho K, Risacher SL, Kim S, et al
    Influence of TSPO genotype on 11C-PBR28 standardized uptake values.
    J Nucl Med. 2013;54:1320-2.
    PubMed     Text format     Abstract available


  483. CHOUIN N , Lindegren S, Frost SH, Jensen H, et al
    Ex vivo activity quantification in micrometastases at the cellular scale using the alpha-camera technique.
    J Nucl Med. 2013;54:1347-53.
    PubMed     Text format     Abstract available


  484. SELVARAJU RK , Velikyan I, Johansson L, Wu Z, et al
    In vivo imaging of the glucagonlike peptide 1 receptor in the pancreas with 68Ga-labeled DO3A-exendin-4.
    J Nucl Med. 2013;54:1458-63.
    PubMed     Text format     Abstract available


  485. WONDERGEM M , Smits ML, Elschot M, de Jong HW, et al
    99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization.
    J Nucl Med. 2013;54:1294-301.
    PubMed     Text format     Abstract available


  486. LUNDQVIST R , Lilja J, Thomas BA, Lotjonen J, et al
    Implementation and validation of an adaptive template registration method for 18F-flutemetamol imaging data.
    J Nucl Med. 2013;54:1472-8.
    PubMed     Text format     Abstract available


  487. DIMASTROMATTEO J , Broisat A, Perret P, Ahmadi M, et al
    In vivo molecular imaging of atherosclerotic lesions in ApoE-/- mice using VCAM-1-specific, 99mTc-labeled peptidic sequences.
    J Nucl Med. 2013;54:1442-9.
    PubMed     Text format     Abstract available


    July 2013
  488. TAVAKOLI S , Zamora D, Ullevig S, Asmis R, et al
    Bioenergetic Profiles Diverge During Macrophage Polarization: Implications for the Interpretation of 18F-FDG PET Imaging of Atherosclerosis.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  489. SHOKOUHI S , Claassen D, Kang H, Ding Z, et al
    Longitudinal Progression of Cognitive Decline Correlates with Changes in the Spatial Pattern of Brain 18F-FDG PET.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  490. USMANIJ EA , Geus-Oei LF, Troost EG, Peters-Bax L, et al
    18F-FDG PET Early Response Evaluation of Locally Advanced Non-Small Cell Lung Cancer Treated with Concomitant Chemoradiotherapy.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  491. TATSCH K , Poepperl G
    Nigrostriatal Dopamine Terminal Imaging with Dopamine Transporter SPECT: An Update.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  492. VIVASH L , Gregoire MC, Lau EW, Ware RE, et al
    18F-Flumazenil: A gamma-Aminobutyric Acid A-Specific PET Radiotracer for the Localization of Drug-Resistant Temporal Lobe Epilepsy.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  493. VAN LAERE K , Ahmad RU, Hudyana H, Dubois K, et al
    Quantification of 18F-JNJ-42259152, a Novel Phosphodiesterase 10A PET Tracer: Kinetic Modeling and Test-Retest Study in Human Brain.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  494. FURUMOTO S , Shinbo R, Iwata R, Ishikawa Y, et al
    In Vitro and In Vivo Characterization of 2-Deoxy-2-18F-Fluoro-D-Mannose as a Tumor-Imaging Agent for PET.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  495. CHEUNG TT , Ho CL, Chen S, Chan SC, et al
    Underestimated Role of 18F-FDG PET for HCC Evaluation and Promise of 18F-FDG PET/MR Imaging in This Setting.
    J Nucl Med. 2013.
    PubMed     Text format    


  496. BAUER M , Karch R, Zeitlinger M, Stanek J, et al
    Interaction of 11C-Tariquidar and 11C-Elacridar with P-Glycoprotein and Breast Cancer Resistance Protein at the Human Blood-Brain Barrier.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  497. WAELBERS T , Polis I, Vermeire S, Dobbeleir A, et al
    5-HT2A Receptors in the Feline Brain: 123I-5-I-R91150 Kinetics and the Influence of Ketamine Measured with Micro-SPECT.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available



  498. Second World Congress on 68Ga PET/CT and PRRT (SWC-2013).
    J Nucl Med. 2013;54:11N-2N.
    PubMed     Text format    


  499. ERWIN WD
    Physics in nuclear medicine.
    J Nucl Med. 2013;54:1168.
    PubMed     Text format    


  500. KOSTAKOGLU L , Gallamini A
    Interim 18F-FDG PET in Hodgkin Lymphoma: Would PET-Adapted Clinical Trials Lead to a Paradigm Shift?
    J Nucl Med. 2013;54:1082-93.
    PubMed     Text format     Abstract available


  501. VALTORTA S , Belloli S, Sanvito F, Masiello V, et al
    Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer.
    J Nucl Med. 2013;54:1106-12.
    PubMed     Text format     Abstract available


  502. PREMI E , Grassi M, Gazzina S, Paghera B, et al
    The neuroimaging signature of frontotemporal lobar degeneration associated with Granulin mutations: an effective connectivity study.
    J Nucl Med. 2013;54:1066-71.
    PubMed     Text format     Abstract available


    June 2013
  503. LEE JW , Lee SM, Lee DH, Kim YJ, et al
    Clinical Utility of 18F-FDG PET/CT Concurrent with 131I Therapy in Intermediate-to-High-Risk Patients with Differentiated Thyroid Cancer: Dual-Center Experience with 286 Patients.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  504. TOYOHARA J , Sakata M, Oda K, Ishii K, et al
    Initial Human PET Studies of Metabotropic Glutamate Receptor Type 1 Ligand 11C-ITMM.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  505. EDER M , Lohr T, Bauder-Wust U, Reber M, et al
    Pharmacokinetic Properties of Peptidic Radiopharmaceuticals: Reduced Uptake of (EH)3-Conjugates in Important Organs.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  506. HONG YS , Kim HO, Kim KP, Lee JL, et al
    3'-Deoxy-3'-18F-Fluorothymidine PET for the Early Prediction of Response to Leucovorin, 5-Fluorouracil, and Oxaliplatin Therapy in Patients with Metastatic Colorectal Cancer.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  507. WONG DF , Kuwabara H, Kim J, Brasic JR, et al
    PET Imaging of High-Affinity alpha4beta2 Nicotinic Acetylcholine Receptors in Humans with 18F-AZAN, a Radioligand with Optimal Brain Kinetics.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  508. ZUKOTYNSKI KA , Fahey FH, Vajapeyam S, Ng SS, et al
    Exploratory Evaluation of MR Permeability with 18F-FDG PET Mapping in Pediatric Brain Tumors: A Report from the Pediatric Brain Tumor Consortium.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  509. CAMPANILE C , Arlt MJ, Kramer SD, Honer M, et al
    Characterization of Different Osteosarcoma Phenotypes by PET Imaging in Preclinical Animal Models.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  510. ZIEGLER S , Braun H, Ritt P, Hocke C, et al
    Systematic Evaluation of Phantom Fluids for Simultaneous PET/MR Hybrid Imaging.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  511. JADVAR H , Desai B, Ji L, Conti PS, et al
    Baseline 18F-FDG PET/CT Parameters as Imaging Biomarkers of Overall Survival in Castrate-Resistant Metastatic Prostate Cancer.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  512. HEINZEL A , Muller D, Langen KJ, Blaum M, et al
    The Use of O-(2-18F-Fluoroethyl)-L-Tyrosine PET for Treatment Management of Bevacizumab and Irinotecan in Patients with Recurrent High-Grade Glioma: A Cost-Effectiveness Analysis.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  513. PARK HJ , Kim CH, Park ES, Park B, et al
    Increased GABA-A Receptor Binding and Reduced Connectivity at the Motor Cortex in Children with Hemiplegic Cerebral Palsy: A Multimodal Investigation Using 18F-Fluoroflumazenil PET, Immunohistochemistry, and MR Imaging.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  514. RAMAKRISHNAN NK , Rybczynska AA, Visser AK, Marosi K, et al
    Small-Animal PET with a sigma-Ligand, 11C-SA4503, Detects Spontaneous Pituitary Tumors in Aged Rats.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  515. LAM MG , Kwee TC, Basu S, Alavi A, et al
    Underestimated Role of 18F-FDG PET for HCC Evaluation and Promise of 18F-FDG PET/MR Imaging in This Setting.
    J Nucl Med. 2013.
    PubMed     Text format    


  516. DORBALA S , Di Carli MF, Delbeke D, Abbara S, et al
    SNMMI/ASNC/SCCT Guideline for Cardiac SPECT/CT and PET/CT 1.0.
    J Nucl Med. 2013.
    PubMed     Text format    


  517. LAM MG , Smits ML
    Value of 99mTc-Macroaggregated Albumin SPECT for Radioembolization Treatment Planning.
    J Nucl Med. 2013.
    PubMed     Text format    


  518. PATEL K , Hadar N, Lee J, Siegel BA, et al
    The Lack of Evidence for PET or PET/CT Surveillance of Patients with Treated Lymphoma, Colorectal Cancer, and Head and Neck Cancer: A Systematic Review.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  519. VANDERHOEK M , Perlman SB, Jeraj R
    Impact of Different Standardized Uptake Value Measures on PET-Based Quantification of Treatment Response.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  520. SIVA S , Byrne K, Seel M, Bressel M, et al
    18F-FDG PET Provides High-Impact and Powerful Prognostic Stratification in the Staging of Merkel Cell Carcinoma: A 15-Year Institutional Experience.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  521. JOHNSON KA , Minoshima S, Bohnen NI, Donohoe KJ, et al
    Update on Appropriate Use Criteria for Amyloid PET Imaging: Dementia Experts, Mild Cognitive Impairment, and Education.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  522. BOLLINENI VR , Kerner GS, Pruim J, Steenbakkers RJ, et al
    PET Imaging of Tumor Hypoxia Using 18F-Fluoroazomycin Arabinoside in Stage III-IV Non-Small Cell Lung Cancer Patients.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  523. GOROVETS A , Marzella L, Rieves D, Yang L, et al
    Efficacy Considerations for U.S. Food and Drug Administration Approval of Diagnostic Radiopharmaceuticals.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  524. CHITNENI SK , Bida GT, Yuan H, Palmer GM, et al
    18F-EF5 PET Imaging as an Early Response Biomarker for the Hypoxia-Activated Prodrug SN30000 Combined with Radiation Treatment in a Non-Small Cell Lung Cancer Xenograft Model.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  525. WONG YY , Raijmakers P, van Campen J, van der Laarse WJ, et al
    11C-Acetate Clearance as an Index of Oxygen Consumption of the Right Myocardium in Idiopathic Pulmonary Arterial Hypertension: A Validation Study Using 15O-Labeled Tracers and PET.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  526. GODIER-FURNEMONT AF , Tekabe Y, Kollaros M, Eng G, et al
    Noninvasive imaging of myocyte apoptosis following application of a stem cell-engineered delivery platform to acutely infarcted myocardium.
    J Nucl Med. 2013;54:977-83.
    PubMed     Text format     Abstract available


  527. ROWE CC , Pejoska S, Mulligan RS, Jones G, et al
    Head-to-head comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for beta-amyloid imaging in aging and dementia.
    J Nucl Med. 2013;54:880-6.
    PubMed     Text format     Abstract available


  528. ALBIN RL , Burke JF, Koeppe RA, Giordani B, et al
    Assessing mild cognitive impairment with amyloid and dopamine terminal molecular imaging.
    J Nucl Med. 2013;54:887-93.
    PubMed     Text format     Abstract available


  529. WU T , Lang J, Sun X, Zhang B, et al
    Monitoring bone marrow stem cells with a reporter gene system in experimental middle cerebral artery occlusion rat models.
    J Nucl Med. 2013;54:984-9.
    PubMed     Text format     Abstract available


  530. BABA JS , Endres CJ, Foss CA, Nimmagadda S, et al
    Molecular imaging of conscious, unrestrained mice with AwakeSPECT.
    J Nucl Med. 2013;54:969-76.
    PubMed     Text format     Abstract available


    May 2013
  531. FENDLER WP , Philippe Tiega DB, Ilhan H, Paprottka PM, et al
    Validation of Several SUV-Based Parameters Derived from 18F-FDG PET for Prediction of Survival After SIRT of Hepatic Metastases from Colorectal Cancer.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  532. ROMINGER A , Brendel M, Burgold S, Keppler K, et al
    Longitudinal Assessment of Cerebral beta-Amyloid Deposition in Mice Overexpressing Swedish Mutant beta-Amyloid Precursor Protein Using 18F-Florbetaben PET.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  533. DUVALL WL , Guma KA, Kamen J, Croft LB, et al
    Reduction in Occupational and Patient Radiation Exposure from Myocardial Perfusion Imaging: Impact of Stress-Only Imaging and High-Efficiency SPECT Camera Technology.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  534. ZEGLIS BM , Sevak KK, Reiner T, Mohindra P, et al
    A Pretargeted PET Imaging Strategy Based on Bioorthogonal Diels-Alder Click Chemistry.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  535. LOHRMANN C , Hauschild O, Meyer PT, Mix M, et al
    Hybrid Imaging of Peripheral Skeletal Disease by SPECT/High-Resolution Flat-Panel CT.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  536. SATO J , Kitagawa Y, Yamazaki Y, Hata H, et al
    18F-Fluoromisonidazole PET Uptake Is Correlated with Hypoxia-Inducible Factor-1alpha Expression in Oral Squamous Cell Carcinoma.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  537. BERTHET L , Cochet A, Kanoun S, Berriolo-Riedinger A, et al
    In Newly Diagnosed Diffuse Large B-Cell Lymphoma, Determination of Bone Marrow Involvement with 18F-FDG PET/CT Provides Better Diagnostic Performance and Prognostic Stratification Than Does Biopsy.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  538. TEHRANI OS , Shields AF
    PET Imaging of Proliferation with Pyrimidines.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  539. GRABNER A , Kentrup D, Edemir B, Sirin Y, et al
    PET with 18F-FDG-Labeled T Lymphocytes for Diagnosis of Acute Rat Renal Allograft Rejection.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  540. RYU IS , Kim JS, Roh JL, Lee JH, et al
    Prognostic Value of Preoperative Metabolic Tumor Volume and Total Lesion Glycolysis Measured by 18F-FDG PET/CT in Salivary Gland Carcinomas.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  541. HIGUCHI T , Yousefi BH, Kaiser F, Gartner F, et al
    Assessment of the 18F-Labeled PET Tracer LMI1195 for Imaging Norepinephrine Handling in Rat Hearts.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  542. HACKEL BJ , Kimura RH, Miao Z, Liu H, et al
    18F-Fluorobenzoate-Labeled Cystine Knot Peptides for PET Imaging of Integrin alphavbeta6.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  543. BYUN BH , Kong CB, Lim I, Choi CW, et al
    Combination of 18F-FDG PET/CT and Diffusion-Weighted MR Imaging as a Predictor of Histologic Response to Neoadjuvant Chemotherapy: Preliminary Results in Osteosarcoma.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  544. LIU S , Li D, Park R, Liu R, et al
    PET Imaging of Colorectal and Breast Cancer by Targeting EphB4 Receptor with 64Cu-Labeled hAb47 and hAb131 Antibodies.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  545. LIU Y , Pierce R, Luehmann HP, Sharp TL, et al
    PET Imaging of Chemokine Receptors in Vascular Injury-Accelerated Atherosclerosis.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  546. MOON SH , Cho SK, Kim WS, Kim SJ, et al
    The Role of 18F-FDG PET/CT for Initial Staging of Nasal Type Natural Killer/T-Cell Lymphoma: A Comparison with Conventional Staging Methods.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  547. GAYKEMA SB , Brouwers AH, Lub-de Hooge MN, Pleijhuis RG, et al
    89Zr-Bevacizumab PET Imaging in Primary Breast Cancer.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  548. LE ROUX PY , Robin P, Delluc A, Abgral R, et al
    V/Q SPECT Interpretation for Pulmonary Embolism Diagnosis: Which Criteria to Use?
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available



  549. SNMMI leadership update: sharing our knowledge through education.
    J Nucl Med. 2013;54:18N.
    PubMed     Text format    



  550. CMS issues decision and draft memos on PET coverage.
    J Nucl Med. 2013;54:15N-7.
    PubMed     Text format    



  551. Joint NCI/SNMMI Workshop on Targeted Radionuclide Therapy.
    J Nucl Med. 2013;54:16N-7.
    PubMed     Text format    


  552. LANGEN KJ
    Replay: being sensitive: to specify when amino acid tracers accumulate in a brain lesion.
    J Nucl Med. 2013;54:826-7.
    PubMed     Text format    


  553. PICHLER R
    Being sensitive: to specify when amino acid tracers accumulate in a brain lesion.
    J Nucl Med. 2013;54:826.
    PubMed     Text format    


  554. MUSTAFA S , Elgazzar AH
    Effect of the NSAID diclofenac on 99mTc-MAG3 and 99mTc-DTPA renography.
    J Nucl Med. 2013;54:801-6.
    PubMed     Text format     Abstract available


  555. CHEN HC , Chang HT, Huang PH, Chang MD, et al
    Molecular imaging of heparan sulfate expression with radiolabeled recombinant eosinophil cationic protein predicts allergic lung inflammation in a mouse model for asthma.
    J Nucl Med. 2013;54:793-800.
    PubMed     Text format     Abstract available


  556. XAVIER C , Vaneycken I, D'huyvetter M, Heemskerk J, et al
    Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer.
    J Nucl Med. 2013;54:776-84.
    PubMed     Text format     Abstract available


    April 2013
  557. HERRMANN K , Dahlbom M, Nathanson D, Wei L, et al
    Evaluation of the Genisys4, a Bench-Top Preclinical PET Scanner.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  558. ZENG D , Zeglis BM, Lewis JS, Anderson CJ, et al
    The Growing Impact of Bioorthogonal Click Chemistry on the Development of Radiopharmaceuticals.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  559. DORE-SAVARD L , Barriere DA, Midavaine E, Belanger D, et al
    Mammary Cancer Bone Metastasis Follow-up Using Multimodal Small-Animal MR and PET Imaging.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  560. MENZEL MI , Farrell EV, Janich MA, Khegai O, et al
    Multimodal Assessment of In Vivo Metabolism with Hyperpolarized [1-13C] MR Spectroscopy and 18F-FDG PET Imaging in Hepatocellular Carcinoma Tumor-Bearing Rats.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  561. JANJIGIAN YY , Viola-Villegas N, Holland JP, Divilov V, et al
    Monitoring Afatinib Treatment in HER2-Positive Gastric Cancer with 18F-FDG and 89Zr-Trastuzumab PET.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  562. BEN-HAIM S , Murthy VL, Breault C, Allie R, et al
    Quantification of Myocardial Perfusion Reserve Using Dynamic SPECT Imaging in Humans: A Feasibility Study.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  563. NIEDERKOHR RD , Greenspan BS, Prior JO, Schoder H, et al
    Reporting Guidance for Oncologic 18F-FDG PET/CT Imaging.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  564. KESHARI KR , Sai V, Wang ZJ, Vanbrocklin HF, et al
    Hyperpolarized [1-13C]Dehydroascorbate MR Spectroscopy in a Murine Model of Prostate Cancer: Comparison with 18F-FDG PET.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  565. SKOUGAARD K , Nielsen D, Jensen BV, Hendel HW, et al
    Comparison of EORTC Criteria and PERCIST for PET/CT Response Evaluation of Patients with Metastatic Colorectal Cancer Treated with Irinotecan and Cetuximab.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  566. SMOLARZ K , Krause BJ, Graner FP, Wagner FM, et al
    (S)-4-(3-18F-Fluoropropyl)-L-Glutamic Acid: An 18F-Labeled Tumor-Specific Probe for PET/CT Imaging--Dosimetry.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  567. BEHESHTI M , Haim S, Zakavi R, Steinmair M, et al
    Impact of 18F-Choline PET/CT in Prostate Cancer Patients with Biochemical Recurrence: Influence of Androgen Deprivation Therapy and Correlation with PSA Kinetics.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  568. SCHALIN-JANTTI C , Ryhanen E, Heiskanen I, Seppanen M, et al
    Planar Scintigraphy with 123I/99mTc-Sestamibi, 99mTc-Sestamibi SPECT/CT, 11C-Methionine PET/CT, or Selective Venous Sampling Before Reoperation of Primary Hyperparathyroidism?
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  569. WAN W , Guo N, Pan D, Yu C, et al
    First Experience of 18F-Alfatide in Lung Cancer Patients Using a New Lyophilized Kit for Rapid Radiofluorination.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available



  570. Second sino-american conference on nuclear medicine.
    J Nucl Med. 2013;54:15N-6N.
    PubMed     Text format    


  571. KAUFMANN P , Gaemperli O
    Reply: cadmium-zinc-telluride SPECT in very morbidly obese patients routinely provides high-diagnostic-quality myocardial perfusion imaging.
    J Nucl Med. 2013;54:661-2.
    PubMed     Text format    


  572. HERSCOVITCH P
    SNMMI offers education, exhibits, and networking in Vancouver.
    J Nucl Med. 2013;54:19N.
    PubMed     Text format    



  573. SNMMI/AACR Meeting looks at molecular imaging in cancer biology and therapy.
    J Nucl Med. 2013;54:17N.
    PubMed     Text format    


  574. WONG KK , Piert M
    Dynamic bone imaging with 99mTc-labeled diphosphonates and 18F-NaF: mechanisms and applications.
    J Nucl Med. 2013;54:590-9.
    PubMed     Text format     Abstract available


  575. NEYT S , Huisman MT, Vanhove C, De Man H, et al
    In vivo visualization and quantification of (Disturbed) Oatp-mediated hepatic uptake and Mrp2-mediated biliary excretion of 99mTc-mebrofenin in mice.
    J Nucl Med. 2013;54:624-30.
    PubMed     Text format     Abstract available


  576. JAMAR F , Buscombe J, Chiti A, Christian PE, et al
    EANM/SNMMI guideline for 18F-FDG use in inflammation and infection.
    J Nucl Med. 2013;54:647-58.
    PubMed     Text format    


    March 2013
  577. SANO K , Mitsunaga M, Nakajima T, Choyke PL, et al
    Acute Cytotoxic Effects of Photoimmunotherapy Assessed by 18F-FDG PET.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  578. SCHIERZ JH , Opfermann T, Steenbeck J, Lopatta E, et al
    Early Dynamic 18F-FDG PET to Detect Hyperperfusion in Hepatocellular Carcinoma Liver Lesions.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  579. SHARMA P , Thakar A, Suman Kc S, Dhull VS, et al
    68Ga-DOTANOC PET/CT for Baseline Evaluation of Patients with Head and Neck Paraganglioma.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  580. BETTENWORTH D , Reuter S, Hermann S, Weckesser M, et al
    Translational 18F-FDG PET/CT Imaging to Monitor Lesion Activity in Intestinal Inflammation.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  581. BIGGI A , Gallamini A, Chauvie S, Hutchings M, et al
    International Validation Study for Interim PET in ABVD-Treated, Advanced-Stage Hodgkin Lymphoma: Interpretation Criteria and Concordance Rate Among Reviewers.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  582. MANABE O , Hattori N, Hirata K, Itoh K, et al
    Diagnostic Accuracy of Lymph Node Metastasis Depends on Metabolic Activity of the Primary Lesion in Thoracic Squamous Esophageal Cancer.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  583. BOKTOR RR , Walker G, Stacey R, Gledhill S, et al
    Reference Range for Intrapatient Variability in Blood-Pool and Liver SUV for 18F-FDG PET.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  584. CROSS DJ , Minoshima S
    Perspectives on Assessment of Stem Cell Therapy in Stroke by 18F-FDG PET.
    J Nucl Med. 2013.
    PubMed     Text format    


  585. WANG J , Chao F, Han F, Zhang G, et al
    PET Demonstrates Functional Recovery After Transplantation of Induced Pluripotent Stem Cells in a Rat Model of Cerebral Ischemic Injury.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  586. MENDA Y , Buatti JM
    PET Imaging During Radiotherapy of Head and Neck Cancer.
    J Nucl Med. 2013.
    PubMed     Text format    


  587. CATANA C , Guimaraes AR, Rosen BR
    PET and MR Imaging: The Odd Couple or a Match Made in Heaven?
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  588. KIM S , Holder DL, Laymon CM, Tudorascu DL, et al
    Clinical Value of the First Dedicated, Commercially Available Automatic Injector for Ictal Brain SPECT in Presurgical Evaluation of Pediatric Epilepsy: Comparison with Manual Injection.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  589. SODERLUND TA , Dickson JC, Prvulovich E, Ben-Haim S, et al
    Value of Semiquantitative Analysis for Clinical Reporting of 123I-2-beta-Carbomethoxy-3beta-(4-iodophenyl)-N-(3-Fluoropropyl)Nortropane SPECT Studies.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  590. ARSANJANI R , Xu Y, Dey D, Fish M, et al
    Improved Accuracy of Myocardial Perfusion SPECT for the Detection of Coronary Artery Disease Using a Support Vector Machine Algorithm.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  591. ZHAO Z , Yoshida Y, Kurokawa T, Kiyono Y, et al
    18F-FES and 18F-FDG PET for Differential Diagnosis and Quantitative Evaluation of Mesenchymal Uterine Tumors: Correlation with Immunohistochemical Analysis.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  592. FAYAD HJ , Lamare F, Le Rest CC, Bettinardi V, et al
    Generation of 4-Dimensional CT Images Based on 4-Dimensional PET-Derived Motion Fields.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  593. HASEEBUDDIN M , Dehdashti F, Siegel BA, Liu J, et al
    11C-Acetate PET/CT Before Radical Prostatectomy: Nodal Staging and Treatment Failure Prediction.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  594. BECKER GA , Ichise M, Barthel H, Luthardt J, et al
    PET Quantification of 18F-Florbetaben Binding to beta-Amyloid Deposits in Human Brains.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  595. KANEKO K , Kawasaki T, Masunari S, Yoshida T, et al
    Determinants of Extraaortic Arterial 18F-FDG Accumulation in Asymptomatic Cohorts: Sex Differences in the Association with Cardiovascular Risk Factors and Coronary Artery Stenosis.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available



  596. Choosing wisely in nuclear medicine and molecular imaging.
    J Nucl Med. 2013;54:17N-8N.
    PubMed     Text format    


  597. DELBEKE D
    Learning: The JNM editorial process.
    J Nucl Med. 2013;54:27A-28A.
    PubMed     Text format    



  598. A focus on football injury.
    J Nucl Med. 2013;54:16N.
    PubMed     Text format    



  599. Guidelines for brain amyloid imaging published.
    J Nucl Med. 2013;54:13N.
    PubMed     Text format    


  600. NAKAZATO R , Berman DS, Hayes SW, Fish M, et al
    Myocardial perfusion imaging with a solid-state camera: simulation of a very low dose imaging protocol.
    J Nucl Med. 2013;54:373-9.
    PubMed     Text format     Abstract available


    February 2013
  601. DEKEMP RA , Declerck J, Klein R, Pan XB, et al
    Multisoftware Reproducibility Study of Stress and Rest Myocardial Blood Flow Assessed with 3D Dynamic PET/CT and a 1-Tissue-Compartment Model of 82Rb Kinetics.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  602. SOLOMON M , Nothdruft RE, Akers W, Edwards WB, et al
    Multimodal Fluorescence-Mediated Tomography and SPECT/CT for Small-Animal Imaging.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  603. PUT S , Schoonooghe S, Devoogdt N, Schurgers E, et al
    SPECT Imaging of Joint Inflammation with Nanobodies Targeting the Macrophage Mannose Receptor in a Mouse Model for Rheumatoid Arthritis.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  604. ZHONG M , Alonso CE, Taegtmeyer H, Kundu BK, et al
    Quantitative PET Imaging Detects Early Metabolic Remodeling in a Mouse Model of Pressure-Overload Left Ventricular Hypertrophy In Vivo.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  605. TOMASI G , Nabulsi N, Zheng MQ, Weinzimmer D, et al
    Determination of In Vivo Bmax and Kd for 11C-GR103545, an Agonist PET Tracer for kappa-Opioid Receptors: A Study in Nonhuman Primates.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  606. WONG DF , Waterhouse R, Kuwabara H, Kim J, et al
    18F-FPEB, a PET Radiopharmaceutical for Quantifying Metabotropic Glutamate 5 Receptors: A First-in-Human Study of Radiochemical Safety, Biokinetics, and Radiation Dosimetry.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  607. RISCHPLER C , Nekolla SG, Dregely I, Schwaiger M, et al
    Hybrid PET/MR Imaging of the Heart: Potential, Initial Experiences, and Future Prospects.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  608. CHENG J , Lei L, Xu J, Sun Y, et al
    18F-Fluoromisonidazole PET/CT: A Potential Tool for Predicting Primary Endocrine Therapy Resistance in Breast Cancer.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  609. LI YJ , Li ZM, Xia XY, Huang HQ, et al
    Prognostic Value of Interim and Posttherapy 18F-FDG PET/CT in Patients with Mature T-Cell and Natural Killer Cell Lymphomas.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  610. JOBSE BN , Rhem RG, Wang IQ, Counter WB, et al
    Detection of Lung Dysfunction Using Ventilation and Perfusion SPECT in a Mouse Model of Chronic Cigarette Smoke Exposure.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  611. COCHET H , Bullier E, Gerbaud E, Durieux M, et al
    Absolute Quantification of Left Ventricular Global and Regional Function at Nuclear MPI Using Ultrafast CZT SPECT: Initial Validation Versus Cardiac MR.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  612. HEUVELING DA , van Schie A, Vugts DJ, Hendrikse NH, et al
    Pilot Study on the Feasibility of PET/CT Lymphoscintigraphy with 89Zr-Nanocolloidal Albumin for Sentinel Node Identification in Oral Cancer Patients.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available



  613. Demonstrating the value of nuclear medicine and molecular imaging.
    J Nucl Med. 2013;54:13N.
    PubMed     Text format    


  614. HABIBOLLAHI P , van den Berg NS, Kuruppu D, Loda M, et al
    Metformin--an Adjunct Antineoplastic Therapy--Divergently Modulates Tumor Metabolism and Proliferation, Interfering with Early Response Prediction by 18F-FDG PET Imaging.
    J Nucl Med. 2013;54:252-8.
    PubMed     Text format     Abstract available



  615. Abstracts of AACR/SNMMI (American Association for Cancer Research/Society of Nuclear Medicine and Molecular Imaging) State-of-the-Art Molecular Imaging in Cancer Biology and Therapy Conference. February 27-March 2, 2013. San Diego, California, USA.
    J Nucl Med. 2013;54 Suppl 1:1-35.
    PubMed     Text format    


  616. ADLER S , Kurdziel K, Lindenberg L, Choyke P, et al
    Reply.
    J Nucl Med. 2013;54:326-7.
    PubMed     Text format    



  617. Congress passes American Medical Isotope Production Act.
    J Nucl Med. 2013;54:11N.
    PubMed     Text format    


  618. BRADER P , Serganova I, Blasberg RG
    Noninvasive molecular imaging using reporter genes.
    J Nucl Med. 2013;54:167-72.
    PubMed     Text format     Abstract available


  619. RISS PJ , Hong YT, Marton J, Caprioli D, et al
    Synthesis and evaluation of 18F-FE-PEO in rodents: an 18F-labeled full agonist for opioid receptor imaging.
    J Nucl Med. 2013;54:299-305.
    PubMed     Text format     Abstract available


  620. SILBERSTEIN EB
    The timing of pregnancy testing in 131I therapy.
    J Nucl Med. 2013;54:327.
    PubMed     Text format    


  621. PILLAI MR , Dash A, Knapp FF Jr
    Sustained availability of 99mTc: possible paths forward.
    J Nucl Med. 2013;54:313-23.
    PubMed     Text format     Abstract available


    January 2013
  622. SCHWARTZ RG , Wexler O, Peterson B, Schwartz AM, et al
    Cadmium-Zinc-Telluride SPECT in Very Morbidly Obese Patients Routinely Provides High-Diagnostic-Quality Myocardial Perfusion Imaging.
    J Nucl Med. 2013.
    PubMed     Text format    


  623. MUZIK O , Mangner TJ, Leonard WR, Kumar A, et al
    15O PET Measurement of Blood Flow and Oxygen Consumption in Cold-Activated Human Brown Fat.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  624. JOHNSON KA , Minoshima S, Bohnen NI, Donohoe KJ, et al
    Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  625. KE AB , Eyal S, Chung FS, Link JM, et al
    Modeling Cyclosporine A Inhibition of the Distribution of a P-Glycoprotein PET Ligand, 11C-Verapamil, into the Maternal Brain and Fetal Liver of the Pregnant Nonhuman Primate: Impact of Tissue Blood Flow and Site of Inhibition.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  626. DEHDASHTI F , Laforest R, Gao F, Shoghi KI, et al
    Assessment of Cellular Proliferation in Tumors by PET Using 18F-ISO-1.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  627. ZHENG MQ , Nabulsi N, Kim SJ, Tomasi G, et al
    Synthesis and Evaluation of 11C-LY2795050 as a kappa-Opioid Receptor Antagonist Radiotracer for PET Imaging.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  628. WOLFS E , Struys T, Notelaers T, Roberts SJ, et al
    18F-FDG Labeling of Mesenchymal Stem Cells and Multipotent Adult Progenitor Cells for PET Imaging: Effects on Ultrastructure and Differentiation Capacity.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  629. HOEBEN BA , Troost EG, Span PN, van Herpen CM, et al
    18F-FLT PET During Radiotherapy or Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma Is an Early Predictor of Outcome.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  630. MCKINLEY ET , Smith RA, Zhao P, Fu A, et al
    3'-Deoxy-3'-18F-Fluorothymidine PET Predicts Response to V600EBRAF-Targeted Therapy in Preclinical Models of Colorectal Cancer.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  631. HICKS RJ , Hofman MS, Ware RE
    Not-So-Random Errors: Randomized Controlled Trials Are Not the Only Evidence of the Value of PET--Rebuttal.
    J Nucl Med. 2013.
    PubMed     Text format    


  632. HEUVELING DA , de Bree R, Vugts DJ, Huisman MC, et al
    Phase 0 Microdosing PET Study Using the Human Mini Antibody F16SIP in Head and Neck Cancer Patients.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  633. HATT M , Groheux D, Martineau A, Espie M, et al
    Comparison Between 18F-FDG PET Image-Derived Indices for Early Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  634. CHEUNG TT , Ho CL, Lo CM, Chen S, et al
    11C-Acetate and 18F-FDG PET/CT for Clinical Staging and Selection of Patients with Hepatocellular Carcinoma for Liver Transplantation on the Basis of Milan Criteria: Surgeon's Perspective.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  635. MATTNER F , Staykova M, Berghofer P, Wong HJ, et al
    Central Nervous System Expression and PET Imaging of the Translocator Protein in Relapsing-Remitting Experimental Autoimmune Encephalomyelitis.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  636. OKAMOTO S , Shiga T, Yasuda K, Ito YM, et al
    High Reproducibility of Tumor Hypoxia Evaluated by 18F-Fluoromisonidazole PET for Head and Neck Cancer.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  637. ADMIRAAL WM , Holleman F, Bahler L, Soeters MR, et al
    Combining 123I-Metaiodobenzylguanidine SPECT/CT and 18F-FDG PET/CT for the Assessment of Brown Adipose Tissue Activity in Humans During Cold Exposure.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  638. ARSANJANI R , Xu Y, Hayes SW, Fish M, et al
    Comparison of Fully Automated Computer Analysis and Visual Scoring for Detection of Coronary Artery Disease from Myocardial Perfusion SPECT in a Large Population.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  639. HIGUCHI T , Rischpler C, Fukushima K, Isoda T, et al
    Targeting of Endothelin Receptors in the Healthy and Infarcted Rat Heart Using the PET Tracer 18F-FBzBMS.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  640. CAODURO C , Porot C, Vuitton DA, Bresson-Hadni S, et al
    The Role of Delayed 18F-FDG PET Imaging in the Follow-up of Patients with Alveolar Echinococcosis.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  641. BARRETT JA , Coleman RE, Goldsmith SJ, Vallabhajosula S, et al
    First-in-Man Evaluation of Two High-Affinity PSMA-Avid Small Molecules for Imaging Prostate Cancer.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  642. WILD D , Bomanji JB, Benkert P, Maecke H, et al
    Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT Within Patients with Gastroenteropancreatic Neuroendocrine Tumors.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  643. WU Z , Liu S, Hassink M, Nair I, et al
    Development and Evaluation of 18F-TTCO-Cys40-Exendin-4: A PET Probe for Imaging Transplanted Islets.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  644. TAKASHIMA T , Wu C, Takashima-Hirano M, Katayama Y, et al
    Evaluation of Breast Cancer Resistance Protein Function in Hepatobiliary and Renal Excretion Using PET with 11C-SC-62807.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  645. WURSLIN C , Schmidt H, Martirosian P, Brendle C, et al
    Respiratory Motion Correction in Oncologic PET Using T1-Weighted MR Imaging on a Simultaneous Whole-Body PET/MR System.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  646. COOK GJ
    Combined 18F-Fluoride and 18F-FDG PET/CT for Evaluation of Malignancy: Results of an International Multicenter Trial.
    J Nucl Med. 2013.
    PubMed     Text format    


  647. WATABE T , Shimosegawa E, Watabe H, Kanai Y, et al
    Quantitative Evaluation of Cerebral Blood Flow and Oxygen Metabolism in Normal Anesthetized Rats: 15O-Labeled Gas Inhalation PET with MRI Fusion.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  648. MASSOLLO M , Marini C, Brignone M, Emionite L, et al
    Metformin Temporal and Localized Effects on Gut Glucose Metabolism Assessed Using 18F-FDG PET in Mice.
    J Nucl Med. 2013.
    PubMed     Text format     Abstract available


  649. SONG S , Xiong C, Lu W, Ku G, et al
    Apoptosis Imaging Probe Predicts Early Chemotherapy Response in Preclinical Models: A Comparative Study with 18F-FDG PET.
    J Nucl Med. 2013;54:104-10.
    PubMed     Text format     Abstract available


  650. BAILEY DL , Willowson KP
    An Evidence-Based Review of Quantitative SPECT Imaging and Potential Clinical Applications.
    J Nucl Med. 2013;54:83-9.
    PubMed     Text format     Abstract available


  651. MULLER C , Struthers H, Winiger C, Zhernosekov K, et al
    DOTA conjugate with an albumin-binding entity enables the first folic acid-targeted 177Lu-radionuclide tumor therapy in mice.
    J Nucl Med. 2013;54:124-31.
    PubMed     Text format     Abstract available


  652. BAZAN JG , Koong AC, Kapp DS, Quon A, et al
    Metabolic tumor volume predicts disease progression and survival in patients with squamous cell carcinoma of the anal canal.
    J Nucl Med. 2013;54:27-32.
    PubMed     Text format     Abstract available


  653. KEALEY S , Turner EM, Husbands SM, Salinas CA, et al
    Imaging imidazoline-I2 binding sites in porcine brain using 11C-BU99008.
    J Nucl Med. 2013;54:139-44.
    PubMed     Text format     Abstract available


  654. LANDAU SM , Breault C, Joshi AD, Pontecorvo M, et al
    Amyloid-beta imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods.
    J Nucl Med. 2013;54:70-7.
    PubMed     Text format     Abstract available


  655. ESTERLIS I , Hannestad JO, Bois F, Sewell RA, et al
    Imaging changes in synaptic acetylcholine availability in living human subjects.
    J Nucl Med. 2013;54:78-82.
    PubMed     Text format     Abstract available


    December 2012
  656. SCHIEPERS C , Huang SC, Dahlbom M
    Dynamic PET/CT with 11C-Acetate in Prostate Cancer.
    J Nucl Med. 2012.
    PubMed     Text format    


  657. SCHWARZ S , Norenberg J, Berridge M, Dragotakes S, et al
    The Future of USP Monographs for PET Drugs.
    J Nucl Med. 2012.
    PubMed     Text format    


  658. KASENDA B , Haug V, Schorb E, Fritsch K, et al
    18F-FDG PET Is an Independent Outcome Predictor in Primary Central Nervous System Lymphoma.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  659. IAGARU A , Mittra E, Mosci C, Dick DW, et al
    Combined 18F-Fluoride and 18F-FDG PET/CT Scanning for Evaluation of Malignancy: Results of an International Multicenter Trial.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  660. ANTONI G , Lubberink M, Estrada S, Axelsson J, et al
    In Vivo Visualization of Amyloid Deposits in the Heart with 11C-PIB and PET.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  661. KIM EE
    Radiopharmaceuticals in Nuclear Pharmacy and Nuclear Medicine.
    J Nucl Med. 2012.
    PubMed     Text format    


  662. LEE J , Lee TS, Ryu J, Hong S, et al
    RGD Peptide-Conjugated Multimodal NaGdF4:Yb3+/Er3+ Nanophosphors for Upconversion Luminescence, MR, and PET Imaging of Tumor Angiogenesis.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  663. RAPP M , Heinzel A, Galldiks N, Stoffels G, et al
    Diagnostic Performance of 18F-FET PET in Newly Diagnosed Cerebral Lesions Suggestive of Glioma.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  664. DANAD I , Raijmakers PG, Appelman YE, Harms HJ, et al
    Hybrid Imaging Using Quantitative H215O PET and CT-Based Coronary Angiography for the Detection of Coronary Artery Disease.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  665. BAEK S , Mueller A, Lim YS, Lee HC, et al
    (4S)-4-(3-18F-Fluoropropyl)-L-Glutamate for Imaging of xC Transporter Activity in Hepatocellular Carcinoma Using PET: Preclinical and Exploratory Clinical Studies.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  666. FUCHS K , Kohlhofer U, Quintanilla-Martinez L, Lamparter D, et al
    In Vivo Imaging of Cell Proliferation Enables the Detection of the Extent of Experimental Rheumatoid Arthritis by 3'-Deoxy-3'-18F-Fluorothymidine and Small-Animal PET.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  667. GROHEUX D , Giacchetti S, Delord M, Hindie E, et al
    18F-FDG PET/CT in Staging Patients with Locally Advanced or Inflammatory Breast Cancer: Comparison to Conventional Staging.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  668. LU MY , Liu YL, Chang HH, Jou ST, et al
    Characterization of Neuroblastic Tumors Using 18F-FDOPA PET.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available



  669. FDA Approves 11C-Choline for PET in Prostate Cancer.
    J Nucl Med. 2012;53:11N.
    PubMed     Text format    



  670. Brookhaven Lab named historic chemical landmark.
    J Nucl Med. 2012;53:12N.
    PubMed     Text format    


  671. CHO SY , Gage KL, Mease RC, Senthamizhchelvan S, et al
    Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-DCFBC, a Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in Patients with Metastatic Prostate Cancer.
    J Nucl Med. 2012;53:1883-91.
    PubMed     Text format     Abstract available


  672. HADDAD D , Zanzonico PB, Carlin S, Chen CH, et al
    A vaccinia virus encoding the human sodium iodide symporter facilitates long-term image monitoring of virotherapy and targeted radiotherapy of pancreatic cancer.
    J Nucl Med. 2012;53:1933-42.
    PubMed     Text format     Abstract available


  673. THIE JA
    Marker selection based on only reproducibility can be questioned.
    J Nucl Med. 2012;53:1993.
    PubMed     Text format    


    November 2012
  674. COOK GJ , Yip C, Siddique M, Goh V, et al
    Are Pretreatment 18F-FDG PET Tumor Textural Features in Non-Small Cell Lung Cancer Associated with Response and Survival After Chemoradiotherapy?
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  675. MIYAMOTO M , Kuroda S, Zhao S, Magota K, et al
    Bone Marrow Stromal Cell Transplantation Enhances Recovery of Local Glucose Metabolism After Cerebral Infarction in Rats: A Serial 18F-FDG PET Study.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  676. EPELBAUM R , Frenkel A, Haddad R, Sikorski N, et al
    Tumor Aggressiveness and Patient Outcome in Cancer of the Pancreas Assessed by Dynamic 18F-FDG PET/CT.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  677. ALF MF , Wyss MT, Buck A, Weber B, et al
    Quantification of Brain Glucose Metabolism by 18F-FDG PET with Real-Time Arterial and Image-Derived Input Function in Mice.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  678. KRAEBER-BODERE F , Carlier T, Naegelen VM, Shochat E, et al
    Differences in the Biologic Activity of 2 Novel MEK Inhibitors Revealed by 18F-FDG PET: Analysis of Imaging Data from 2 Phase I Trials.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  679. SYVANEN S , Labots M, Tagawa Y, Eriksson J, et al
    Altered GABAA Receptor Density and Unaltered Blood-Brain Barrier Transport in a Kainate Model of Epilepsy: An In Vivo Study Using 11C-Flumazenil and PET.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  680. LUDWIG DR , Friehling M, Schwartzman D, Saba S, et al
    On the Importance of Image Gating for the Assay of Left Ventricular Mechanical Dyssynchrony Using SPECT.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  681. CATANA C , Drzezga A, Heiss WD, Rosen BR, et al
    PET/MRI for Neurologic Applications.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  682. GAO H , Kiesewetter DO, Zhang X, Huang X, et al
    PET of Glucagonlike Peptide Receptor Upregulation After Myocardial Ischemia or Reperfusion Injury.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  683. MULLER C , Zhernosekov K, Koster U, Johnston K, et al
    A Unique Matched Quadruplet of Terbium Radioisotopes for PET and SPECT and for alpha- and beta--Radionuclide Therapy: An In Vivo Proof-of-Concept Study with a New Receptor-Targeted Folate Derivative.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  684. IMBERT L , Poussier S, Franken PR, Songy B, et al
    Compared Performance of High-Sensitivity Cameras Dedicated to Myocardial Perfusion SPECT: A Comprehensive Analysis of Phantom and Human Images.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available



  685. Goodman recognized with 2012 Aebersold Award.
    J Nucl Med. 2012;53:21N.
    PubMed     Text format    


  686. SGOUROS G , Zanzonico P
    Humm recognized with Loevinger-Berman Award.
    J Nucl Med. 2012;53:20N.
    PubMed     Text format    



  687. Alavi and Larson awarded 2012 Benedict Cassen Prize.
    J Nucl Med. 2012;53:19N.
    PubMed     Text format    



  688. Berman receives de Hevesy Award.
    J Nucl Med. 2012;53:18N.
    PubMed     Text format    



  689. Henry N. Wagner, Jr., MD 1927-2012.
    J Nucl Med. 2012;53:13N-4N.
    PubMed     Text format    


  690. ULIEL L , Royal HD, Darcy MD, Zuckerman DA, et al
    From the angio suite to the gamma-camera: vascular mapping and 99mTc-MAA hepatic perfusion imaging before liver radioembolization--a comprehensive pictorial review.
    J Nucl Med. 2012;53:1736-47.
    PubMed     Text format     Abstract available


  691. DI GIALLEONARDO V , Signore A, Scheerstra EA, Visser AK, et al
    11C-hydroxytryptophan uptake and metabolism in endocrine and exocrine pancreas.
    J Nucl Med. 2012;53:1755-63.
    PubMed     Text format     Abstract available


  692. MIZRAHI R , Rusjan P, Vitcu I, Ng A, et al
    Whole-body distribution and radiation dosimetry of 11C-(+)-PHNO, a D2/3 agonist ligand.
    J Nucl Med. 2012;53:1802-6.
    PubMed     Text format     Abstract available


    October 2012
  693. RAZUMIENKO EJ , Scollard DA, Reilly RM
    Small-Animal SPECT/CT of HER2 and HER3 Expression in Tumor Xenografts in Athymic Mice Using Trastuzumab Fab-Heregulin Bispecific Radioimmunoconjugates.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  694. ADRIAENS AM , Polis IE, Vermeire ST, Waelbers T, et al
    The Influence of Morphine on Cerebral 5-HT2A Availability in Dogs: a SPECT Study.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  695. RAJARAM M , Tahari AK, Lee AH, Lodge MA, et al
    Cardiac PET/CT Misregistration Causes Significant Changes in Estimated Myocardial Blood Flow.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  696. VERBEEK HH , Plukker JT, Koopmans KP, de Groot JW, et al
    Clinical Relevance of 18F-FDG PET and 18F-DOPA PET in Recurrent Medullary Thyroid Carcinoma.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  697. SCHOFFELEN R , van der Graaf WT, Sharkey RM, Franssen GM, et al
    Quantitative Immuno-SPECT Monitoring of Pretargeted Radioimmunotherapy with a Bispecific Antibody in an Intraperitoneal Nude Mouse Model of Human Colon Cancer.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  698. KIM JH , Lee JS, Song IC, Lee DS, et al
    Comparison of Segmentation-Based Attenuation Correction Methods for PET/MRI: Evaluation of Bone and Liver Standardized Uptake Value with Oncologic PET/CT Data.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  699. GOORDEN MC , van der Have F, Kreuger R, Ramakers RM, et al
    VECTor: A Preclinical Imaging System for Simultaneous Submillimeter SPECT and PET.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  700. IDEMA AJ , Hoffmann AL, Boogaarts HD, Troost EG, et al
    3'-Deoxy-3'-18F-Fluorothymidine PET-Derived Proliferative Volume Predicts Overall Survival in High-Grade Glioma Patients.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  701. XU G , Zhao L, He Z
    Performance of Whole-Body PET/CT for the Detection of Distant Malignancies in Various Cancers: A Systematic Review and Meta-Analysis.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  702. FONTI R , Larobina M, Del Vecchio S, De Luca S, et al
    Metabolic Tumor Volume Assessed by 18F-FDG PET/CT for the Prediction of Outcome in Patients with Multiple Myeloma.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  703. VAVERE AL , Butch ER, Dearling JL, Packard AB, et al
    64Cu-p-NH2-Bn-DOTA-hu14.18K322A, a PET Radiotracer Targeting Neuroblastoma and Melanoma.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  704. SINGHAL T , Narayanan TK, Jacobs MP, Bal C, et al
    11C-Methionine PET for Grading and Prognostication in Gliomas: A Comparison Study with 18F-FDG PET and Contrast Enhancement on MRI.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  705. AVRAM AM
    Role of SPECT/CT, Versus Traditional Practices, in Individualizing Treatment of Thyroid Carcinoma: Reply.
    J Nucl Med. 2012.
    PubMed     Text format    


  706. BASU S , Abhyankar A
    Role of SPECT/CT, Versus Traditional Practices, in Individualizing Treatment of Thyroid Carcinoma.
    J Nucl Med. 2012.
    PubMed     Text format    


  707. KIM DY , Kim HS, Le UN, Jiang SN, et al
    Evaluation of a Mitochondrial Voltage Sensor, (18F-Fluoropentyl)Triphenylphosphonium Cation, in a Rat Myocardial Infarction Model.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  708. HICKS RJ , Ware RE, Hofman MS
    Not-So-Random Errors: Randomized Controlled Trials Are Not the Only Evidence of the Value of PET.
    J Nucl Med. 2012.
    PubMed     Text format    



  709. SNM 2012 image of the year.
    J Nucl Med. 2012;53:23N.
    PubMed     Text format    


  710. MAURER AH
    2012 SNM highlights lecture: general clinical specialties.
    J Nucl Med. 2012;53:15N-23N.
    PubMed     Text format    


  711. WATANABE Y
    New findings on the underlying neural mechanism of emotion induced by frightening music.
    J Nucl Med. 2012;53:1497-8.
    PubMed     Text format    


  712. SPANU A , Sanna D, Chessa F, Cottu P, et al
    Breast scintigraphy with breast-specific gamma-camera in the detection of ductal carcinoma in situ: a correlation with mammography and histologic subtype.
    J Nucl Med. 2012;53:1528-33.
    PubMed     Text format     Abstract available


  713. LIU H , Carpenter CM, Jiang H, Pratx G, et al
    Intraoperative imaging of tumors using Cerenkov luminescence endoscopy: a feasibility experimental study.
    J Nucl Med. 2012;53:1579-84.
    PubMed     Text format     Abstract available


    September 2012
  714. BROCKSCHNIEDER D , Schmitt-Willich H, Heinrich T, Varrone A, et al
    Preclinical Characterization of a Novel Class of 18F-Labeled PET Tracers for Amyloid-beta
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  715. KINOSHITA M , Arita H, Goto T, Okita Y, et al
    A Novel PET Index, 18F-FDG-11C-Methionine Uptake Decoupling Score, Reflects Glioma Cell Infiltration.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  716. WONG WH , Li H, Baghaei H, Zhang Y, et al
    Engineering and Performance (NEMA and Animal) of a Lower-Cost Higher-Resolution Animal PET/CT Scanner Using Photomultiplier-Quadrant-Sharing Detectors.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  717. HONG H , Zhang Y, Nayak TR, Engle JW, et al
    Immuno-PET of Tissue Factor in Pancreatic Cancer.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  718. HAUG AR , Cindea-Drimus R, Auernhammer CJ, Reincke M, et al
    The Role of 68Ga-DOTATATE PET/CT in Suspected Neuroendocrine Tumors.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  719. WAINER Z , Daniels MG, Callahan J, Binns D, et al
    Sex and SUVmax: Sex-Dependent Prognostication in Early Non-Small Cell Lung Cancer.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  720. ELMENHORST D , Meyer PT, Matusch A, Winz OH, et al
    Caffeine Occupancy of Human Cerebral A1 Adenosine Receptors: In Vivo Quantification with 18F-CPFPX and PET.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  721. CHAN SC , Wang HM, Ng SH, Hsu CL, et al
    Utility of 18F-Fluoride PET/CT and 18F-FDG PET/CT in the Detection of Bony Metastases in Heightened-Risk Head and Neck Cancer Patients.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  722. FREUDENBERG R , Oehme L, Kotzerke J
    Radiation Exposure Should Not Limit Bone Scintigraphy with 18F-NaF.
    J Nucl Med. 2012.
    PubMed     Text format    


  723. LEE HS , Kim SW, Kim BH, Jung SY, et al
    Predicting Nonsentinel Lymph Node Metastasis Using Lymphoscintigraphy in Patients with Breast Cancer.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  724. AKAMATSU G , Ishikawa K, Mitsumoto K, Taniguchi T, et al
    Improvement in PET/CT Image Quality with a Combination of Point-Spread Function and Time-of-Flight in Relation to Reconstruction Parameters.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  725. RAVIZZINI G
    A Concise Guide to Nuclear Medicine.
    J Nucl Med. 2012.
    PubMed     Text format    


  726. BENGEL FM , Minoshima S
    2012 SNM Highlights Lectures.
    J Nucl Med. 2012;53:15N-31N.
    PubMed     Text format    


  727. WALLBERG H , Grafstrom J, Cheng Q, Lu L, et al
    HER2-positive tumors imaged within 1 hour using a site-specifically 11C-labeled Sel-tagged affibody molecule.
    J Nucl Med. 2012;53:1446-53.
    PubMed     Text format     Abstract available


  728. THOREK DL , Abou DS, Beattie BJ, Bartlett RM, et al
    Positron lymphography: multimodal, high-resolution, dynamic mapping and resection of lymph nodes after intradermal injection of 18F-FDG.
    J Nucl Med. 2012;53:1438-45.
    PubMed     Text format     Abstract available


  729. BOSWELL CA , Mundo EE, Zhang C, Stainton SL, et al
    Differential effects of predosing on tumor and tissue uptake of an 111In-labeled anti-TENB2 antibody-drug conjugate.
    J Nucl Med. 2012;53:1454-61.
    PubMed     Text format     Abstract available


  730. FIECHTER M , Gebhard C, Fuchs TA, Ghadri JR, et al
    Cadmium-zinc-telluride myocardial perfusion imaging in obese patients.
    J Nucl Med. 2012;53:1401-6.
    PubMed     Text format     Abstract available


  731. VRIEZE A , Schopman JE, Admiraal WM, Soeters MR, et al
    Fasting and postprandial activity of brown adipose tissue in healthy men.
    J Nucl Med. 2012;53:1407-10.
    PubMed     Text format     Abstract available


    August 2012
  732. KIM EE
    Nuclear Medicine Board Review: Questions and Answers for Self-Assessment.
    J Nucl Med. 2012.
    PubMed     Text format    


  733. VERBURG FA , Dietlein M, Freudenberg L, Leboulleux S, et al
    Recombinant Human TSH Versus Thyroid Hormone Withdrawal.
    J Nucl Med. 2012.
    PubMed     Text format    


  734. BARTLETT RM , Beattie BJ, Naryanan M, Georgi JC, et al
    Image-Guided PO2 Probe Measurements Correlated with Parametric Images Derived from 18F-Fluoromisonidazole Small-Animal PET Data in Rats.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  735. CECCARINI J , Vrieze E, Koole M, Muylle T, et al
    Optimized In Vivo Detection of Dopamine Release Using 18F-Fallypride PET.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  736. IIMA M , Nakamoto Y, Kanao S, Sugie T, et al
    Clinical Performance of 2 Dedicated PET Scanners for Breast Imaging: Initial Evaluation.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  737. ZHANG Y , Chen Q, Du F, Hu Y, et al
    Frightening Music Triggers Rapid Changes in Brain Monoamine Receptors: A Pilot PET Study.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  738. KARANTANIS D , Kalkanis D, Allen-Auerbach M, Bogsrud TV, et al
    Oncologic 18F-FDG PET/CT: Referring Physicians' Point of View.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  739. TAGLIABUE E , Campiglio M, Balsari A, Menard S, et al
    PET Prediction of Response to Trastuzumab in ErbB2-Positive Human Xenograft Model.
    J Nucl Med. 2012.
    PubMed     Text format    


  740. JAGODA EM , Lang L, Bhadrasetty V, Histed S, et al
    Immuno-PET of the Hepatocyte Growth Factor Receptor Met Using the 1-Armed Antibody Onartuzumab.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  741. SONG JJ , De Ridder D, Van de Heyning P, Vanneste S, et al
    Mapping Tinnitus-Related Brain Activation: An Activation-Likelihood Estimation Metaanalysis of PET Studies.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  742. YAMASAKI T , Fujinaga M, Kawamura K, Yui J, et al
    In Vivo Measurement of the Affinity and Density of Metabotropic Glutamate Receptor Subtype 1 in Rat Brain Using 18F-FITM in Small-Animal PET.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  743. CHENG G , Alavi A
    The Value of 18F-FDG PET/CT in the Assessment of Cardiac Malignancy Remains to Be Defined.
    J Nucl Med. 2012.
    PubMed     Text format    


  744. AMTAGE F , Spehl TS, Hellwig S, Sahm U, et al
    Assessment of Striatal Dopamine D2/D3 Receptor Availability with PET and 18F-Desmethoxyfallypride: Comparison of Imaging Protocols Suited for Clinical Routine.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  745. LIM R , Eaton A, Lee NY, Setton J, et al
    18F-FDG PET/CT Metabolic Tumor Volume and Total Lesion Glycolysis Predict Outcome in Oropharyngeal Squamous Cell Carcinoma.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  746. VAN ELMPT W , Ollers M, Dingemans AM, Lambin P, et al
    Response Assessment Using 18F-FDG PET Early in the Course of Radiotherapy Correlates with Survival in Advanced-Stage Non-Small Cell Lung Cancer.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  747. SOBIC-SARANOVIC D , Grozdic I, Videnovic-Ivanov J, Vucinic-Mihailovic V, et al
    The Utility of 18F-FDG PET/CT for Diagnosis and Adjustment of Therapy in Patients with Active Chronic Sarcoidosis.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  748. MARTINEZ-MOLLER A , Eiber M, Nekolla SG, Souvatzoglou M, et al
    Workflow and Scan Protocol Considerations for Integrated Whole-Body PET/MRI in Oncology.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  749. HOLLAND JP , Cumming P, Vasdev N
    PET of Signal Transduction Pathways in Cancer.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  750. HALL MA , Pinkston KL, Wilganowski N, Robinson H, et al
    Comparison of mAbs Targeting Epithelial Cell Adhesion Molecule for the Detection of Prostate Cancer Lymph Node Metastases with Multimodal Contrast Agents: Quantitative Small-Animal PET/CT and NIRF.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  751. GALLDIKS N , Stoffels G, Filss CP, Piroth MD, et al
    Role of O-(2-18F-Fluoroethyl)-L-Tyrosine PET for Differentiation of Local Recurrent Brain Metastasis from Radiation Necrosis.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  752. KARIMI-ASHTIANI S , Arsanjani R, Fish M, Kavanagh P, et al
    Direct Quantification of Left Ventricular Motion and Thickening Changes Using Rest-Stress Myocardial Perfusion SPECT.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  753. KISHINO T , Hoshikawa H, Nishiyama Y, Yamamoto Y, et al
    Usefulness of 3'-Deoxy-3'-18F-Fluorothymidine PET for Predicting Early Response to Chemoradiotherapy in Head and Neck Cancer.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  754. JOSEPH UA
    Case-Based Nuclear Medicine.
    J Nucl Med. 2012.
    PubMed     Text format    


  755. TURKINGTON T , Wong T
    R. Edward Coleman, MD, 1943-2012.
    J Nucl Med. 2012;53:16N-7N.
    PubMed     Text format    


  756. MAHMOOD S , Martinez de Llano SR
    The role of imaging physicians in industry.
    J Nucl Med. 2012;53:14N-5N.
    PubMed     Text format    


  757. YAMAZATO R , Yamamoto H, Tadehara F, Teragawa H, et al
    Association between aortic valve calcification and myocardial ischemia, especially in asymptomatic patients.
    J Nucl Med. 2012;53:1216-21.
    PubMed     Text format     Abstract available


  758. VIDAL M , Vidal-Sicart S, Torrents A, Perissinotti A, et al
    Accuracy and reproducibility of lymphoscintigraphy for sentinel node detection in patients with cutaneous melanoma.
    J Nucl Med. 2012;53:1193-9.
    PubMed     Text format     Abstract available


    July 2012
  759. MATUSKEY D , Pittman B, Planeta-Wilson B, Walderhaug E, et al
    Age Effects on Serotonin Receptor 1B as Assessed by PET.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  760. HILLMER AT , Wooten DW, Slesarev MS, Ahlers EO, et al
    PET Imaging of alpha4beta2* Nicotinic Acetylcholine Receptors: Qualitative Analysis of 18F-Nifene Kinetics in the Nonhuman Primate.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  761. RISCHKE HC , Benz MR, Wild D, Mix M, et al
    Correlation of the Genotype of Paragangliomas and Pheochromocytomas with Their Metabolic Phenotype on 3,4-Dihydroxy-6-18F-Fluoro-L-Phenylalanin PET.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  762. DELBEKE D , Royal HD, Frey KA, Graham MM, et al
    SNM/ABNM Joint Position Statement on Optimizing Training in Nuclear Medicine in the Era of Hybrid Imaging.
    J Nucl Med. 2012.
    PubMed     Text format    


  763. MURALIDHARAN V , Kwok M, Lee ST, Lau L, et al
    Prognostic Ability of 18F-FDG PET/CT in the Assessment of Colorectal Liver Metastases.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  764. CARLIN S , Humm JL
    PET of Hypoxia: Current and Future Perspectives.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  765. ERBA PA , Conti U, Lazzeri E, Sollini M, et al
    Added Value of 99mTc-HMPAO-Labeled Leukocyte SPECT/CT in the Characterization and Management of Patients with Infectious Endocarditis.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  766. SILBERSTEIN EB , Alavi A, Balon HR, Clarke SE, et al
    The SNM Practice Guideline for Therapy of Thyroid Disease with 131I 3.0.
    J Nucl Med. 2012.
    PubMed     Text format    


  767. PFEIFER A , Knigge U, Mortensen J, Oturai P, et al
    Clinical PET of Neuroendocrine Tumors Using 64Cu-DOTATATE: First-in-Humans Study.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  768. THEODORE WH , Martinez AR, Khan OI, Liew CJ, et al
    PET of Serotonin 1A Receptors and Cerebral Glucose Metabolism for Temporal Lobectomy.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  769. BUCHBENDER C , Heusner TA, Lauenstein TC, Bockisch A, et al
    Oncologic PET/MRI, Part 2: Bone Tumors, Soft-Tissue Tumors, Melanoma, and Lymphoma.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  770. FAHEY FH
    SNM leadership update: ensuring the health of our profession.
    J Nucl Med. 2012;53:22N.
    PubMed     Text format    


  771. KING B
    SNMTS leadership update: welcome to the new frontier: our collective futures.
    J Nucl Med. 2012;53:20N.
    PubMed     Text format    



  772. Outstanding JNMT articles for 2011.
    J Nucl Med. 2012;53:18N.
    PubMed     Text format    


  773. SCHULTZ MK
    Second world congress on 68Ga molecular imaging.
    J Nucl Med. 2012;53:14N.
    PubMed     Text format    


  774. SCHINDLER TH , Dilsizian V
    Schelbert receives ACC award.
    J Nucl Med. 2012;53:14N.
    PubMed     Text format    


  775. GROPLER RJ , Siegal B
    In memoriam: Michael J. Welch, PhD, 1939-2012.
    J Nucl Med. 2012;53:17N-8.
    PubMed     Text format    



  776. It's official: SNM members endorse name change.
    J Nucl Med. 2012;53:13N.
    PubMed     Text format    


  777. WALKER RC , Brown TL, Jones-Jackson LB, De Blanche L, et al
    Imaging of multiple myeloma and related plasma cell dyscrasias.
    J Nucl Med. 2012;53:1091-101.
    PubMed     Text format     Abstract available


  778. GHADRI JR , Fiechter M, Veraguth K, Gebhard C, et al
    Coronary calcium score as an adjunct to nuclear myocardial perfusion imaging for risk stratification before noncardiac surgery.
    J Nucl Med. 2012;53:1081-6.
    PubMed     Text format     Abstract available


  779. KLEIJNEN J , Westwood M, Wolff R, Whiting P, et al
    Evidence-based assessment of PET in Germany.
    J Nucl Med. 2012;53:1166-7.
    PubMed     Text format    


    June 2012
  780. FIECHTER M , Ghadri JR, Gebhard C, Fuchs TA, et al
    Diagnostic Value of 13N-Ammonia Myocardial Perfusion PET: Added Value of Myocardial Flow Reserve.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  781. SONG BI , Lee SW, Jeong SY, Chae YS, et al
    18F-FDG Uptake by Metastatic Axillary Lymph Nodes on Pretreatment PET/CT as a Prognostic Factor for Recurrence in Patients with Invasive Ductal Breast Cancer.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  782. DEWARAJA YK , Frey EC, Sgouros G, Brill AB, et al
    MIRD Pamphlet No. 23: Quantitative SPECT for Patient-Specific 3-Dimensional Dosimetry in Internal Radionuclide Therapy.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  783. WIRIYASERMKUL P , Nagamori S, Tominaga H, Oriuchi N, et al
    Transport of 3-Fluoro-L-alpha-Methyl-Tyrosine by Tumor-Upregulated L-Type Amino Acid Transporter 1: A Cause of the Tumor Uptake in PET.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  784. CHUN SY , Reese TG, Ouyang J, Guerin B, et al
    MRI-Based Nonrigid Motion Correction in Simultaneous PET/MRI.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  785. BUCK D , Forschler A, Lapa C, Schuster T, et al
    18F-FDG PET Detects Inflammatory Infiltrates in Spinal Cord Experimental Autoimmune Encephalomyelitis Lesions.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  786. KURDZIEL KA , Shih JH, Apolo AB, Lindenberg L, et al
    The Kinetics and Reproducibility of 18F-Sodium Fluoride for Oncology Using Current PET Camera Technology.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  787. BROSKI SM , Hunt CH, Johnson GB, Subramaniam RM, et al
    The Added Value of 18F-FDG PET/CT for Evaluation of Patients with Esthesioneuroblastoma.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  788. HUANG T , Civelek AC, Li J, Jiang H, et al
    Tumor Microenvironment-Dependent 18F-FDG, 18F-Fluorothymidine, and 18F-Misonidazole Uptake: A Pilot Study in Mouse Models of Human Non-Small Cell Lung Cancer.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  789. VAISSIER PE , Goorden MC, Vastenhouw B, van der Have F, et al
    Fast Spiral SPECT with Stationary gamma-Cameras and Focusing Pinholes.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  790. GOERTZEN AL , Bao Q, Bergeron M, Blankemeyer E, et al
    NEMA NU 4-2008 Comparison of Preclinical PET Imaging Systems.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  791. SASAKI T , Ito H, Kimura Y, Arakawa R, et al
    Quantification of Dopamine Transporter in Human Brain Using PET with 18F-FE-PE2I.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  792. MIAO Z , Ren G, Liu H, Qi S, et al
    PET of EGFR Expression with an 18F-Labeled Affibody Molecule.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  793. VIEL T , Talasila KM, Monfared P, Wang J, et al
    Analysis of the Growth Dynamics of Angiogenesis-Dependent and -Independent Experimental Glioblastomas by Multimodal Small-Animal PET and MRI.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  794. SCHEIBLER F , Zumbe P, Janssen I, Viebahn M, et al
    Randomized Controlled Trials on PET: A Systematic Review of Topics, Design, and Quality.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  795. GREGORY DL , Hicks RJ, Hogg A, Binns DS, et al
    Effect of PET/CT on Management of Patients with Non-Small Cell Lung Cancer: Results of a Prospective Study with 5-Year Survival Data.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  796. FOWLER AM , Chan SR, Sharp TL, Fettig NM, et al
    Small-Animal PET of Steroid Hormone Receptors Predicts Tumor Response to Endocrine Therapy Using a Preclinical Model of Breast Cancer.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available



  797. FDA Approves 18F-Florbetapir PET Agent.
    J Nucl Med. 2012;53:15N.
    PubMed     Text format    


  798. NG TS , Bading JR, Park R, Sohi H, et al
    Quantitative, Simultaneous PET/MRI for Intratumoral Imaging with an MRI-Compatible PET Scanner.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  799. SEGALL G
    SNM leadership update: a president's year in review.
    J Nucl Med. 2012;53:22N.
    PubMed     Text format    


  800. ROYAL HD
    Diagnostic radiology and nuclear radiology program requirements changes challenged.
    J Nucl Med. 2012;53:16N.
    PubMed     Text format    


  801. SCHNEIDER C , Kahraman D, Kobe C
    Differentiated Thyroid Carcinoma: Is There Any Evidence for the Use of Recombinant Human TSH in Thyroid Hormone-Secreting Metastasis?
    J Nucl Med. 2012.
    PubMed     Text format    


    May 2012
  802. ALKONYI B , Barger GR, Mittal S, Muzik O, et al
    Accurate Differentiation of Recurrent Gliomas from Radiation Injury by Kinetic Analysis of alpha-11C-Methyl-L-Tryptophan PET.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  803. BROCKMANN K , Reimold M, Globas C, Hauser TK, et al
    PET and MRI Reveal Early Evidence of Neurodegeneration in Spinocerebellar Ataxia Type 17.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  804. GALLDIKS N , Langen KJ, Holy R, Pinkawa M, et al
    Assessment of Treatment Response in Patients with Glioblastoma Using O-(2-18F-Fluoroethyl)-L-Tyrosine PET in Comparison to MRI.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  805. BROUWER OR , Buckle T, Vermeeren L, Klop WM, et al
    Comparing the Hybrid Fluorescent-Radioactive Tracer Indocyanine Green-99mTc-Nanocolloid with 99mTc-Nanocolloid for Sentinel Node Identification: A Validation Study Using Lymphoscintigraphy and SPECT/CT.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  806. BUCKLE T , Brouwer OR, Valdes Olmos RA, van der Poel HG, et al
    Relationship Between Intraprostatic Tracer Deposits and Sentinel Lymph Node Mapping in Prostate Cancer Patients.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  807. LODGE MA , Chaudhry MA, Wahl RL
    Noise Considerations for PET Quantification Using Maximum and Peak Standardized Uptake Value.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  808. KOOPMAN KE , la Fleur SE, Fliers E, Serlie MJ, et al
    Assessing the Optimal Time Point for the Measurement of Extrastriatal Serotonin Transporter Binding with 123I-FP-CIT SPECT in Healthy, Male Subjects.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  809. SCHEIBLER F , Sauerland S, Lange S
    Evidence-Based Assessment of PET in Germany.
    J Nucl Med. 2012.
    PubMed     Text format    


  810. LYALL A , Capobianco J, Strauss HW, Gonen M, et al
    Treadmill Exercise Inducing Mild to Moderate Ischemia Has No Significant Effect on Skeletal Muscle or Cardiac 18F-FDG Uptake and Image Quality on Subsequent Whole-Body PET Scan.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  811. PETERSON TE , Shokouhi S
    Advances in Preclinical SPECT Instrumentation.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  812. YANAGAWA M , Tatsumi M, Miyata H, Morii E, et al
    Evaluation of Response to Neoadjuvant Chemotherapy for Esophageal Cancer: PET Response Criteria in Solid Tumors Versus Response Evaluation Criteria in Solid Tumors.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  813. BUCHBENDER C , Heusner TA, Lauenstein TC, Bockisch A, et al
    Oncologic PET/MRI, Part 1: Tumors of the Brain, Head and Neck, Chest, Abdomen, and Pelvis.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  814. BARBER TW , Duong CP, Leong T, Bressel M, et al
    18F-FDG PET/CT Has a High Impact on Patient Management and Provides Powerful Prognostic Stratification in the Primary Staging of Esophageal Cancer: A Prospective Study with Mature Survival Data.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  815. KRAMER-MAREK G , Bernardo M, Kiesewetter DO, Bagci U, et al
    PET of HER2-Positive Pulmonary Metastases with 18F-ZHER2:342 Affibody in a Murine Model of Breast Cancer: Comparison with 18F-FDG.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  816. HERRERO P , Laforest R, Shoghi K, Zhou D, et al
    Feasibility and Dosimetry Studies for 18F-NOS as a Potential PET Radiopharmaceutical for Inducible Nitric Oxide Synthase in Humans.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  817. RAHBAR K , Seifarth H, Schafers M, Stegger L, et al
    Differentiation of Malignant and Benign Cardiac Tumors Using 18F-FDG PET/CT.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  818. NEWBERG AB , Arnold SE, Wintering N, Rovner BW, et al
    Initial Clinical Comparison of 18F-Florbetapir and 18F-FDG PET in Patients with Alzheimer Disease and Controls.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  819. TIAN J , Smith MF, Ahmad G, Dilsizian V, et al
    Integration of 3-Dimensional Scar Models from SPECT to Guide Ventricular Tachycardia Ablation.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  820. LEMOINE L , Becker G, Vacher B, Billard T, et al
    Radiosynthesis and Preclinical Evaluation of 18F-F13714 as a Fluorinated 5-HT1A Receptor Agonist Radioligand for PET Neuroimaging.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  821. BAHDE R , Kapoor S, Bhargava KK, Schilsky ML, et al
    PET with 64Cu-Histidine for Noninvasive Diagnosis of Biliary Copper Excretion in Long-Evans Cinnamon Rat Model of Wilson Disease.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  822. NORMANDIN MD , Petersen KF, Ding YS, Lin SF, et al
    In Vivo Imaging of Endogenous Pancreatic beta-Cell Mass in Healthy and Type 1 Diabetic Subjects Using 18F-Fluoropropyl-Dihydrotetrabenazine and PET.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  823. KIM JY , Lee SW, Kim JS, Kim SY, et al
    Diagnostic Value of Neck Node Status Using 18F-FDG PET for Salivary Duct Carcinoma of the Major Salivary Glands.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  824. DIJKGRAAF I , Franssen GM, McBride WJ, D'Souza CA, et al
    PET of Tumors Expressing Gastrin-Releasing Peptide Receptor with an 18F-Labeled Bombesin Analog.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  825. MARSHALL HR , Prato FS, Deans L, Theberge J, et al
    Variable Lung Density Consideration in Attenuation Correction of Whole-Body PET/MRI.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  826. FUKUSHIMA K , Javadi MS, Higuchi T, Bravo PE, et al
    Impaired Global Myocardial Flow Dynamics Despite Normal Left Ventricular Function and Regional Perfusion in Chronic Kidney Disease: A Quantitative Analysis of Clinical 82Rb PET/CT Studies.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  827. SEGALL G
    Advancing Nuclear Medicine and Molecular Imaging through Strategic Partnerships.
    J Nucl Med. 2012;53:15N.
    PubMed     Text format    


  828. ANDERSON CJ , Fahey FH, Hunt K
    Proposed name change for the society of nuclear medicine.
    J Nucl Med. 2012;53:11N.
    PubMed     Text format    


  829. AVRAM AM
    Radioiodine Scintigraphy with SPECT/CT: An Important Diagnostic Tool for Thyroid Cancer Staging and Risk Stratification.
    J Nucl Med. 2012;53:754-64.
    PubMed     Text format     Abstract available



  830. Think tank findings on radiation safety in cardiovascular care.
    J Nucl Med. 2012;53:14N.
    PubMed     Text format    


  831. DELBEKE D
    Update on guidelines.
    J Nucl Med. 2012;53:13N.
    PubMed     Text format    


  832. SHOKEEN M , Zheleznyak A, Wilson JM, Jiang M, et al
    Molecular imaging of very late antigen-4 (alpha4beta1 integrin) in the premetastatic niche.
    J Nucl Med. 2012;53:779-86.
    PubMed     Text format     Abstract available


  833. DE LANGEN AJ , Vincent A, Velasquez LM, van Tinteren H, et al
    Repeatability of 18F-FDG uptake measurements in tumors: a metaanalysis.
    J Nucl Med. 2012;53:701-8.
    PubMed     Text format     Abstract available


  834. KUWABARA H , McCaul ME, Wand GS, Earley CJ, et al
    Dissociative changes in the Bmax and KD of dopamine D2/D3 receptors with aging observed in functional subdivisions of the striatum: a revisit with an improved data analysis method.
    J Nucl Med. 2012;53:805-12.
    PubMed     Text format     Abstract available


  835. FUCHS K , Kukuk D, Reischl G, Foller M, et al
    Oxygen breathing affects 3'-deoxy-3'-18F-fluorothymidine uptake in mouse models of arthritis and cancer.
    J Nucl Med. 2012;53:823-30.
    PubMed     Text format     Abstract available


  836. HILLMAN BJ
    A broader importance of NOPR to the future of nuclear imaging.
    J Nucl Med. 2012;53:677-8.
    PubMed     Text format    


    April 2012
  837. JOSEPH UA
    Positron Emission Tomography.
    J Nucl Med. 2012.
    PubMed     Text format    


  838. DRZEZGA A , Souvatzoglou M, Eiber M, Beer AJ, et al
    First Clinical Experience with Integrated Whole-Body PET/MR: Comparison to PET/CT in Patients with Oncologic Diagnoses.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  839. BERKER Y , Franke J, Salomon A, Palmowski M, et al
    MRI-Based Attenuation Correction for Hybrid PET/MRI Systems: A 4-Class Tissue Segmentation Technique Using a Combined Ultrashort-Echo-Time/Dixon MRI Sequence.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  840. GIALLEONARDO VD , Signore A, Glaudemans A, Dierckx R, et al
    N-(4-18F-Fluorobenzoyl)Interleukin-2 for PET of Human-Activated T Lymphocytes.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  841. DOSS M , Kolb HC, Zhang JJ, Belanger MJ, et al
    Biodistribution and Radiation Dosimetry of the Integrin Marker 18F-RGD-K5 Determined from Whole-Body PET/CT in Monkeys and Humans.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  842. TAKASHIMA T , Kitamura S, Wada Y, Tanaka M, et al
    PET Imaging-Based Evaluation of Hepatobiliary Transport in Humans with (15R)-11C-TIC-Me.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  843. ZHU Z , Miao W, Li Q, Dai H, et al
    99mTc-3PRGD2 for Integrin Receptor Imaging of Lung Cancer: A Multicenter Study.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  844. YOSHIMOTO M , Hayakawa T, Mutoh M, Imai T, et al
    In Vivo SPECT Imaging with 111In-DOTA-c(RGDfK) to Detect Early Pancreatic Cancer in a Hamster Pancreatic Carcinogenesis Model.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  845. RISCHPLER C , Higuchi T, Fukushima K, Javadi MS, et al
    Transient Ischemic Dilation Ratio in 82Rb PET Myocardial Perfusion Imaging: Normal Values and Significance as a Diagnostic and Prognostic Marker.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  846. SOSSI V , Dinelle K, Jivan S, Fischer K, et al
    In Vivo Dopamine Transporter Imaging in a Unilateral 6-Hydroxydopamine Rat Model of Parkinson Disease Using 11C-Methylphenidate PET.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  847. ZIESSMAN H
    Nuclear Medicine Residency vs Nuclear Radiology Fellowship.
    J Nucl Med. 2012;53:13N.
    PubMed     Text format    



  848. From the literature.
    J Nucl Med. 2012;53:22N-6.
    PubMed     Text format    


  849. PAPPAS V
    SNM travels to Miami Beach for 2012 annual meeting.
    J Nucl Med. 2012;53:19N.
    PubMed     Text format    


  850. SRIVASTAVA SC
    International focus on theragnostics.
    J Nucl Med. 2012;53:17N.
    PubMed     Text format    


  851. HANNESTAD J , Subramanyam K, Dellagioia N, Planeta-Wilson B, et al
    Glucose metabolism in the insula and cingulate is affected by systemic inflammation in humans.
    J Nucl Med. 2012;53:601-7.
    PubMed     Text format     Abstract available


    March 2012
  852. FRISCH K , Jakobsen S, Sorensen M, Munk OL, et al
    [N-Methyl-11C]Cholylsarcosine, a Novel Bile Acid Tracer for PET/CT of Hepatic Excretory Function: Radiosynthesis and Proof-of-Concept Studies in Pigs.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  853. GOH V , Engledow A, Rodriguez-Justo M, Shastry M, et al
    The Flow-Metabolic Phenotype of Primary Colorectal Cancer: Assessment by Integrated 18F-FDG PET/Perfusion CT with Histopathologic Correlation.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  854. TIXIER F , Hatt M, Le Rest CC, Le Pogam A, et al
    Reproducibility of Tumor Uptake Heterogeneity Characterization Through Textural Feature Analysis in 18F-FDG PET.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  855. HILLNER BE , Siegel BA, Hanna L, Shields AF, et al
    Impact of 18F-FDG PET Used After Initial Treatment of Cancer: Comparison of the National Oncologic PET Registry 2006 and 2009 Cohorts.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  856. CHENG VY , Slomka PJ, Le Meunier L, Tamarappoo BK, et al
    Coronary Arterial 18F-FDG Uptake by Fusion of PET and Coronary CT Angiography at Sites of Percutaneous Stenting for Acute Myocardial Infarction and Stable Coronary Artery Disease.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  857. HEINZEL A , Stock S, Langen KJ, Muller D, et al
    Cost-Effectiveness Analysis of Amino Acid PET-Guided Surgery for Supratentorial High-Grade Gliomas.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  858. PARK H , Wood D, Hussain H, Meyer CR, et al
    Introducing Parametric Fusion PET/MRI of Primary Prostate Cancer.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  859. YOON HS , Ko GB, Kwon SI, Lee CM, et al
    Initial Results of Simultaneous PET/MRI Experiments with an MRI-Compatible Silicon Photomultiplier PET Scanner.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  860. SAUTER AW , Winterstein S, Spira D, Hetzel J, et al
    Multifunctional Profiling of Non-Small Cell Lung Cancer Using 18F-FDG PET/CT and Volume Perfusion CT.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  861. ZHOU Y , Sojkova J, Resnick SM, Wong DF, et al
    Relative Equilibrium Plot Improves Graphical Analysis and Allows Bias Correction of Standardized Uptake Value Ratio in Quantitative 11C-PiB PET Studies.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  862. SCHWARTZ J , Humm JL, Divgi CR, Larson SM, et al
    Bone Marrow Dosimetry Using 124I-PET.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  863. BENGTSSON T , Hicks RJ, Peterson A, Port RE, et al
    18F-FDG PET as a Surrogate Biomarker in Non-Small Cell Lung Cancer Treated with Erlotinib: Newly Identified Lesions Are More Informative Than Standardized Uptake Value.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  864. KRAMER-MAREK G , Gijsen M, Kiesewetter DO, Bennett R, et al
    Potential of PET to Predict the Response to Trastuzumab Treatment in an ErbB2-Positive Human Xenograft Tumor Model.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  865. GRAHAM MM , Jacene HA
    Molecular Imaging Training for Nuclear Medicine Residents.
    J Nucl Med. 2012.
    PubMed     Text format    


  866. XIE BQ , Tian YQ, Zhang J, Zhao SH, et al
    Evaluation of Left and Right Ventricular Ejection Fraction and Volumes from Gated Blood-Pool SPECT in Patients with Dilated Cardiomyopathy: Comparison with Cardiac MRI.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  867. VAN DEN ABBEELE AD , Gatsonis C, de Vries DJ, Melenevsky Y, et al
    ACRIN 6665/RTOG 0132 Phase II Trial of Neoadjuvant Imatinib Mesylate for Operable Malignant Gastrointestinal Stromal Tumor: Monitoring with 18F-FDG PET and Correlation with Genotype and GLUT4 Expression.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available



  868. From the literature.
    J Nucl Med. 2012;53:22N-6.
    PubMed     Text format    


  869. SEGALL G
    SNM and global cooperation.
    J Nucl Med. 2012;53:19N.
    PubMed     Text format    


  870. ANDERSON CJ , Piwnica-Worms D
    SNM and AACR announce joint conference.
    J Nucl Med. 2012;53:18NA.
    PubMed     Text format    



  871. Howard J. Dworkin, MD, 1932-2012.
    J Nucl Med. 2012;53:16N.
    PubMed     Text format    



  872. SNM 2012 annual meeting in Miami.
    J Nucl Med. 2012;53:13NA.
    PubMed     Text format    


  873. ZIESSMAN H
    Hippocrates and certification.
    J Nucl Med. 2012;53:13N.
    PubMed     Text format    


  874. MEES G , Dierckx R, Mertens K, Vermeire S, et al
    99mTc-labeled tricarbonyl his-CNA35 as an imaging agent for the detection of tumor vasculature.
    J Nucl Med. 2012;53:464-71.
    PubMed     Text format     Abstract available


  875. OH M , Kim JS, Kim JY, Shin KH, et al
    Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.
    J Nucl Med. 2012;53:399-406.
    PubMed     Text format     Abstract available


  876. PERRONE-FILARDI P , Pinto FJ
    Looking for myocardial viability after a STICH trial: not enough to close the door.
    J Nucl Med. 2012;53:349-52.
    PubMed     Text format    


  877. TOYOHARA J , Elsinga PH, Ishiwata K, Sijbesma JW, et al
    Evaluation of 4'-[methyl-11C]thiothymidine in a rodent tumor and inflammation model.
    J Nucl Med. 2012;53:488-94.
    PubMed     Text format     Abstract available


    February 2012
  878. MENA E , Turkbey B, Mani H, Adler S, et al
    11C-Acetate PET/CT in Localized Prostate Cancer: A Study with MRI and Histopathologic Correlation.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  879. KAO YH , Hock Tan AE, Burgmans MC, Irani FG, et al
    Image-Guided Personalized Predictive Dosimetry by Artery-Specific SPECT/CT Partition Modeling for Safe and Effective 90Y Radioembolization.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  880. CAROLI A , Prestia A, Chen K, Ayutyanont N, et al
    Summary Metrics to Assess Alzheimer Disease-Related Hypometabolic Pattern with 18F-FDG PET: Head-to-Head Comparison.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  881. COCHET A , Pigeonnat S, Khoury B, Vrigneaud JM, et al
    Evaluation of Breast Tumor Blood Flow with Dynamic First-Pass 18F-FDG PET/CT: Comparison with Angiogenesis Markers and Prognostic Factors.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  882. ZANNETTI A , Iommelli F, Speranza A, Salvatore M, et al
    3'-Deoxy-3'-18F-Fluorothymidine PET/CT to Guide Therapy with Epidermal Growth Factor Receptor Antagonists and Bcl-xL Inhibitors in Non-Small Cell Lung Cancer.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  883. KRAMER SD , Mu L, Muller A, Keller C, et al
    5-(2-18F-Fluoroethoxy)-L-Tryptophan as a Substrate of System L Transport for Tumor Imaging by PET.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  884. HAUG AR , Tiega Donfack BP, Trumm C, Zech CJ, et al
    18F-FDG PET/CT Predicts Survival After Radioembolization of Hepatic Metastases from Breast Cancer.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  885. KELLER SH , Sibomana M, Olesen OV, Svarer C, et al
    Methods for Motion Correction Evaluation Using 18F-FDG Human Brain Scans on a High-Resolution PET Scanner.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  886. DEHDASHTI F , Laforest R, Gao F, Aft RL, et al
    Assessment of Progesterone Receptors in Breast Carcinoma by PET with 21-18F-Fluoro-16alpha,17alpha-[(R)-(1'-alpha-furylmethylidene)Dioxy]-19-Norpregn- 4-Ene-3,20-Dione.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  887. JOSHI AD , Pontecorvo MJ, Clark CM, Carpenter AP, et al
    Performance Characteristics of Amyloid PET with Florbetapir F 18 in Patients with Alzheimer's Disease and Cognitively Normal Subjects.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  888. CSELENYI Z , Jonhagen ME, Forsberg A, Halldin C, et al
    Clinical Validation of 18F-AZD4694, an Amyloid-beta-Specific PET Radioligand.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  889. KEIDING S
    Bringing Physiology into PET of the Liver.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  890. WALTER F , Cloughesy T, Walter MA, Lai A, et al
    Impact of 3,4-Dihydroxy-6-18F-Fluoro-L-Phenylalanine PET/CT on Managing Patients with Brain Tumors: The Referring Physician's Perspective.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  891. MADRU R , Kjellman P, Olsson F, Wingardh K, et al
    99mTc-Labeled Superparamagnetic Iron Oxide Nanoparticles for Multimodality SPECT/MRI of Sentinel Lymph Nodes.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  892. ANTUNES IF , Doorduin J, Haisma HJ, Elsinga PH, et al
    18F-FEAnGA for PET of beta-Glucuronidase Activity in Neuroinflammation.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  893. VAN NOSTRAND D , Khorjekar GR, O'Neil J, Moreau S, et al
    Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in the Identification of Metastasis in Differentiated Thyroid Cancer with 131I Planar Whole-Body Imaging and 124I PET.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  894. LEE J , Yun M, Kim KS, Lee JD, et al
    Risk Stratification of Gallbladder Polyps (1-2 cm) for Surgical Intervention with 18F-FDG PET/CT.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  895. BRAVO PE , Pinheiro A, Higuchi T, Rischpler C, et al
    PET/CT Assessment of Symptomatic Individuals with Obstructive and Nonobstructive Hypertrophic Cardiomyopathy.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  896. LOHITH TG , Zoghbi SS, Morse CL, Araneta MF, et al
    Brain and Whole-Body Imaging of Nociceptin/Orphanin FQ Peptide Receptor in Humans Using the PET Ligand 11C-NOP-1A.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  897. MOU T , Zhao Z, Fang W, Peng C, et al
    Synthesis and Preliminary Evaluation of 18F-Labeled Pyridaben Analogues for Myocardial Perfusion Imaging with PET.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  898. LEE JT , Campbell DO, Satyamurthy N, Czernin J, et al
    Stratification of Nucleoside Analog Chemotherapy Using 1-(2'-Deoxy-2'-18F-Fluoro-beta-D-Arabinofuranosyl)Cytosine and 1-(2'-Deoxy-2'-18F-Fluoro-beta-L-Arabinofuranosyl)-5-Methylcytosine PET.
    J Nucl Med. 2012;53:275-80.
    PubMed     Text format     Abstract available


  899. TAIEB D , Neumann H, Rubello D, Al-Nahhas A, et al
    Modern Nuclear Imaging for Paragangliomas: Beyond SPECT.
    J Nucl Med. 2012;53:264-74.
    PubMed     Text format     Abstract available


  900. GARIN E , Lenoir L, Rolland Y, Edeline J, et al
    Dosimetry Based on 99mTc-Macroaggregated Albumin SPECT/CT Accurately Predicts Tumor Response and Survival in Hepatocellular Carcinoma Patients Treated with 90Y-Loaded Glass Microspheres: Preliminary Results.
    J Nucl Med. 2012;53:255-63.
    PubMed     Text format     Abstract available


  901. DUNET V , Rossier C, Buck A, Stupp R, et al
    Performance of 18F-Fluoro-Ethyl-Tyrosine (18F-FET) PET for the Differential Diagnosis of Primary Brain Tumor: A Systematic Review and Metaanalysis.
    J Nucl Med. 2012;53:207-14.
    PubMed     Text format     Abstract available


  902. LEVIN CS
    Promising New Photon Detection Concepts for High-Resolution Clinical and Preclinical PET.
    J Nucl Med. 2012;53:167-70.
    PubMed     Text format     Abstract available



  903. From the literature.
    J Nucl Med. 2012;53:18N-21.
    PubMed     Text format    


  904. FAHEY FH
    Strengthening our profession through community and collaboration.
    J Nucl Med. 2012;53:14N.
    PubMed     Text format    


  905. CLARKE B , Merrill J
    SNM submits imaging endpoint comments to FDA.
    J Nucl Med. 2012;53:13N.
    PubMed     Text format    


  906. BOTKIN C , Henkin R
    What is an NMAA?
    J Nucl Med. 2012;53:12N.
    PubMed     Text format    


  907. ZIESSMAN H
    From the newsline editor.
    J Nucl Med. 2012;53:11N.
    PubMed     Text format    


  908. SHERIF HM , Saraste A, Nekolla SG, Weidl E, et al
    Molecular Imaging of Early alphavbeta3 Integrin Expression Predicts Long-Term Left-Ventricle Remodeling After Myocardial Infarction in Rats.
    J Nucl Med. 2012;53:318-23.
    PubMed     Text format     Abstract available


  909. SENTHAMIZHCHELVAN S , Hobbs RF, Song H, Frey EC, et al
    Tumor dosimetry and response for 153Sm-ethylenediamine tetramethylene phosphonic acid therapy of high-risk osteosarcoma.
    J Nucl Med. 2012;53:215-24.
    PubMed     Text format     Abstract available


  910. XU Y , Chang E, Liu H, Jiang H, et al
    Proof-of-concept study of monitoring cancer drug therapy with cerenkov luminescence imaging.
    J Nucl Med. 2012;53:312-7.
    PubMed     Text format     Abstract available


  911. STELTER L , Evans MJ, Jungbluth AA, Zanzonico P, et al
    Novel mechanistic insights into arginine deiminase pharmacology suggest 18F-FDG is not suitable to evaluate clinical response in melanoma.
    J Nucl Med. 2012;53:281-6.
    PubMed     Text format     Abstract available


    January 2012
  912. BROCKENBROUGH JS , Vesselle H
    Kinetic Analysis of 18F-FLT PET in Lung Tumors.
    J Nucl Med. 2012.
    PubMed     Text format    


  913. BADING JR
    Kinetic Analysis of 18F-FLT PET in Lung Tumors.
    J Nucl Med. 2012.
    PubMed     Text format    


  914. RADHAKRISHNAN V , Kumar R, Malhotra A, Bakhshi S, et al
    Role of PET/CT in Staging and Evaluation of Treatment Response After 3 Cycles of Chemotherapy in Locally Advanced Retinoblastoma: A Prospective Study.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  915. TANG D , Hight MR, McKinley ET, Fu A, et al
    Quantitative Preclinical Imaging of TSPO Expression in Glioma Using N,N-Diethyl-2-(2-(4-(2-18F-Fluoroethoxy)Phenyl)-5,7-Dimethylpyrazolo[1,5-a]Pyrimi din-3-yl)Acetamide.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  916. GROHEUX D , Hindie E, Giacchetti S, Delord M, et al
    Triple-Negative Breast Cancer: Early Assessment with 18F-FDG PET/CT During Neoadjuvant Chemotherapy Identifies Patients Who Are Unlikely to Achieve a Pathologic Complete Response and Are at a High Risk of Early Relapse.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  917. VAN KRUCHTEN M , Glaudemans AW, de Vries EF, Beets-Tan RG, et al
    PET Imaging of Estrogen Receptors as a Diagnostic Tool for Breast Cancer Patients Presenting with a Clinical Dilemma.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  918. SETOAIN X , Pavia J, Seres E, Garcia R, et al
    Validation of an Automatic Dose Injection System for Ictal SPECT in Epilepsy.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  919. LOPEZ GUERRA JL , Gladish G, Komaki R, Gomez D, et al
    Large Decreases in Standardized Uptake Values After Definitive Radiation Are Associated with Better Survival of Patients with Locally Advanced Non-Small Cell Lung Cancer.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  920. HIRVONEN J , Kreisl WC, Fujita M, Dustin I, et al
    Increased In Vivo Expression of an Inflammatory Marker in Temporal Lobe Epilepsy.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  921. SLOMKA PJ , Alexanderson E, Jacome R, Jimenez M, et al
    Comparison of Clinical Tools for Measurements of Regional Stress and Rest Myocardial Blood Flow Assessed with 13N-Ammonia PET/CT.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  922. YOUSSEF G , Leung E, Mylonas I, Nery P, et al
    The Use of 18F-FDG PET in the Diagnosis of Cardiac Sarcoidosis: A Systematic Review and Metaanalysis Including the Ontario Experience.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  923. PARKER CA , Gunn RN, Rabiner EA, Slifstein M, et al
    Radiosynthesis and Characterization of 11C-GSK215083 as a PET Radioligand for the 5-HT6 Receptor.
    J Nucl Med. 2012.
    PubMed     Text format     Abstract available


  924. PERSSON M , Madsen J, Ostergaard S, Jensen MM, et al
    Quantitative PET of Human Urokinase-Type Plasminogen Activator Receptor with 64Cu-DOTA-AE105: Implications for Visualizing Cancer Invasion.
    J Nucl Med. 2012;53:138-45.
    PubMed     Text format     Abstract available


  925. NAYAK TK , Garmestani K, Milenic DE, Brechbiel MW, et al
    PET and MRI of Metastatic Peritoneal and Pulmonary Colorectal Cancer in Mice with Human Epidermal Growth Factor Receptor 1-Targeted 89Zr-Labeled Panitumumab.
    J Nucl Med. 2012;53:113-20.
    PubMed     Text format     Abstract available


  926. CARTER SF , Scholl M, Almkvist O, Wall A, et al
    Evidence for Astrocytosis in Prodromal Alzheimer Disease Provided by 11C-Deuterium-L-Deprenyl: A Multitracer PET Paradigm Combining 11C-Pittsburgh Compound B and 18F-FDG.
    J Nucl Med. 2012;53:37-46.
    PubMed     Text format     Abstract available


  927. CHANG KP , Tsang NM, Liao CT, Hsu CL, et al
    Prognostic Significance of 18F-FDG PET Parameters and Plasma Epstein-Barr Virus DNA Load in Patients with Nasopharyngeal Carcinoma.
    J Nucl Med. 2012;53:21-8.
    PubMed     Text format     Abstract available


  928. HATT M , Le Pogam A, Visvikis D, Pradier O, et al
    Impact of Partial-Volume Effect Correction on the Predictive and Prognostic Value of Baseline 18F-FDG PET Images in Esophageal Cancer.
    J Nucl Med. 2012;53:12-20.
    PubMed     Text format     Abstract available



  929. From the literature.
    J Nucl Med. 2012;53:21N-24N.
    PubMed     Text format    


  930. SEGALL G
    Molding the future of the profession.
    J Nucl Med. 2012;53:17N.
    PubMed     Text format    



  931. SNM journals' new mobile interface.
    J Nucl Med. 2012;53:15NA.
    PubMed     Text format    



  932. Schelbert completes service as JNM editor-in-chief.
    J Nucl Med. 2012;53:14N.
    PubMed     Text format    


  933. ZIESSMAN HA
    Newsline 2012: 25 years of age.
    J Nucl Med. 2012;53:13N.
    PubMed     Text format    


  934. VANDERHOEK M , Perlman SB, Jeraj R
    Impact of the definition of peak standardized uptake value on quantification of treatment response.
    J Nucl Med. 2012;53:4-11.
    PubMed     Text format     Abstract available


  935. HESKAMP S , Laverman P, Rosik D, Boschetti F, et al
    Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer.
    J Nucl Med. 2012;53:146-53.
    PubMed     Text format     Abstract available


  936. QU W , Oya S, Lieberman BP, Ploessl K, et al
    Preparation and characterization of L-[5-11C]-glutamine for metabolic imaging of tumors.
    J Nucl Med. 2012;53:98-105.
    PubMed     Text format     Abstract available


  937. XU YZ , Cha YM, Feng D, Powell BD, et al
    Impact of myocardial scarring on outcomes of cardiac resynchronization therapy: extent or location?
    J Nucl Med. 2012;53:47-54.
    PubMed     Text format     Abstract available


  938. BOELLAARD R
    Mutatis mutandis: harmonize the standard!
    J Nucl Med. 2012;53:1-3.
    PubMed     Text format    


  939. HWANG DO W , Lee DS, Kim S
    Gene expression profiles for genotoxic effects of silica-free and silica-coated cobalt ferrite nanoparticles.
    J Nucl Med. 2012;53:106-12.
    PubMed     Text format     Abstract available


    December 2011
  940. MINAMIMOTO R , Toyohara J, Seike A, Ito H, et al
    4'-[Methyl-11C]-Thiothymidine PET/CT for Proliferation Imaging in Non-Small Cell Lung Cancer.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


  941. HILLMAN BJ , Frank RA, Rodriguez GM
    New Pathways to Medicare Coverage for Innovative PET Radiopharmaceuticals: Report of a Medical Imaging & Technology Alliance (MITA) Workshop.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


  942. KUWABARA H , Wong DF, Gao Y, Valentine H, et al
    PET Imaging of Nicotinic Acetylcholine Receptors in Baboons with 18F-AZAN, a Radioligand with Improved Brain Kinetics.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


  943. BOHNEN NI , Djang DS, Herholz K, Anzai Y, et al
    Effectiveness and Safety of 18F-FDG PET in the Evaluation of Dementia: A Review of the Recent Literature.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


  944. SCHWARZENBERG J , Czernin J, Cloughesy TF, Ellingson BM, et al
    3'-Deoxy-3'-18F-Fluorothymidine PET and MRI for Early Survival Predictions in Patients with Recurrent Malignant Glioma Treated with Bevacizumab.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


  945. DJANG DS , Janssen MJ, Bohnen N, Booij J, et al
    SNM Practice Guideline for Dopamine Transporter Imaging with 123I-Ioflupane SPECT 1.0.
    J Nucl Med. 2011.
    PubMed     Text format    


  946. DELBEKE D , Dillehay GL, Segall GM, Hillman BJ, et al
    MITA PET Coverage Workshop.
    J Nucl Med. 2011;52:27N.
    PubMed     Text format    


  947. BOELLAARD R
    Need for Standardization of 18F-FDG PET/CT for Treatment Response Assessments.
    J Nucl Med. 2011;52 Suppl 2:93S-100S.
    PubMed     Text format     Abstract available


  948. VACH W , Hoilund-Carlsen PF, Gerke O, Weber WA, et al
    Generating Evidence for Clinical Benefit of PET/CT in Diagnosing Cancer Patients.
    J Nucl Med. 2011;52 Suppl 2:77S-85S.
    PubMed     Text format     Abstract available


  949. WARE RE , Hicks RJ
    Doing More Harm than Good? Do Systematic Reviews of PET by Health Technology Assessment Agencies Provide an Appraisal of the Evidence That Is Closer to the Truth than the Primary Data Supporting Its Use?
    J Nucl Med. 2011;52 Suppl 2:64S-73S.
    PubMed     Text format     Abstract available


  950. LARSON SM
    The janus project: the remaking of nuclear medicine and radiology.
    J Nucl Med. 2011;52 Suppl 2:3S-9S.
    PubMed     Text format    


  951. SCHWAIGER M , Wester HJ
    How Many PET Tracers Do We Need?
    J Nucl Med. 2011;52 Suppl 2:36S-41S.
    PubMed     Text format     Abstract available


  952. DELBEKE D , Segall GM
    Status of and trends in nuclear medicine in the United States.
    J Nucl Med. 2011;52 Suppl 2:24S-8S.
    PubMed     Text format     Abstract available


  953. DONDI M , Kashyap R, Paez D, Pascual T, et al
    Trends in nuclear medicine in developing countries.
    J Nucl Med. 2011;52 Suppl 2:16S-23S.
    PubMed     Text format     Abstract available


  954. SCHELBERT HR
    Nuclear medicine at a crossroads.
    J Nucl Med. 2011;52 Suppl 2:10S-5S.
    PubMed     Text format     Abstract available


  955. YANG Y , Czernin J
    Contribution of imaging to cancer care costs.
    J Nucl Med. 2011;52 Suppl 2:86S-92S.
    PubMed     Text format     Abstract available


  956. WEBER WA
    Is there evidence for evidence-based medical imaging?
    J Nucl Med. 2011;52 Suppl 2:74S-6S.
    PubMed     Text format    


  957. FREUDENBERG LS , Beyer T
    Subjective perception of radiation risk.
    J Nucl Med. 2011;52 Suppl 2:29S-35S.
    PubMed     Text format     Abstract available


  958. CZERNIN J , Weber WA
    Issues and controversies in nuclear medicine. Introduction.
    J Nucl Med. 2011;52 Suppl 2:1S-2S.
    PubMed     Text format    


  959. PAPPAS V
    A check-up on SNM's financial health.
    J Nucl Med. 2011;52:26N.
    PubMed     Text format    


  960. ECKELMAN WC , Maurer AH, Sajdak RA, Basso DA, et al
    A name change for the Society: perspectives.
    J Nucl Med. 2011;52:22N-5N.
    PubMed     Text format    


  961. DEWARAJA YK , Sgouros G
    Koral receives 2011 Loevinger-Berman Award.
    J Nucl Med. 2011;52:20N.
    PubMed     Text format    



  962. SNM 2020 Task Force Assesses Environment for Profession, Society.
    J Nucl Med. 2011;52:18N.
    PubMed     Text format    


  963. XU Y , Liu H, Cheng Z
    Harnessing the power of radionuclides for optical imaging: Cerenkov luminescence imaging.
    J Nucl Med. 2011;52:2009-18.
    PubMed     Text format     Abstract available


  964. ABIRAJ K , Mansi R, Tamma ML, Fani M, et al
    Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumors.
    J Nucl Med. 2011;52:1970-8.
    PubMed     Text format     Abstract available


  965. SPIRNAK J
    "Treadmill exercise does not affect image quality on subsequent whole body FDG PET scan".
    J Nucl Med. 2011;52:2020.
    PubMed     Text format    


  966. BALON HR
    Updated practice guideline for somatostatin receptor scintigraphy.
    J Nucl Med. 2011;52:1838.
    PubMed     Text format    


  967. EARY JF , Conrad EU
    Imaging in sarcoma.
    J Nucl Med. 2011;52:1903-13.
    PubMed     Text format     Abstract available


    November 2011
  968. CHAN T
    Computerized Method for Automatic Evaluation of Lean Body Mass from PET/CT: Comparison with Predictive Equations.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


  969. OGAWA M , Nakamura S, Saito Y, Kosugi M, et al
    What Can Be Seen by 18F-FDG PET in Atherosclerosis Imaging? The Effect of Foam Cell Formation on 18F-FDG Uptake to Macrophages In Vitro.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


  970. LIEBERMAN BP , Ploessl K, Wang L, Qu W, et al
    PET of Glutaminolysis in Tumors by 18F-(2S,4R)4-Fluoroglutamine.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


  971. DELSO G , Furst S, Jakoby B, Ladebeck R, et al
    Performance Measurements of the Siemens mMR Integrated Whole-Body PET/MR Scanner.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


  972. ZANZONICO P
    Virtual Reality for Dose Optimization in Pediatric Nuclear Medicine: Better Than the Real Thing.
    J Nucl Med. 2011.
    PubMed     Text format    


  973. LODGE MA , Mhlanga JC, Cho SY, Wahl RL, et al
    Effect of Patient Arm Motion in Whole-Body PET/CT.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


  974. OUDE MUNNINK TH , Arjaans ME, Timmer-Bosscha H, Schroder CP, et al
    PET with the 89Zr-Labeled Transforming Growth Factor-beta Antibody Fresolimumab in Tumor Models.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


  975. OZAWA M , Takahashi K, Akazawa KH, Takashima T, et al
    PET of Aromatase in Gastric Parietal Cells Using 11C-Vorozole.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


  976. POEPPEL TD , Binse I, Petersenn S, Lahner H, et al
    68Ga-DOTATOC Versus 68Ga-DOTATATE PET/CT in Functional Imaging of Neuroendocrine Tumors.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


  977. O'DONOGHUE JA , Smith-Jones PM, Humm JL, Ruan S, et al
    124I-huA33 Antibody Uptake Is Driven by A33 Antigen Concentration in Tissues from Colorectal Cancer Patients Imaged by Immuno-PET.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


  978. DERLIN T , Habermann CR, Lengyel Z, Busch JD, et al
    Feasibility of 11C-Acetate PET/CT for Imaging of Fatty Acid Synthesis in the Atherosclerotic Vessel Wall.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


  979. HERRMANN K , Buck AK, Schuster T, Rudelius M, et al
    A Pilot Study to Evaluate 3'-Deoxy-3'-18F-Fluorothymidine PET for Initial and Early Response Imaging in Mantle Cell Lymphoma.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


  980. BASU S
    18F-FDG PET/CT as a Sensitive and Early Treatment Monitoring Tool: Will This Become the Major Thrust for Its Clinical Application in Infectious and Inflammatory Disorders?
    J Nucl Med. 2011.
    PubMed     Text format    


  981. KAHRAMAN D , Scheffler M, Zander T, Nogova L, et al
    Quantitative Analysis of Response to Treatment with Erlotinib in Advanced Non-Small Cell Lung Cancer Using 18F-FDG and 3'-Deoxy-3'-18F-Fluorothymidine PET.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


  982. KAUHANEN S , Schalin-Jantti C, Seppanen M, Kajander S, et al
    Complementary Roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in Medullary Thyroid Cancer.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


  983. CEULEMANS AG , Hernot S, Zgavc T, Caveliers V, et al
    Serial Semiquantitative Imaging of Brain Damage Using Micro-SPECT and Micro-CT After Endothelin-1-Induced Transient Focal Cerebral Ischemia in Rats.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


  984. LIU Y , Pressly ED, Abendschein DR, Hawker CJ, et al
    Targeting Angiogenesis Using a C-Type Atrial Natriuretic Factor-Conjugated Nanoprobe and PET.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


  985. ZIESSMAN HA
    General nuclear medicine.
    J Nucl Med. 2011;52:20N-8N.
    PubMed     Text format    


  986. GOURNI E , Demmer O, Schottelius M, D'Alessandria C, et al
    PET of CXCR4 Expression by a 68Ga-Labeled Highly Specific Targeted Contrast Agent.
    J Nucl Med. 2011;52:1803-10.
    PubMed     Text format     Abstract available


  987. VANGESTEL C , Van de Wiele C, Van Damme N, Staelens S, et al
    99mTc-(CO)3 His-Annexin A5 Micro-SPECT Demonstrates Increased Cell Death by Irinotecan During the Vascular Normalization Window Caused by Bevacizumab.
    J Nucl Med. 2011;52:1786-94.
    PubMed     Text format     Abstract available


  988. COTTONE L , Valtorta S, Capobianco A, Belloli S, et al
    Evaluation of the Role of Tumor-Associated Macrophages in an Experimental Model of Peritoneal Carcinomatosis Using 18F-FDG PET.
    J Nucl Med. 2011;52:1770-7.
    PubMed     Text format     Abstract available


  989. BENZ MR , Herrmann K, Walter F, Garon EB, et al
    18F-FDG PET/CT for Monitoring Treatment Responses to the Epidermal Growth Factor Receptor Inhibitor Erlotinib.
    J Nucl Med. 2011;52:1684-9.
    PubMed     Text format     Abstract available


  990. SEGALL G
    An education opportunity for all: SNM's Mid-Winter Meeting.
    J Nucl Med. 2011;52:33N.
    PubMed     Text format    


  991. WOOLFENDEN JM
    Notification of proposed SNM Bylaws change.
    J Nucl Med. 2011;52:30N-1N.
    PubMed     Text format    


  992. ANDERSON CJ
    Gathering member feedback on SNM name change.
    J Nucl Med. 2011;52:29N-30N.
    PubMed     Text format    


  993. LARSON SM
    Oncology.
    J Nucl Med. 2011;52:13N-20N.
    PubMed     Text format    


  994. LEWIS MR
    Looking through the vascular normalization window: timing antiangiogenic treatment and chemotherapy with (99m)Tc-annexin A5.
    J Nucl Med. 2011;52:1670-2.
    PubMed     Text format    


  995. TERWISSCHA VAN SCHELTINGA AG , van Dam GM, Nagengast WB, Ntziachristos V, et al
    Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies.
    J Nucl Med. 2011;52:1778-85.
    PubMed     Text format     Abstract available


  996. HARRIS RS , Venegas JG, Wongviriyawong C, Winkler T, et al
    (18)F-FDG uptake rate is a biomarker of eosinophilic inflammation and airway response in asthma.
    J Nucl Med. 2011;52:1713-20.
    PubMed     Text format     Abstract available


  997. RAZAVIAN M , Tavakoli S, Zhang J, Nie L, et al
    Atherosclerosis plaque heterogeneity and response to therapy detected by in vivo molecular imaging of matrix metalloproteinase activation.
    J Nucl Med. 2011;52:1795-802.
    PubMed     Text format     Abstract available


  998. ROWE CC , Villemagne VL
    Brain amyloid imaging.
    J Nucl Med. 2011;52:1733-40.
    PubMed     Text format     Abstract available


    October 2011
  999. GUIDUCCI L , Burchielli S, Chubuchny V, Sicari R, et al
    Maternal and Sex Dependency of Insulin Resistance: Longitudinal PET and Echocardiography Study from the Healthy Fetus to the Adult Minipig.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


  1000. ROBERTSON R , Germanos MS, Manfredi MG, Smith PG, et al
    Multimodal Imaging with 18F-FDG PET and Cerenkov Luminescence Imaging After MLN4924 Treatment in a Human Lymphoma Xenograft Model.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


  1001. SIDDIQUE M , Frost ML, Blake GM, Moore AE, et al
    The Precision and Sensitivity of 18F-Fluoride PET for Measuring Regional Bone Metabolism: A Comparison of Quantification Methods.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


  1002. MENEZES LJ , Kotze CW, Agu O, Richards T, et al
    Investigating Vulnerable Atheroma Using Combined 18F-FDG PET/CT Angiography of Carotid Plaque with Immunohistochemical Validation.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


  1003. HATT M , Cheze-le Rest C, van Baardwijk A, Lambin P, et al
    Impact of Tumor Size and Tracer Uptake Heterogeneity in 18F-FDG PET and CT Non-Small Cell Lung Cancer Tumor Delineation.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


  1004. LEMOINE L , Andries J, Le Bars D, Billard T, et al
    Comparison of 4 Radiolabeled Antagonists for Serotonin 5-HT7 Receptor Neuroimaging: Toward the First PET Radiotracer.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


  1005. KUMAR SR , Gallazzi FA, Quinn TP, Deutscher SL, et al
    64Cu-Labeled Peptide for PET of Breast Carcinomas Expressing the Thomsen-Friedenreich Carbohydrate Antigen.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


  1006. VOS FJ , Bleeker-Rovers CP, Kullberg BJ, Adang EM, et al
    Cost-Effectiveness of Routine 18F-FDG PET/CT in High-Risk Patients with Gram-Positive Bacteremia.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


  1007. KERSEMANS V , Thompson J, Cornelissen B, Woodcock M, et al
    Micro-CT for Anatomic Referencing in PET and SPECT: Radiation Dose, Biologic Damage, and Image Quality.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


  1008. FOX JJ , Autran-Blanc E, Morris MJ, Gavane S, et al
    Practical Approach for Comparative Analysis of Multilesion Molecular Imaging Using a Semiautomated Program for PET/CT.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


  1009. HAUG AR , Rominger A, Mustafa M, Auernhammer C, et al
    Treatment with Octreotide Does Not Reduce Tumor Uptake of 68Ga-DOTATATE as Measured by PET/CT in Patients with Neuroendocrine Tumors.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


  1010. SZANDA I , Mackewn J, Patay G, Major P, et al
    National Electrical Manufacturers Association NU-4 Performance Evaluation of the PET Component of the NanoPET/CT Preclinical PET/CT Scanner.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


  1011. PAPPAS V
    Reaching outside of our community.
    J Nucl Med. 2011;52:32N.
    PubMed     Text format    


  1012. ROWE C
    Neurosciences.
    J Nucl Med. 2011;52:22N-9N.
    PubMed     Text format    


  1013. SCHWAIGER M
    Cardiovascular.
    J Nucl Med. 2011;52:15N-22N.
    PubMed     Text format    


  1014. CARTER EA , Bonab AA, Paul K, Yerxa J, et al
    Association of heat production with 18F-FDG accumulation in murine brown adipose tissue after stress.
    J Nucl Med. 2011;52:1616-20.
    PubMed     Text format     Abstract available


  1015. PAUL M , Wichter T, Kies P, Gerss J, et al
    Cardiac sympathetic dysfunction in genotyped patients with arrhythmogenic right ventricular cardiomyopathy and risk of recurrent ventricular tachyarrhythmias.
    J Nucl Med. 2011;52:1559-65.
    PubMed     Text format     Abstract available


  1016. AXENTE M , He J, Bass CP, Hirsch JI, et al
    Comprehensive approach to coregistration of autoradiography and microscopy images acquired from a set of sequential tissue sections.
    J Nucl Med. 2011;52:1621-9.
    PubMed     Text format     Abstract available


  1017. CHEEBSUMON P , van Velden FH, Yaqub M, Frings V, et al
    Effects of image characteristics on performance of tumor delineation methods: a test-retest assessment.
    J Nucl Med. 2011;52:1550-8.
    PubMed     Text format     Abstract available


  1018. GLASER JE , Chamarthy M, Haramati LB, Esses D, et al
    Successful and safe implementation of a trinary interpretation and reporting strategy for V/Q lung scintigraphy.
    J Nucl Med. 2011;52:1508-12.
    PubMed     Text format     Abstract available


    September 2011
  1019. LIGA R , Marini C, Coceani M, Filidei E, et al
    Structural Abnormalities of the Coronary Arterial Wall--in Addition to Luminal Narrowing--Affect Myocardial Blood Flow Reserve.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


  1020. SEGALL G
    Planning for the future of nuclear and molecular imaging.
    J Nucl Med. 2011;52:23N.
    PubMed     Text format    


  1021. ROYAL HD
    Updates from the ABNM.
    J Nucl Med. 2011;52:18N.
    PubMed     Text format    



  1022. Recall of CardioGen-82.
    J Nucl Med. 2011;52:17N.
    PubMed     Text format    



  1023. New SNM/SNMTS officers.
    J Nucl Med. 2011;52:15N-7N.
    PubMed     Text format    


  1024. ROUZET F , Bachelet-Violette L, Alsac JM, Suzuki M, et al
    Radiolabeled fucoidan as a p-selectin targeting agent for in vivo imaging of platelet-rich thrombus and endothelial activation.
    J Nucl Med. 2011;52:1433-40.
    PubMed     Text format     Abstract available


  1025. DI CARLI MF , Charytan D, McMahon GT, Ganz P, et al
    Coronary circulatory function in patients with the metabolic syndrome.
    J Nucl Med. 2011;52:1369-77.
    PubMed     Text format     Abstract available


  1026. LEYTON JV , Hu M, Gao C, Turner PV, et al
    Auger electron radioimmunotherapeutic agent specific for the CD123+/CD131- phenotype of the leukemia stem cell population.
    J Nucl Med. 2011;52:1465-73.
    PubMed     Text format     Abstract available


  1027. GRIMES J , Celler A, Birkenfeld B, Shcherbinin S, et al
    Patient-specific radiation dosimetry of 99mTc-HYNIC-Tyr3-octreotide in neuroendocrine tumors.
    J Nucl Med. 2011;52:1474-81.
    PubMed     Text format     Abstract available


    August 2011
  1028. HEISS WD , Raab P, Lanfermann H
    Multimodality Assessment of Brain Tumors and Tumor Recurrence.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


  1029. STADLBAUER A , Hammen T, Grummich P, Buchfelder M, et al
    Classification of peritumoral fiber tract alterations in gliomas using metabolic and structural neuroimaging.
    J Nucl Med. 2011;52:1227-34.
    PubMed     Text format     Abstract available


  1030. MCAFEE J
    50 years ago in JNM.
    J Nucl Med. 2011;52:19N.
    PubMed     Text format    


  1031. KNIGHT LC
    Molecular imaging curriculum overdue.
    J Nucl Med. 2011;52:19N.
    PubMed     Text format    


  1032. ZIESSMAN HA , Tulchinsky M, Maurer A
    Consensus report on standardization of sincalide cholescintigraphy.
    J Nucl Med. 2011;52:16N.
    PubMed     Text format    


  1033. VARRONE A , Stepanov V, Nakao R, Toth M, et al
    Imaging of the striatal and extrastriatal dopamine transporter with (18)F-LBT-999: quantification, biodistribution, and radiation dosimetry in nonhuman primates.
    J Nucl Med. 2011;52:1313-21.
    PubMed     Text format     Abstract available


  1034. BENGEL FM
    Imaging targets of the sympathetic nervous system of the heart: translational considerations.
    J Nucl Med. 2011;52:1167-70.
    PubMed     Text format     Abstract available


  1035. FOLKERSMA H , Boellaard R, Yaqub M, Kloet RW, et al
    Widespread and prolonged increase in (R)-(11)C-PK11195 binding after traumatic brain injury.
    J Nucl Med. 2011;52:1235-9.
    PubMed     Text format     Abstract available


  1036. VILLEMAGNE VL , Ong K, Mulligan RS, Holl G, et al
    Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias.
    J Nucl Med. 2011;52:1210-7.
    PubMed     Text format     Abstract available


    July 2011
  1037. TOYOHARA J , Nariai T, Sakata M, Oda K, et al
    Whole-Body Distribution and Brain Tumor Imaging with 11C-4DST: A Pilot Study.
    J Nucl Med. 2011.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


All AMEDEO services are free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Amedeo is a Flying Publisher website.

   Design: